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ABSTRACT

Arsenic is a pervasive environmental contaminant derived from both natural and
anthropogenic sources. Epidemiological evidence supports a correlation between arsenic
exposure in drinking water and increased rates of psychiatric disorders, including
depression, in exposed populations. Previous studies have established that perinatal
exposure to arsenic (through all three trimesters of fetal/neonatal development, DAE) has
long-lasting consequences into adulthood including deficits in learning and memory,
molecular aberrations in the hypothalamic-adrenal-pituitary (HPA) axis, and depressivelike symptoms in mice. The studies described in this dissertation were designed to assess
the impact of DAE on adult hippocampal neurogenesis (AHN) as a possible mechanism
of action for arsenic-induced susceptibility to depression.
v

Three sets of experiments were developed to test the hypothesis that DAE induces
aberrant epigenetic regulation of neuronal genes involved in AHN leading to depressivelike symptoms. First, arsenic-induced morphological and functional damage to the
hippocampus was assessed: DAE reduced differentiation and survival of neural
progenitor cells in the dentate gyrus (DG) of the hippocampus and induced depressivelike behaviors after exposure to a predator odor (2,4,5-trimethylthiazoline, TMT) in adult
male offspring. DAE also blunted the HPA axis stress response, as measured by plasma
corticosterone levels, after TMT exposure. Second, two treatment paradigms,
environmental enrichment (EE) or chronic treatment with fluoxetine, were performed to
determine the reversibility of damage and the causality of aberrant AHN as a mechanism
of action. Both treatments ameliorated deficits in AHN, while fluoxetine prevented
depressive-like behaviors and reversed arsenic-blunted stress responses in exposed
animals. Third, morphological deficits in AHN were associated with abnormal gene
expression in the DG of several factors in pathways associated with neurogenesis. Global
histone

modifications

and

next-generation

sequencing

following

chromatin

immunoprecipitation (ChIP-Seq) were performed to assess the regulation of gene
expression in the DG. DAE increased levels of activating histone marks, including H3K4
trimethylation and H3K9 acetylation, specifically in the DG of adult males, with altered
expression of their respective chromatin modifiers, Mll1 and GCN5/PCAF. ChIP-Seq
analysis is currently underway to demonstrate the specific genes associated H3K4
trimethylation (indicative of increased gene expression) after DAE in the DG. The
research presented in this dissertation demonstrates that aberrant AHN is a likely
candidate for DAE-induced hippocampal damage leading to greater susceptibility to

vi

stress-induced depression in adulthood via aberrant epigenetic regulation of gene
expression. These studies provide a basis for investigating the effect of DAE on
epigenetic programming during embryonic development leading to neurogenic deficits
observed in adulthood.
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1.0 Epigenetic regulation of adult neurogenesis as a mechanism for
arsenic-induced susceptibility to depression
1.1 Arsenic exposure and neurological function: an introduction
1.1.1 Arsenic in the environment
Arsenic is a common, pervasive environmental contaminant that affects almost every
major organ system in the body including the brain. Exposure to arsenic mainly occurs
through ingestion of contaminated food or water in which arsenic accumulates due to 1)
natural sources such as the leaching of arsenic from geological features and 2)
anthropogenic sources including industrial activities (i.e. burning of fossil fuels and
smelting processes) and the use of products containing arsenic like herbicides, pesticides,
wood preservatives, animal feeds, and semiconductors (EPA, 2014). Currently, the World
Health Organization (WHO) considers a safe limit of 10 µg/L (parts-per-billion, ppb)
arsenic in drinking water with a maximum permissible level of 50 µg/L (ppb). Despite
these guidelines, arsenic exposure is a worldwide health concern as several millions of
people are exposed to this metalloid at levels that well exceed the WHO standard; even
still, epidemiological evidence suggests that low-level exposure to arsenic (in the ppb
range) can be harmful to humans (Zierold et al., 2004). Additionally, exposure can occur
via several unregulated sources in which high concentrations of arsenic can be found:
these include everyday products like wood varnish and fruit juice (Wilson et al., 2012).
Further, several countries including China, India, and Bangladesh do not have access to
arsenic-free water and as such, the mass poisoning of these populations due to high
amounts of arsenic in ground water is considered one of the most insidious worldwide
health epidemics.
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1.1.2 Arsenic metabolism
Inorganic arsenic, found in drinking water, exists in two oxidation states as As3+
(arsenite) and As5+ (arsenate), both of which readily accumulate in the body. Arsenite is
more toxic than arsenate as it reacts with thiol groups in proteins and crosses cellular
membranes, but both inorganic forms are considerably more toxic than their organic
arsenical counterparts such as arsenobetaine, found in marine life (Marchiset-Ferlay et al.,
2012). While absorption of arsenic mainly occurs in the intestines via ingestion of
arsenic-contaminated food or drinking water, some exposure can occur via absorption
through the skin or inhalation via activities such as mining and ore smelting. Regardless
of method of exposure, arsenic can accumulate in the heart, lungs, kidneys, liver, muscles,
and brain (Singh et al., 2011). Uptake of arsenic occurs adventitiously via transport
systems that have developed for other metals such as selenium and phosphate or via
transport proteins such as aquaporins and glucose transporters (Liu et al., 2006; Rosen &
Liu, 2009). Arsenic biotransformation after ingestion includes several metabolic REDOX
reactions and associated methylation steps to form six arsenical species that are excreted
from the body; these include the trivalent and pentavalent forms of inorganic arsenic and
the mono- and dimethylated metabolites of each inorganic form. Several studies have
demonstrated that the speciation of arsenic, not only the total exposure, impacts type and
severity of molecular dysfunction (Dodmane et al., 2013; Wang et al., 2014).
Additionally, the enzymes responsible or the metabolism of arsenic also play a role in the
development of arsenic-related diseases; for example, a particular haplotype of arsenic
methyltransferase AS3MT (for the monomethylation of the trivalent form, MMA(III)) is
associated with more efficient metabolism of arsenic (Engstrom et al., 2013).
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Detoxification of arsenic after exposure actually produces more toxic species (conversion
of arsenate to arsenite) using glutathione (GSH) and other thiol groups as reducing agents.
The conversion to arsenite allows arsenic to pass through cellular membranes, as the
ionization of As5+ at physiological pH levels prohibits this passage. Arsenite is then
distributed throughout tissues into cytosol where it undergoes methylation, which is
catalyzed by S-adenosyl methionine (SAM), the universal methyl donor cofactor. Arsenic
is thought to deplete the levels of SAM in the body, particularly under chronic exposure
conditions, leading to hypomethylation of DNA and other aberrant epigenetic processes
including histone posttranslational modifications that require methyl groups (Ren et al.,
2011). However, the mechanisms by which arsenic impedes epigenetic processes are still
under investigation.

1.1.3 Arsenic-induced neurotoxicity
Paradoxically, arsenic has been used as both poison and a therapeutic for centuries.
Currently, arsenic trioxide (As2O3) is used to treat refractory or relapsed acute
promyelocytic leukemia (APL), which is a variant of acute myeloid leukemia (AML).
Arsenic readily crosses the blood brain barrier and thus leads to remission of symptoms
for APL patients with central nervous system (CNS) involvement (Kiguchi et al., 2010).
Yet, arsenic’s reputation is predominately nefarious: it acts as a co-carcinogen, and while
it may be useful or APL patients, arsenic induces severe CNS damage resulting in both
peripheral and central neuropathies. Chronic exposure to arsenic results in
encephalopathy and toxic delirium with deficits in neurological functioning including
learning, short-term memory, and concentration. Low doses often impair psychomotor
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speed and attention, with particularly adverse effects on verbal processing and learning
(Vahidnia et al., 2007). Epidemiological studies on arsenic exposure and common
neurological outcomes including deficits in learning and memory and the increased
incidence of psychiatric disorders like depression will be discussed in detail in Chapter 2.

The mechanisms by which arsenic induces neurotoxicity are still under investigation:
these include increased oxidative stress and interference with protein expression and
function leading to disordered brain structure and increased neurodegeneration. Arsenic
toxicity induces the release of reactive oxygen species and lipid peroxidases, which are
concurrent with decreased levels of superoxide dismutase and glutathione (Singh et al.,
2011). Aberrant protein expression and function after arsenic exposure is associated with
axonal deterioration and degeneration of dopaminergic neurons and increased apoptosis
via activation of the MAPK pathway in cerebral neurons (Namgung & Xia, 2001;
Vahidnia et al., 2008). Additionally, the expression and metabolism of several
neurotransmitters are impacted by arsenic exposure: these include acetylcholine,
glutamate, adrenaline, noradrenaline, dopamine, and serotonin in specific brain regions
including the frontal cortex and hippocampus, two regions associated with mental health
disorders like depression (Tyler & Allan, 2014). The possible mechanisms of arsenicinduced neurotoxicity and the rodent and human studies that have been done to elucidate
these mechanisms will be discussed in greater detail in Chapter 2.

4

1.1.4 Developmental arsenic exposure and depression
As the neuropathies associated with arsenic exposure have been well characterized, for
the purposes of this dissertation, the connection between arsenic exposure and major
depressive disorder (depression) will be the predominant focus. Research has established
that depression is linked with the imbalance of amino acids, neurotransmitters, thyroid
and adrenal hormones, nutrients and minerals, and fatty acids; however, the role of
environmental factors in the etiology of depression, including toxins like arsenic is still
under investigation. Exposure to lead, mercury, cadmium, manganese and arsenic have
all been linked to the onset of depression, likely via altered neurobiological mechanisms
in the CNS (Onishchenko et al., 2008; Bowler et al., 2011; Haider et al., 2013;
Scinicariello & Buser, 2014). As such, this dissertation will explore the mechanisms of
arsenic-induced toxicity in the etiology of depression. It should be noted that the model
of arsenic exposure used throughout these studies is that of developmental exposure to 50
ppb arsenic during the three trimester equivalents of pregnancy in the mouse model. The
early pre- and postnatal environment has been demonstrated to impact behavior and
susceptibility to psychiatric disorders in adulthood (Hochberg et al., 2011). In several
studies, negative environmental exposures (handling, poor maternal care, stress, toxins)
induce alterations in the offspring’s endocrine stress response and are likely associated
with the behavioral endophenotypes of anxiety and depression (Hellemans et al., 2008;
Stiller et al., 2011; Bolton et al., 2013; Freund et al., 2013). (The term, endophenotype, is
used extensively in the field of psychiatry to denote particular intermediate phenotypes
that are part of a heterogeneous complex illness based on genotype. Endophenotypes are
measurable (molecular, behavioral, physiological) features that contribute to a disease,
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and thus this word is the most appropriate for measures of animal behavior in describing
characteristics of psychiatric disorders (Gottesman & Gould, 2003).) While the exposure
to some environmental factors can be controlled, arsenic exposure, even in low doses, is
unavoidable because of its ubiquitous presence in the environment. Research on arsenic
exposure, hepatic function and the susceptibility to cancer have demonstrated that in
utero arsenic can have long-lasting effects on the molecular biology of an organism well
into adulthood. Therefore, we are interested in how low level exposure to arsenic during
development can impact an offspring’s susceptibility to depression. The following
sections will introduce and discuss depression, its mechanisms of action, including adult
hippocampal neurogenesis and epigenetic regulation of gene expression.

1.2 Depression: an overview
Major depressive disorder (MDD) is the most pervasive mental disorder in the United
States and affects over 350 million people worldwide (Kessler et al., 2005). The World
Health Organization estimates the depression is the most expensive health care burden
and accounts for in excess of 31 billion dollars per year in lost productivity time in the
U.S. alone (Stewart et al., 2003). Currently, mental health assessment utilizes guidelines
established by the Diagnostic and Statistical Manual of Mental Disorders (DSM-V),
published by the American Psychiatric Association. Patients may not have all symptoms,
due to the heterogeneity of MDD; however, the type and severity of depression (rather
than cause) can be distinguished. Two particular features in all depressive cases are 1)
depressed mood with 2) loss of interest or pleasure. At least one of the following
symptoms presents as well: significant alteration in weight along with reduced or
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increased appetite; insomnia or hypersomnia; agitation or psychomotor retardation;
fatigue or loss of energy; feelings of worthlessness or excessive guilt; reduced
concentration; and recurrent thoughts of death or suicide. These symptoms present most
of the day and nearly every day for at least two weeks causing significant distress or
impairment of normal function. Other forms of depression include major depression with
melancholia, a more acute form of major depression in which loss of reactivity is quite
severe; psychotic depression; adjustment disorder with depressed mood; dysthymia;
mixed anxiety and depression; post-natal (or postpartum) depression; and adolescent
depression. Over 50% of patients with MDD suffer from current comorbid psychiatric
disorders including anxiety, bipolar disorder, substance use disorder and personality
disorder (Melartin et al., 2002; Aina & Susman, 2006). While the type and severity of
depressive states differ, current theories offer a few common mechanisms that may
underlie the overall phenotype of “depressive-like” symptoms.

1.2.1 Animal models of depression
Modeling any type of human behavior in a rodent is difficult, but the complexity in
modeling depression is compounded due to the variety of symptoms and the
heterogeneity and unknown etiology of the disease. Recapitulating MDD in a mouse
model requires the simplicity of measured phenotypes that can be reproduced and then
evaluated in a rodent.

McKinney and Bunney established three sets of criterion in the 1960’s for establishing
valid models of psychiatric diseases; these include face validity, construct validity, and
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predictive validity (McKinney & Bunney, 1969). Each mouse model and subsequent
behavioral assessments to identify depressive-like behaviors or other psychiatric
disorders typically conform to one or more of these criteria. For face validity, the animal
should exhibit symptoms that are similar to those observed in humans as measured using
appropriate behavioral assessments (see below). A mouse model can have good face
validity without appropriate construct (or etiologic) validity, in which the symptoms in
both animals and humans are based on the same neurobiological mechanisms. This is the
most difficult type of criteria for a mouse model of depression since there are several
theories on the etiology of MDD (see sections below). If a model has both appropriate
construct and face validity, then it should respond to pharmacological manipulation to
have predictive validity, in that the animal will respond to treatment similar to humans.
The more criteria that are met by an animal model, the more scientifically valid this
model can be. Thus, for our purposes of the arsenic exposure paradigm, to determine that
these animals have what we term “depression”, we must be able to detect depressive-like
behaviors using appropriate behavioral assays (face validity), observe similar disease
progression and neurobiological symptoms molecularly (construct validity), and observe
similar response to treatments given to depressed patients (predictive validity).

There are several models of depression used in research today: these include lesion
models where animals are bulbectomized, pharmacological models that use
glucocorticoids or reserpine to induce depressive-like symptoms, genetic models that use
various molecular theories of the etiology of depression as a basis for knock-ins or
knock-outs of gene function, and stress models in which different types of stress (chronic,
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intermittent, restraint, etc.) are used to induce a depressive-like state. Discussing each of
these models is beyond the scope of this introduction, as we are not attempting to create a
model using arsenic, but rather assess the effect of arsenic on the risk of developing
depression. In humans, chronic arsenic exposure has been correlated with an increased
risk of depression, while adult rodent offspring exposed to arsenic during the perinatal
period exhibit depressive-like symptoms in traditional behavioral assessments (see
below) and demonstrate face validity. Thus, in order to establish that arsenic induces
depression in a rodent model, we must demonstrate etiologic validity (i.e. molecular
mechanisms of depression) and predictive validity (responses to antidepressants). These
criteria have been assessed in Aim 1 of these dissertation studies.

1.2.2 Behavioral assessments of depression
To determine if a rodent model achieves these criteria set by McKinney and Bunney and
demonstrates endophenotypes associated with depression appropriate behavioral
assessments must be conducted. However, each behavioral assessment has its own
limitations. As depression can be characterized (in humans) as having at least the overall
criteria of depressed mood and loss of pleasure (anhedonia), behavioral assays have been
developed to measure these symptoms in rodents. While animals cannot have a
“depressed” mood, there are three particular paradigms in which despair-based behavior
can be construed as “depression”; these include the forced swim task (FST), the tail
suspension task (TST), and learned helplessness (LH) task. These three assessments are
based on the hypothesis that animals will attempt to escape aversive stimuli, and lack of
escape may be indicative of depressive-like behavior (Crawley, 2007).
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When rodents are placed in water they all exhibit acute escape behaviors including
climbing and swimming; after a period of time, these behaviors cease and the rodents
display immobility. The latency to cease swimming and the total immobility can be
considered a measure of depression compared to control counterparts. This task was
developed in the 1970’s and is referenced as the Porsolt forced swim task; experience in
the FST can induce this “despair” based behavior in rodents, which will display increased
immobility and decreased latency if they have undergone chronic uncontrollable stress
(stress model of depression). Additionally, animals provided antidepressants typically
exhibit active escape behavior longer than control counterparts given a vehicle drug. The
tail suspension task is used to measure escape oriented behaviors as well; however, this
task is not appropriate for rodent strains like the C57BL/6 mice used in our studies that
naturally exhibit tail climbing behavior (Mayorga & Lucki, 2001). In both tasks, lack of
active coping behavior (swimming or climbing) is interpreted as depressive-like behavior.
However, it should be noted that there is some disagreement in the behavioral
neuroscience field as to whether immobility observed in the FST is actually depression or
simply a passive stress coping behavior. Additionally, some researchers purport that the
FST assesses stress-induced anxiety rather than depression, as it is unlikely that a short
period of inescapable stress induces depression in a wild type mouse. However, the FST
in particular provides good predictive validity for antidepressant compounds and is thus
used for high throughput screening of potential therapeutics (Dedic, 2011). Another form
of inescapable stress that results in passive versus active coping responses is the learned
helplessness task. Animals are exposed to uncontrollable and unpredictable aversive
shocks for a sufficient period of time that will result in deficits in escape behaviors; after
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a period of time, animals are provided with a means to escape the shock. The measure of
1) latency to escape the shock and 2) the attempts to escape are indicative of “learned
helplessness”. The rodent learns that it has no control over the shock stimulus and is
helpless to avoid the stressor; this acquired behavior is quite long-lasting in animals and
is considered closer to a model of depression due to appropriate face validity (Buccafusco
& Buccafusco, 2009). This theory of learned helplessness, developed by Martin E.P.
Seligman, was based on the notion a depressed individual believes that the outcome of a
situation is independent of his or her actions and thus feels powerless in a situation
(Seligman, 1972). The learned helplessness task also provides appropriate predictive
validity in response to antidepressants, and thus was used for behavioral despair
assessments in the studies described in this dissertation (Chourbaji et al., 2005).

1.2.3: Confounding factors in depression assessments
Since excessive anxiety can emerge as part of depression and many patients with some
form of depression have comorbid anxiety symptoms, it is difficult to distinguish
between the two in certain behavioral assessments (Berton & Nestler, 2006). For example,
increased anxiety-like behavior can emerge as hyperlocomotion leading to increased
active swimming behavior in the FST (and thus decreased immobility); this behavior
could then be interpreted lack of depressive-like symptoms (Gardier & Bourin, 2001).
Depression is considered a pathological condition, whereas anxiety may be construed as a
normal cognitive response to certain situations. Anxiety behavior activates the stress
response, which an animal can use to initiate mobility in response to a threat; this
response may be considered protective on some level (Dedic, 2011). However, excessive

11

anxiety in response to stimuli not considered threatening can evolve into an anxiety
disorder and may be part of a depressive phenotype. For our purposes here, we will only
discuss anxiety measures that are related to depression.

Mice are naturally inquisitive and inclined to explore novel environments, although they
do show aversion to well-lit environments. Thus, the time exploring an open well-lit area
can be used to determine level of anxiety and locomotion. Arsenic differentially impacts
locomotion, with low levels resulting in increased locomotion and high levels resulting in
decreased locomotion (See Chapter 2); thus assessment of behavior in an open area can
be used for analysis of alterations in locomotion that might play a role in the response to
behavioral tasks aimed at determining depressive-like behavior. The open field test
(OFT), or novel exploration of an unknown area, is typically used for determining state
anxiety, while trait anxiety is determined by measuring exploration of an environment the
animal has already been habituated to (or the second day of the OFT). This behavioral
task takes advantage of conflicting tendencies: avoidance of a potentially dangerous area
that is brightly lit and the inherent exploration of novel environments (Dedic, 2011).
Additionally, the open field test has been used extensively for prediction of anxiolytic
outcomes of various drugs; however, the use of the elevated plus maze and the light/dark
box is more common (Griebel & Holmes, 2013).

Anhedonic behavior, indicative of loss of pleasure for normally rewarding activities
including sexual experience and consumption, can be measured in animal models as
indicative of depressive-like behavior. Chronically stressed animals that display
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depressive-like symptoms in other behavioral tasks also lack normal responses to
typically rewarding stimuli. The preference for highly palatable foods, including sugar,
can be used to characterize hedonic behavior; this test is called the sucrose consumption
test and assesses the preference for the sugar solution over water. However, as with other
measures, there are confounds with this assessment, in that food and water deprivation
preceding the test for 18-24 hours may affect the behavior and thus the interpretation of
reduced sucrose preference (Mateus-Pinheiro et al., 2014). Additionally, the metabolic
and sensory influence of such a task cannot be ruled out either, and some literature
suggests that sucrose preference lacks predictive validity (Forbes et al., 1996). In general,
mice display depressive-like symptoms manifested as decreased sucrose consumption,
decreased ability to perceive associations between environment and reward (conditioned
place preference), and decreased sensitivity to brain stimulation (self-stimulation) (Dedic,
2011).

1.2.4 Heritability versus environmental factors in the etiology of depression
The etiology of major depressive disorder, while extensively studied, is not well
understood. As a result, of the 41 million people treated for MDD patients in the US, only
30% report receiving relief from depressive symptoms (NIMH, 2014). Many MDD
patients never obtain full remission of symptoms likely due to biological variation of
individuals. Indeed, the most recent genome wide association study (GWAS) on major
depressive disorder reported that heritability only accounts for 40% of MDD cases and
that no common genetic variant (specific loci reaching GWAS significance) is associated
with MDD (Major Depressive Disorder Working Group of the Psychiatric et al., 2013).
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While single nucleotide polymorphisms (SNPs) have been identified in many of the
MDD cases, including in genes associated with Wnt and serotonin signaling, thus far,
none of the analyses have sufficient power and only account for a small proportion of
heritability. Further, monozygotic twin studies of depression demonstrate high
discordance of the disorder and individual variability in gene expression (Byrne et al.,
2013). The non-genetic risk of development of depression is poorly defined, but typically
emerges as a manifestation from many common experiences including childhood trauma,
emotional stress, physical illness, and even viral infections. As such, the role of
environmental factors in the etiology of MDD is widely acknowledged but still requires
further investigation.

Depression has mostly been studied in the context of stress-induced depression, using
mouse models; yet maladaptation to stress leading to depression is highly variable, and
very little is known about what makes some individuals more “resilient” to stress or
adversity and others more vulnerable to it (Krishnan & Nestler, 2008). Over that past few
decades, toxins like arsenic have been implicated in the pathophysiology of depression,
as epidemiological studies have demonstrated significant correlations among individuals
exposed to toxins and the incidence of depression. These studies are discussed in detail in
Chapter 2. They have collectively provided convincing data that arsenic exposure may
underlie some of the MDD cases around the world. However, the mechanism by which
arsenic imparts this toxicity on the brain to induce a depressive-like endophenotype is
still under investigation by our lab and others.
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1.2.5 Antidepressant actions give rise to the monoaminergic hypothesis of depression
The current state of the literature on the pathology of depression is mostly derived from
the pharmacology of the antidepressants used to treat MDD patients. As with many
scientific discoveries, the antidepressant actions of compounds were serendipitously
found as a side effect in the treatment of other illnesses. Iproniazid, originally developed
for the treatment of tuberculosis, showed significant antidepressant action in TB patients,
while imipramine (Tofranil) was developed as a treatment for schizophrenia (in which it
monumentally failed, but was successful as an antidepressant) (Alamo & Lopez-Munoz,
2009). Iproniazid, an irreversible nonselective monoamine oxidase inhibitor (MAOi),
prevents the breakdown of several monoamine neurotransmitters or biogenic amines
including catecholamines (dopamine, norepinephrine, adrenaline) and indolamines
(serotonin, melatonin, histamines). Imipramine, a tricyclic antidepressant (TCA), acts
primarily on the serotonin transporter (SERT) and has affinity for the norepinephrine
transporter (NET) and some affinity the dopamine transporter (DAT). The use of these
drugs that modulate monoaminergic function, while initially developed for other
treatments, improved depression in as many as 50% of treated patients (though some with
severe side effects). This favorable response to these monoaminergic agents gave rise to
the “monoamine hypothesis of depression”, suggesting that depression is caused by
deficits in monoaminergic signaling particularly the noradrenergic and serotonergic
pathways (Krishnan & Nestler, 2008).

The serotonergic system modulates several behavioral and physiological responses in the
body, including the modulation of mood, emotion, sleep, and appetite. In the context of
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depression, it is thought that synaptic serotonin levels are depleted; thus, many
antidepressant drugs pharmacologically block the reuptake transporters in presynaptic
neurons. This allows for increased extracellular concentration of serotonin in the synaptic
cleft leading to greater interaction with serotonin receptors on the postsynaptic cell,
ultimately alleviating depressive symptoms (See Figure 1.1). Further support for this
hypothesis derives from a subset of patients who developed depression after treatment
with an antihypertensive drug called reserpine, whose main mode of action is the
depletion of monoamines (Krishnan & Nestler, 2008). Currently, the use of TCAs and
MAOIs has declined as new drugs, particularly selective serotonin reuptake inhibitors
(SSRIs) like fluoxetine and paroxetine, which have fewer side effects,

Figure 1.1. Selective serotonin reuptake inhibitors are commonly used as antidepressants. (CNS
Forum)
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have dominated the market for their efficacy and selectivity. While the pharmacological
actions of these drugs are quite rapid, with plasma levels of serotonin increasing within
thirty minutes of administration of the drug, the alleviation of depressive symptoms takes
several weeks, suggesting that the pathophysiology of depression is more complicated
than the monoamine hypothesis purports.

1.2.6 The neurogenic hypothesis of depression
Postmortem analysis of patients with depression has demonstrated alterations in the
structure of the hippocampus, particularly neuronal atrophy and reduced granule cell
numbers (with normal progenitor cell populations) in the dentate gyrus (Duman, 2002).
MDD patients treated with SSRIs however do not exhibit hippocampal atrophy or
reduced cell numbers compared to untreated patients (Boldrini et al., 2013). Additionally,
the dentate gyrus of the hippocampus preferentially responds to antidepressant treatment
with a concurrent rise in the number of neural progenitor cells and subsequent number of
granule neurons at the same time of alleviation of behavioral symptoms. As such, the
neurogenic hypothesis of depression asserts that newborn neurons in the hippocampus are
required for efficacy of antidepressants and regulation of mood (Eisch & Petrik, 2012).

Seminal studies determined that intact neurogenesis was required for the efficacy of
antidepressants, including fluoxetine, for amelioration of depressive-like symptoms in
rodent models (Malberg et al., 2000; Malberg & Duman, 2003; Santarelli et al., 2003).
Additionally, chronic fluoxetine treatment increases survival of neural progenitor cells in
control animals (Wang et al, 2008), and attenuates certain stress-induced depressive
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behaviors via neurogenic mechanisms in adult rodents (David et al., 2009). The delay
between the initiation of antidepressant treatment, like fluoxetine, and the alleviation of
depressive-like behavior in rodents and humans is comparable to the amount of time
required for maturation of a newborn neuron, approximately 4-6 weeks (Santarelli et al.,
2003; Eisch et al., 2008). Further, adult neurogenesis (as discussed below) is extremely
sensitive to modulation of the stress axis (hypothalamic-pituitary-adrenal axis, HPA),
with increased stress leading to concurrent decreases in neurogenesis along with
increased depressive-like behaviors in rodents.

Indeed, as with the monoamine hypothesis, there are several caveats: in some studies,
ablation of newborn neurons in the hippocampus did not result in depressive-like
symptoms in rodents. Some antidepressants seem to have an effect on mood independent
of adult neurogenesis though this varies based on the type of behavioral assessment used
to measure depressive-like symptoms (David et al., 2009). However, there are a number
of studies demonstrating the functional importance of adult neurogenesis in the
hippocampus in which cognition is greatly diminished after ablation and subsequent risk
of psychiatric disorders increases. The strongest evidence of the role neurogenesis plays
in depression is that 1) treatments that ameliorate depressive-like symptoms in rodent and
in humans normalize aberrant neurogenesis, 2) blocking neurogenesis inhibits the
molecular and behavioral responses to antidepressants in rodent models, and 3) the one
common underlying external factor associated with depression, namely stress, has
deleterious effects on neurogenesis correlated with increased incidence of depression
(Hsieh & Eisch, 2010).
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1.2.7 The contribution of stress in the etiology of depression
The contribution of environmental factors in the etiology of depression is quite high as
the genetic risk for developing depression is only 40 percent. Environmental factors can
include toxin exposure (discussed later), gender, adverse childhood experiences, trauma,
personality traits, and stressful life events. Many epidemiological studies suggest a
correlation between stressful events and an increased risk for developing depression.
Everyone experiences stress differently such that the vulnerability to depression is quite
difficult to assess; however, there are molecular indications of the association between
stress and depression that are common among humans and rodent models.

1.2.7.1 The hypothalamus-adrenal-pituitary axis
A stressor is considered any (real or imaginary) disturbance in homeostasis for an
organism. The neuroendocrine and autonomic responses to a stressor are coordinated
through hypothalamic-pituitary-adrenal (HPA) axis (See Figure 1.2). Classically, the
initiation of the stress response begins in the paraventricular nucleus (PVN) of the
hypothalamus (though there is some evidence of frontal cortex initiation); PVN neurons
excrete adrenocorticotrophin releasing hormone (CRH) and arginine vasopressin into the
pituitary gland. These hormones induce the release of adrenocorticotropic hormones
(ACTH) from the anterior pituitary, which act on the adrenal cortex to stimulate synthesis
and secretion of glucocorticoids (corticosterone in rodents and cortisol in humans).
Glucocorticoid production and secretion then modulates the feedback inhibition of the
stress response by interaction with glucocorticoid and mineralocorticoid receptors (GR
and MR) in various tissues, including almost all structures in the brain in addition to the
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components of the HPA axis itself (cortex, hippocampus, and pituitary gland). Activation
of GR and MR in the frontal cortex and hippocampus, in particular, provides negative
feedback on the HPA axis and reduces the tone of the stress response (Tsigos & Chrousos,
2002; Joels & Baram, 2009).

Figure 1.2. The hypothalamic-adrenal-pituitary axis regulates the stress response. (Adapted from
Hyman, 2009)

A recent meta-analysis of 414 studies on the relationship between HPA dysfunction and
depression suggests that depression is highly correlated with hyperactivity of the HPA
axis, although the variability of this association is dependent on subtypes of depression
(Stetler & Miller, 2011). The authors determined that in the studies assessed, a majority
of depressed patients had elevated cortisol and ACTH compared to non-depressed
controls; however, they did not find a correlation between altered CRH, although many
studies have reported reduced levels of CRH in depressed patients. It should be noted that
20

among the studies assessed, different factors might affect the methodologies in measuring
these hormones including tissue type, time of day, age, and subtype of depression. Yet,
the prevailing theory is that hyperactivity of the HPA axis is due (in part) to reduced
feedback by endogenous glucocorticoids: depressed patients given dexamethasone (DEX,
a synthetic glucocorticoid) do not exhibit suppression of HPA activity, while healthy
patients respond readily to even small doses of DEX, indicative of appropriate feedback
inhibition as measured by reduced cortisol levels up to 24 hours later (Pariante &
Lightman, 2008). Additionally, reduced GR function in various tissues, including the
brain, has been measured in patients with successful antidepressant therapies typically
associated with increased GR expression. There is sufficient evidence in the literature
that excessive stress exposure, mediated through increased levels of cortisol and eventual
HPA axis dysfunction, damages brain structures and their function, leading to impaired
plasticity and a subsequent endophenotype of depression (Stepanichev et al., 2014).
Using the arsenic exposure paradigm described above, the Allan lab has found many
perturbations in the stress axis that provide evidence suggesting that arsenic induces
dysregulation of the HPA axis (Goggin et al., 2012). Yet, how these perturbations
eventually lead to depression is unknown and currently under investigation.

1.2.7.2 Stress inhibits neurogenesis
Dysregulation of the HPA axis in depressed patients has been reported in many studies,
though the particular neurobiological mechanism likely varies as both hyper- and hypoactivity of the HPA have been reported (Anacker et al., 2011a). One mechanism by
which stress leads to increased depression is via perturbation of adult neurogenesis; that

21

is, the cascade of reduced negative feedback inhibition in response to stress likely
contributes the neurogenic hypothesis of depression. Neurogenesis is highly sensitive to
many factors (as discussed later), particularly stress. Several animal models of depression
induced by acute or chronic stressors concurrently reduce adult neurogenesis (Cameron
& Gould, 1994; Malberg & Duman, 2003; Yun et al., 2010). Indeed, even in nondepressed animals, social isolation, chronic social defeat stress, or even sleep deprivation
result in deficits in neurogenesis. One form of acute stress that will be used in these
dissertation studies is brief exposure to a predator odor (trimethylthiazoline, TMT, a
component of fox urine), which activates the HPA axis, produces anxiety-like behavior,
and after chronic exposure, decreases many components of neurogenesis. There have
been a few conflicting reports as to the effect of stress on neurogenesis, however, these
are likely due to species variation and non-standardized methods (Danzer, 2012). The
mechanism by which stress reduces neurogenesis is still under investigation; however,
one common theory is that reduced granule cell number results in loss of GR and MR
leading to impaired modulation of HPA axis feedback, particularly in response to the
DEX test (Snyder et al., 2011). The next section will discuss neurogenesis in greater
detail as a candidate mechanism of toxin-induced depression.

1.3 Adult neurogenesis: a candidate mechanism of action
Adult neurogenesis can be broadly defined as the birth of new neurons from existing
neural stem cells that functionally incorporate into the surrounding neural circuitry. This
mechanism of neuronal birth was previously thought to occur only during the embryonic
and perinatal stages of life in the brain, as the brain was perceived to be a stable, rigid
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structure as perpetuated by Ramon y Cajal. Research from Altman and Das in 1965
challenged the prevailing theory of the rigidity of the brain, but it was not until the 1990’s,
due to the advent of a lineage tracer bromodeoxyuridine (BrdU), when several groups
simultaneously published observations of newborn neurons in the brains of songbirds and
adult mammals including humans (Eriksson et al., 1998; Gould et al., 1998; Cameron &
McKay, 2001). Since then, an explosion in research focusing on the mechanisms and
functions of adult neurogenesis has been underway.

1.3.1 Components of adult neurogenesis
Adult neurogenesis occurs in two neurogenic niches in the brain: the subventricular zone
of the lateral ventricles where neuroblasts migrate along the rostral migratory stream to
the olfactory bulb and differentiate into interneurons, and the subgranular zone of the
dentate gyrus in the hippocampus, in which new dentate granule cells are produced (See
Figure 1.3) For the purposes of this introduction, the discussion will focus on adult
hippocampal neurogenesis (AHN).

The process of adult neurogenesis is multifaceted and can be divided into several
components. Each neurogenic niche contains a pool of neural stem cells (NSC; type-1
progenitor cells) with radial-glial like properties that can either symmetrically divide to
maintain the neurogenic niche or asymmetrically divide, undergo fate determination, and
give rise to neural progenitor cells (NPCs). These NPCs, also referred to as transiently
amplifying cells (TAPs or type-2 progenitor cells), migrate into the granule cell layer

23

Figure 1.3. Adult hippocampal neurogenesis is comprised of many phases. (Adapted from Schouten
et al. 2012)

(GCL) and undergo either division themselves to form more progenitors or several stages
of maturation into excitatory glutamatergic granule neurons. Neuroblasts derived from
NPCs exhibit the microtubule associated protein doublecortin (DCX) along with PSANCAM; eventually these newborn neurons elongate their axons and dendritic branches to
establish synaptic connections with mature granule neurons for integration into the
established circuitry. This integration time is approximately four to eight weeks,
depending on the level of “maturation” assessed, and the histological markers NeuN,
calretinin, and calbindin can be used to assess the existence of a mature newborn neurons
(Ming & Song, 2005). Post-natal or adult neurogenesis reflects embryonic neurogenesis,
except that these processes occur in a mature microenvironment and integration occurs
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into pre-existing circuitry (Mateus-Pinheiro et al., 2011). As such, each component of
AHN is heavily regulated and depends on a complex choreography of gene expression.
The various processes of AHN give rise to the heterogeneous cell types that comprise the
dentate gyrus, and several markers can be used to identify each of these stages. During
the mitotic phase of the cell cycle, NSC and NPCs can incorporate BrdU into their DNA
during the replication process (S-phase); this mark is then persistently expressed in all
daughter cells (though it fades as the number of mitotic cycles increases) and can be
detected using immunohistochemistry. Additionally, mitotic activity can be followed
through endogenous Ki67, which is expressed during all phases of mitosis. Combinations
of markers and morphological assessment of labeled cells are used in concert to identify
cell types in the dentate gyrus to determine three overall processes: proliferation of
progenitors, differentiation of those progenitors into immature and mature neurons, and
the survival of these cells over time.

Figure 1.3 depicts some histological markers that can be used to identify the various cell
types within the dentate gyrus. For the studies described in this dissertation, identification
of proliferation can be determined with BrdU, Ki67, PSA-NCAM, while immature and
mature neurons are identifying using DCX and NeuN, respectively. Survival can be
assessed by identifying the BrdU label many weeks after its incorporation in these cells.
It should be noted that progenitor cells can also give rise to glia in a process known as
gliogenesis; thus, fate specification is also a crucial step in the formation of these cells, as
several external factors have been shown to alter the ratio of formation of glia and
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neurons. For our purposes here, we will focus on mechanisms regulating the formation of
neurons and the purpose of those neurons in the context of mental health.

1.3.2 The function of newborn neurons in the context of depression
The dentate gyrus is the first destination in the classic trisynaptic circuitry of the
hippocampus. Glutamatergic granule cells of the dentate function to modulate the
excitatory and inhibitory input from the entorhinal cortex, called the perforant pathway
(Danzer, 2012). Mossy fibers, or the axons from the dentate granule cells, synapse on the
CA3 pyramidal neurons, which provide inputs for the CA1 pyramidal neurons through
their axons, termed the Schaffer collaterals. CA1 neurons then project back into the
entorhinal cortex. Recent evidence suggests that the integration of new neurons in the
dentate gyrus impacts the overall trisynaptic hippocampal circuit. How exactly these new
neurons influence the circuitry, and ultimately, regulate emotion, is not well understood
(Deng et al., 2010); however, recent reports have provided evidence of the effect of new
neurons on learning and memory.

Adult neurogenesis is a form of specialized synaptic plasticity. Newborn neurons are
thought to play distinct roles in certain forms of learning and memory and in mood
regulation (Shors et al., 2002). While many studies have used different ablation strategies,
rodent models, and behavioral tasks, the consensus in the literature seems to be that
newborn neurons, particularly those aged one to three weeks, are important for several
different types of hippocampal-dependent tasks including spatial learning and memory
and pattern separation (Shors et al., 2001; Snyder et al., 2005; Cameron & Glover, 2014).
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Pattern separation, shown to be important in both computational and experimental models
(Deng et al., 2010; Aasebo et al., 2011; Sahay et al., 2011), is of particular interest as
newborn neurons likely aid in episodic memory. In many of the daily experiences we
have, similar episodes or events need to be distinctive from one another in a
spatiotemporal manner in order to remember these events in the appropriate context: this
representation seems to be carried out by newborn neurons (Nakashiba et al., 2012).
Pattern separation may be critical in discerning between past and present experiences, as
memory deficits and incorrect distinctions among events are common for patients with
depression; indeed, a recent study showed a correlation between reduced ability to
accurately complete pattern separation tasks and the severity of depression (Shelton &
Kirwan, 2013). Further, depression is likely due, in part, to inaccurate processing of
stressful events: a recent study by Cameron and Snyder demonstrated that newborn
neurons were required to mediate the stress response and that reduced adult neurogenesis
leads to concurrent inappropriate responses to dexamethasone and increased behavioral
despair (Snyder et al., 2011). The authors suggest that the negative control the
hippocampus imparts on the HPA axis is via this particular subset of newborn neurons;
this is fitting in that stress has been shown to negatively impact AHN and is associated
with an increased risk of developing depression. While the particular role that newborn
neurons play in the context of depression is still under investigation, one prevailing
theory is that overgeneralization observed in several psychiatric disorders, including
anxiety and depression, may derive from reduced AHN (Kheirbek et al., 2012). Since the
hippocampus integrates information from several brain regions, some of which are part of
the limbic system as emotion is tightly associated with memory, newborn neurons likely
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allow for lifelong adaptation to new experiences and remembering those experiences
accurately (Kempermann et al., 2008).

1.3.3 Epigenetic regulation of neurogenesis
The complex processes involved in neurogenesis are orchestrated by interactions among
intrinsic and extrinsic elements, from internal transcription factors and epigenetic
modifications to growth factors and neurotrophins from the surrounding milieu. The
intracellular epigenetic program in particular is responsive to extrinsic physiological
factors and environmental stimuli that allow it to “align” the progression of neurogenesis
with the external demands of cognition (Mateus-Pinheiro et al., 2011). Yet, what is
known about the epigenetic regulation of neurogenesis is limited to select studies
focusing on different epigenetic factors on particular components of neurogenesis; an
overall picture of this regulation has yet to be formulated.

The current state of the literature suggests that the first phase of AHN, adult neural stem
cell proliferation, is epigenetically regulated by the competing interactions of the
trithorax (TrxG) and polycomb (PcG) chromatin modifying enzymes. The polycomb
repressive complexes 1 and 2 (PRC1, PRC2) contain sets of proteins that are recruited to
chromatin targets to catalyze the ubiquitination of histone 2A (H2AUb1) or the
trimethylation of lysine 27 on histone 3 (H3K27me3) for suppression of gene expression,
respectively. How the recruitment to particular targets occurs is not known, and the role
that each protein plays has yet to be elucidated. However, one protein in PRC1 has been
determined to be essential for neural stem cell maintenance: the zinc finger protein, B-
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cell specific Moloney murine leukemia virus integration site 1, or Bmi1, which controls
self-renewal of many different stem cell types in the body including NSCs (Lobo et al.,
2007). Deficits in Bmi1 result in loss of proliferation and renewal capacity via reduced
repression (lack of H3K27me3 or H2AUb1) of genes coding for the cell cycle inhibitors
p16, p19, and p21 (Molofsky et al., 2003). Overexpression of Bmi1 leads to increased
proliferation, at least in one study (Yadirgi et al., 2011). Bmi1 requires EZH2, a protein
in the PRC2, for repression of p16 and p19, suggesting collaboration between PRC1 and
PRC2. EZH2 is expressed in embryonic neural stem cells and expression is lost as these
cells differentiate into neurons; however, its role in adult neurogenesis has not been
determined to date. Loss of either EZH2 or Bmi1 can lead to increased neuronal
production (i.e. differentiation and maturation) but at the expense of a depleted progenitor
pool. Evidence of the function of the PRC1 and PRC2 complexes and their respective
proteins suggest that PcG proteins function to repress the expression of prodifferentiation genes to maintain the niche of neural stem cells (Ma et al., 2010; Jobe et
al., 2012).

Conversely, TrxG complexes contain proteins associated with up-regulation of gene
expression, including the SET domain factor Mll1, which contains H3K4
methyltransferase activity. Mll1 is required for neuronal differentiation in the
subventricular zone of the lateral ventricles (the other location of adult neurogenesis in
the brain) with increased H3K4me3 levels associated with activation of Dlx2 (Lim et al.,
2009). While Mll1 has been shown to bind to the Dlx2 promoter, MLL1-deficient mice
do not have reduced H3K4me3 methylation of Dlx2. However, these mice do have
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abnormally high bivalent chromatin domains containing both H3K4me3 and H3K27me3
modifications for poised transcription, particularly on Dlx2. This suggests that the TrxG
complexes may recruit a demethylase for H3K27me3, though this protein has yet to be
identified (Ma et al., 2010). Demethylase proteins (as opposed to simply histone
methyltransferases), likely play a role in adult neurogenesis, as Jmjd3, a histone
demethylase for H3K27me3, has been shown to be required for fate specification and
differentiation during embryonic development (Jepsen et al., 2007). While few studies
have been performed, there is evidence to suggest that histone methylation plays an
important role in AHN, not only in the maintenance of the progenitor pool via repression
mediated by PcG proteins, but also in neuronal maturation mediated by the TrxG proteins
that allow for the transition from repressed to activate transcriptional states in postnatal
neural progenitors.

Reports have provided evidence suggesting that histone acetylation and deacetylation are
also required for various components of adult neurogenesis as rapid changes in
acetylation can allow for better control of gene expression. But this regulation is still
complex: while self-renewal of NSCs and NPCs have been shown to involve the histone
acetyltransferase (HAT) Querkopf (Merson et al., 2006), Querkopf-deficient mice have
reduced neural differentiation, suggesting that this protein is required for both
proliferation and differentiation in AHN. Indeed, increasing overall acetylation of
histones via histone deacetylase inhibitors (HDACi) has been demonstrated to induce
differentiation of NPCs in the hippocampus via up-regulation of transcription factors
such as NeuroD and Tlx1 (Ma et al., 2010). However, deficits in HDACs can impair
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differentiation as well, as knockout of HDAC2 reduces maturation NPCs in the adult
brain (Jawerka et al., 2010). As such, the precise roles for each histone acetyltransferase
(HAT) and HDAC will no doubt need to be determined for AHN. HDAC2 in particular,
while paramount for maturation of neurons during adult neurogenesis, inhibits pro-neural
genes in postmitotic neurons when involved with the REST complex (see below). Studies
using sodium butyrate (NaB) and suberoylanilide hydroxamic acid (SAHA), both
HDACis, demonstrate that increasing acetylation reduces proliferation of NPCs while
simultaneously altering the expression profiles of several transcription factors. Both
HDACis decrease the expression of Sox2, Hes1, and Hes5, the transcription factors that
maintain the stem cell niche, and increase expression of Neurod1 and Neurog1, proneural transcription factors important for differentiation (Zhou et al., 2011a). Overall, it
can be stated that HDAC activity seems to be important for maintenance of the
proliferative pool of neural progenitors and that the use of HDACis can increase
differentiation; however, more studies are required to elucidate the particular mechanisms
for each group of HATs and HDACs. Additionally, it has been hypothesized that the
rapid turnover of acetylation of histones, as compared with slower rates of demethylation,
allows for more precise control of the timing of gene expression for cell cycle exit, fate
specification, and differentiation programs in adult neurogenesis (Ma et al., 2010).

There are several other epigenetic factors involved in adult neurogenesis, but our
understanding of their roles is only as distinct subsets of proteins rather than a coherent
picture of the overall regulation of neurogenesis. For example, methyl CpG binding
protein 1, Mdb1 controls cell cycle exit via binding to fibroblast growth factor 1 (Fgf1),
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to initiate differentiation (Li et al., 2008). Mbd1 and methyl CpG binding protein 2
(MeCP2) associate with methylated DNA, known for repression of transcription, and are
both highly expressed in the brain. Both of these proteins regulate NSC and neurogenesis
via regulation of other epigenetic factors: for example, MeCP2 becomes phosphorylated
during neuronal activity which affects its binding to brain-derived neurotrophic factor
(BDNF), a neurotrophin that is critical for synaptic plasticity and maturation of neurons
(Na & Monteggia, 2011). Removal of MeCP2 likely allows for recruitment of chromatin
modifiers like HATs (and HDACs) to allow for increased transcription of BDNF for
increasing AHN. Yet, MeCP2 allows for the transition from immature to mature neurons
where it is highly expressed, and deficiency in this protein leads to reduced numbers of
mature neurons (Smrt et al., 2007). Additionally, Gadd45b, a DNA excision repair
protein that also functions as an immediate early gene in the brain, initiates the rapid
demethylation of several genes (including BDNF) involved in AHN after neuronal
activity, thus allowing for the niche to respond to external stimuli (Ma et al., 2009). To
complicate matters, several microRNAs and long interspersed nuclear elements (LINE)
have been shown to be important for regulation of AHN. For example, miR-137 represses
the expression of EZH2 (in PRC2) leading to reduced H3K27me3 levels, allowing for the
TrxG proteins to activate pro-neural programs (Smrt et al., 2010); conversely, miR-184 is
a target of Mbd1 for inhibition of maturation via Numb-like proteins, while miR-124
represses Sox transcription factors that are expressed for maintenance and renewal of
NSC (Cheng et al., 2009). Several new lines of query have suggested that the crosstalk
among histone modifiers, DNA methylation, and microRNAs create the rich and intricate
regulation of adult neurogenesis (Jobe et al., 2012).
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While many chromatin-modifying proteins have been separately identified to play a role
in cell-fate specification and maturation of neurons, a collective underlying mechanism
that coordinates the epigenetic regulation of gene expression in maturing neurons may be
via the neuron restrictive silencing factor NRSF, also known as REST. This zinc finger
protein binds to a conserved 21-23 bp motif (neuron restrictive silencing element, RE1)
typically found in neuronal gene promoter regions. This sequence has been found in
genes encoding ion channels, neurotransmitter receptors, and neurotrophins (Hsieh &
Gage, 2005). REST complexes with mSin3A/B, Co-REST, and HDAC1/HDAC2. CoREST recruits several chromatin-modifying enzymes for silencing genes including
MeCP2, heterochromatin protein 1 (HP1), suppressor of variegation 39h1 (Suv39h1), and
the histone deacetylases 1 and 2 (HDAC1/2) (Ballas et al., 2005). Several genes
important for proper AHN contain RE1 elements to which REST binds, including
corticotrophin releasing factor (CRH), BDNF, and the serotonin 1A receptor (5HTA1);
these genes also play a role in the pathophysiology of depression and action of
antidepressants (Otsuki et al., 2010). However, REST may not only play a repressive
role: double stranded RNA that matches the NRSE sequence that is co-expressed with
NRSF in neural progenitor cells of the hippocampus has been shown to covert NRSF
from a repressor to an activator by removal from neuron specific genes for the induction
of neurogenesis (Kuwabara et al., 2005). Additionally, NRSF may play a dual role for
neural development: NRSF is released from neural genes as progenitors differentiate into
cortical neurons and NRSE-containing genes are activated during neurogenesis (Ballas et
al., 2005). REST recruits its corepressors to NSC chromatin to reduce the expression of
pro-neural genes for appropriately timed differentiation, as REST deficiency leads to
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increased AHN at the expense of the renewal of NSCs and if left unchecked, reduces the
progenitor pool ultimately leading to deficits in AHN (Gao et al., 2011). REST also
interacts with other transcription factors and epigenetic modifiers including cAMP
response element binding protein, CREB, and miR-124 to control the switching from
self-renewal to differentiation depending on the requirements of the niche, yet its role is
still under investigation as REST seems to be required for proper AHN (Mateus-Pinheiro
et al., 2011).

Overall, epigenetic programs in the dentate gyrus allow for the precise orchestration of
transitions from one state of neurogenesis to the next. From proliferating progenitors to
maturing neurons, these modifications allow the this special niche of the hippocampus to
respond to external stimuli, such as when new information needs to be processed for
pattern recognition and ultimately retrieved for spatial memory. Based on this dynamic
response to external stimuli mediated through epigenetic factors, adult hippocampal
neurogenesis seems to be particularly sensitive and highly responsive, thus making it a
good candidate for the adverse actions of arsenic exposure. The next section explores
these external stimuli that impact AHN.

1.3.4 The effects of environmental factors on neurogenesis
As we have previously discussed, adult neurogenesis is important for appropriate
responses to stress, certain forms of learning and memory, and the efficacy of
antidepressants. AHN is comprised of several processes including proliferation of NSCs,
differentiation of NPCs, and survival and integration of newborn neurons into the
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hippocampal circuitry. These processes are tightly controlled by epigenetic modifications
for which current research is still elucidating the larger picture. Importantly, it is via these
modifications that AHN can respond to the environment and to experiences to
appropriately provide newborn neurons for hippocampal function.

There are many positive external stimuli that increase AHN. Physical exercise (running)
stimulates proliferation of neural progenitor cells, and the mechanism for this enhanced
component of AHN may be mediated through VEGF secretion, BDNF, and factors that
promote vascularization of the brain (van Praag et al., 1999b; During & Cao, 2006;
Boehme et al., 2011). Experience in novel and enriching environments promotes
maturation and survival of newborn neurons (Kempermann et al., 1997). Including a
running wheel in an enriched environment synergistically enhances all aspects of AHN
with a profound increase in the capacity for learning and memory (Fabel et al., 2009;
Bekinschtein et al., 2011). Sexual experience increases cell proliferation and
differentiation depending on timing and frequency, and even episodes of learning, where
the task does not induce an overt stress response, can increase AHN. However, this
potentiation of AHN via learning is dependent on the timing of maturation: newborn
neurons primed with an activity to “learn from” will survive and integrate into the
hippocampal circuitry (Dobrossy et al., 2003). Of the average 5,000 neurons that are born
each day in the adult mouse, almost half, if not most, die before differentiation and
integration (Cameron & McKay, 2001). It is currently unknown why such a high rate of
apoptosis occurs in the dentate gyrus; however, based on evidence suggesting that the
first week after birth is critical, it is thought that learning or some “effortful” experience
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will mediate the maturation and incorporation of these new cells into the circuit (Shors et
al., 2012). Indeed, newborn neurons that do survive and continue to develop are very
stable and may permanently replace the developmental granule cells, though this idea is
still under some debate (Dayer et al., 2003). This “use it or lose it” phenomenon suggests
that continued learning enhances AHN thereby allowing the brain to be primed for
learning (Shors et al., 2012). Learning itself can activate the HPA axis, and interestingly,
most of the external factors that positively regulate AHN, including running, enrichment,
and sexual experience, all require activation of the HPA axis for a stress response. Even
the action of some antidepressants, particularly sertraline, an SSRI more commonly
known as Zoloft, increases differentiation of neural progenitors via increasing expression
of the glucocorticoid receptor (Anacker et al., 2013). This finding is contrary to other
reports suggesting that stress reduces AHN; however, it should be noted that a certain
amount of stress is required for experience-dependent learning, and as such, the effect of
stress on AHN is complex (Glasper et al., 2012). One prevailing theory is that rewarding
experiences (including learning) are likely to elicit a positive outcome on AHN, possibly
mediated through reduced HPA tone via hippocampal GR or increased dopamine,
oxytocin, and growth factors (Schoenfeld & Gould, 2012).

In general, stress is considered to be a negative regulator of AHN, with both acute and
chronic stress impairing both proliferation and differentiation of NPCs. Different types of
stressful events have been assessed for their impact on AHN and subsequent learning and
memory; these include predator odor, intruder or dominant/subordination stress, electric
shock, and physical restraint. The timing, duration, and type of stress play a role in how
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severe these effects can be: acute stressors induce deficits in proliferation while chronic
stressors reduce maturation and the number of differentiated NPCs (Schoenfeld & Gould,
2012). Even paradigms of stressful learning, including prolonged maze training, can
impair proliferation, regardless of the learning outcome (Aztiria et al., 2007). Other
factors that reduce AHN include aging and neurodegeneration (Li et al., 2009b; Sun et al.,
2009a), insulin deficits or resistance (Stranahan et al., 2008), inflammation (Carpentier &
Palmer, 2009), which reduces proliferation and fate commitment associated with
increasingly reactive microglia (Monje et al., 2003), and some forms of ischemia and
seizure activity, though these particular events lead to increased proliferation at first
followed by deficits in maturation, aberrant migration, and reduced synaptic connectivity
(Jessberger et al., 2007a; Jessberger et al., 2007b; Ming & Song, 2011). Of particular
interest is the negative effect of toxins on neurogenesis. There have been many studies
demonstrating that alcohol intake impairs AHN, although these studies have conflicting
results based on development, dose, and the extent and timing of exposure (Nixon, 2006;
Valenzuela et al., 2012; Gil-Mohapel et al., 2014). In general, drugs of abuse, including
nicotine, opiates, and stimulants, typically elicit reduced proliferation of NPCs (Hsieh &
Eisch, 2010). Interestingly, the reduction in AHN induced by cocaine for example, may
create greater vulnerability to the development of addiction itself (Yamaguchi et al.,
2004; Noonan et al., 2010; Deschaux et al., 2014). Exposure to heavy metals, particularly
lead and mercury, reduces proliferation and differentiation of NPCs especially when
exposure occurs during development (Falluel-Morel et al., 2007; Rai et al., 2010). Recent
reports have demonstrated that even common contaminants such as bis-phenol A (BPA)
reduce AHN and can lead to learning and memory deficits (Kim et al., 2011b; Jang et al.,
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2012). Chapter 2 will provide more detail on the effects of toxin exposure on
hippocampal learning, memory, and neurogenesis, particularly in the context of arsenic
exposure.

Environmental stimulus can have positive and negative effects on AHN, suggesting that
the processes that comprise AHN are highly adaptive and yet sensitive. These processes
provide a platform for the brain to respond to environmental cues likely mediated through
epigenetic processes in order to maintain a responsive hippocampal circuitry for
processing new information. To better understand how these epigenetic processes work, a
brief introduction to epigenetics will be provided.

1.4 Epigenetics: the basics
In the 1940’s, Conrad Waddington mused on the molecular underpinnings of cellular
differentiation: how exactly do organisms develop from single cells into complex
structures with multiple cellular phenotypes? To answer this conundrum, he proposed the
notion of an “epigenetic landscape” in which fate determination, or a particular path in
the landscape, could be “chosen” by a cell based on networks of gene interactions. This
idea stemmed from his (and others) observations of what we refer to as differential gene
expression, in which totipotent stem cells are able to differentiate into the various cell
types of the body due to particular patterns of gene expression. Waddington coined the
term epigenetics, inspired by Aristotle’s “epigenesis”, to refer to the branch of biology
that would study the “causal interactions between genes and their products which bring
the phenotype into being” (Waddington, 1968). Based on our current understanding,
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epigenetics, roughly translated as “above the genome”, may now be broadly defined as
heritable, reversible changes in gene expression that are not the result of changes in
underlying DNA sequences. For the purposes of neuroscience, epigenetics has been
conceived as the bridge between nature and nurture: environmental factors including
stress, toxins, and even experiences such as trauma or learning, influence gene expression
patterns – which depending on cell type – may be heritable.

1.4.1 DNA methylation
There are several components of epigenetic gene regulation including DNA methylation
(DNAme), histone posttranslational modifications (HPTM), and noncoding RNAs. DNA
methylation is the most widely studied component of epigenetics. It occurs almost
exclusively at the 5’ carbon of pyrimidine ring of cytosine residues to generate 5-methyl
cytosine at symmetric CpG dinucleotide sites in the genome, although there have been
some recent reports suggesting that other nucleotides may also contain methylation
(Rudenko & Tsai, 2014). Three highly conserved enzymes, the DNA methyltransferases
(DNMT1, DNMT3A, DNMT3B), impart single methyl groups (CH3) from the universal
methyl donor S-adenosyl methionine (SAM). Mammals have less CpG sites than other
eukaryotes likely due to progressive elimination from the genome as deamination of 5methylctyosines to thymine residues (Antequera & Bird, 1993). Due to this gradual
evolutionary loss, CpG dinucleotides only occur at 5-10% of the expected frequency
(approximately 28 million CpGs in the human genome) and rough estimates suggest that
only 60-80% of these single CpG sites are methylated (Smith & Meissner, 2013). These
methylated CpG sites can occur in heterochromatin, or regions of the DNA not actively
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transcribed. CpG “islands” are actually CG dense regions ranging from 1-4 kb and have
the expected frequency of CpG content (G+C content of greater than 60% and ratio of
CpG to GpC of at least 0.6) (Baylin et al., 1998). These islands are typically present in 5’
regulatory regions of genes including transcriptional start sites and are conspicuously not
methylated, with only 10% containing DNA methylation. Genes that contain CpG islands
include most constitutively expressed genes (typically considered housekeeping genes)
and genes important for developmental regulation. CpG dinucleotides within promoters
without CpG islands are usually methylated based on the tissue specificity and are
indicative of the transcriptional status of the gene, which has become the simplistic rule
of this type of epigenetic mark. In essence, methylation of a CpG is indicative of
repression of gene expression, while demethylation of a CpG can be indicative of active
transcription. However, the bulk of DNA methylation is considered static across tissues
throughout the lifespan of an organism, though the exceptions to these criteria occur in
germline DNA and during early embryonic development when massive demethylation of
the parental genomes occurs (Smith & Meissner, 2013). Indeed, since the most DNAme
occurs in CpGs localized to heterochromatin and CpG islands are typically not
methylated, the presence of a CpG dinucleotide within a promoter of gene of interest can
be quite useful for studying gene expression. DNAme is critical to development of an
organism, and in the context of developmental toxins, is the most widely studied
epigenetic mechanism for toxicity. Arsenic exposure disrupts the balance of methyl donor
groups (i.e., SAM), thereby resulting in aberrant DNA methylation. Discussion of
arsenic’s effect on DNAme will be further discussed in Chapter 2. It should be noted a
new line of query into epigenetic processes has emerged in recent years. The process of
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active demethylation of DNA has not been elucidated to date, although demethylation of
DNA likely occurs through TET-mediated mechanism including hydroxymethylation,
which allows for activation of gene expression associated with behavior (Li et al., 2014).

1.4.2 Histone modifications
Histone posttranslational modifications are another epigenetic mechanism that impact
gene expression. Negatively charged DNA is counterbalanced by positively charged
histone proteins that bind and package the DNA to form chromatin; this structure
regulates the expression of DNA by allowing or inhibiting access to the genes (Bannister
& Kouzarides, 2011). The core of the chromatin consists of the nucleosome, which is
comprised of 147 bp of DNA wrapped ~1.65 turns around a histone octamer. The
octamer is made of dimers of H2A and H2B and heterodimers of H3 and H4 with H1
acting as a linker. Variants of histone proteins, such as H2A.Z, are associated with
different parts of the DNA like active promoter regions (Day & Sweatt, 2011), and
recently, have been shown to be important for learning and memory (Zovkic et al., 2014).
The N-terminal domains of histone proteins or the “tails”, rich in basic amino acids,
protrude from the nucleosome and can interact with adjacent nucleosomes or the DNA
itself. These tails contain covalent modifications: these include acetylation, methylation,
ubiquitination, and SUMOlyation of lysine residues; methylation of arginine residues;
phosphorylation of serine and threonine residues; and ADP-ribosylation of glutamate
residues. These modifications or “marks” aid the diverse functions of nucleosomes
including regulation of chromatin structure, recruitment of remodeling enzymes,
influencing of transcription, and DNA repair, replication, and recombination. Histone
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modifications are particularly dynamic and easily influenced by external factors, which
for the brain, includes everything from emotional experiences to increased circulating
neurotrophins. Yet, these HPTMs can be consistent in some cell types; for example,
HPTM, along with DNA methylation, help maintain the “stemness” of neural stem cells
(Smith & Meissner, 2013). Particular combinations of histone marks and chromatin
remodeling enzymes confer structural variation to the chromatin: heterochromatin
contains histone marks that recruit repressor proteins to inhibit transcription, while
euchromatin contains “active” marks that are permissive for transcription. Remodeling of
the chromatin allows for groups of nucleosomes to become more or less accessible to
modify the availability of promoters to transcription factors and associated machinery,
thereby regulating gene expression.

1.4.3 Chromatin modifying proteins
Remodeling of chromatin for gene expression is widespread in the brain and allows for
dynamic regulation in both the developing and adult nervous system. There are several
classes of enzymes that are responsible this remodeling, which is collectively considered
the addition and removal of epigenetic marks and the recruitment of remodeling factors
to alter gene expression. In general, methylation of a residue results in a neutral charge on
the histone, and depending on the location of the lysine or arginine residue, can be
associated with active or inactive transcription. Acetylation and phosphorylation of basic
amino acids both result in a negative charge to the histone, which decreases the packing
efficiency of nucleosome; thus these modifications are typically associated with active
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transcription. For our purposes, we will limit the discussion of chromatin remodeling
factors to those responsible for the acetylation or methylation of histone proteins.

Acetylation of N-terminal tails of histone proteins is conferred by histone
acetyltransferases (HAT), which provide an acetyl group from acetyl-CoA for lysine
residues. Acetylation relaxes the nucleosome configuration by reducing the positive
charge of lysine to reduce the interaction between the histone tail and the negatively
charged DNA phosphate backbone. Currently, there are two classes of HATS (type A and
B), each of which is further categorized into families based on sequence and functional
homology. Type A HATs include proteins belonging to the GNAT, MYST, and
CBP/p300 families. The p300 HAT and its homolog CREB binding protein (CBP) both
induce activation of gene expression of several transcription factors that are paramount
for learning and memory (Rudenko & Tsai, 2014). More is known about the action of
histone deacetylase proteins (HDAC) in the brain: HDACs catalyze the inversion of the
acetylation reaction to a deacetylated state, which packages the DNA into more
condensed chromatin. There are 11 HDAC proteins (so far) separated in three classes:
Class 1 HDACs (1, 2, 3, 8) and class 2 HDACs (4, 5, 6, 9, 10), both of which are cell
type restricted. A third class of HDACs is the NAD-dependent sirtuin deacetylase
proteins (SIRT). SIRT1 has been shown to play a protective role in neurodegeneration
models of AD, such that activation of SIRT1 reduces synapse loss and improves learning
and memory (Graff et al., 2013). Additionally, inhibition of HDAC activity via HDAC
inhibitors like valproate or sodium butyrate has been shown to increase learning and
memory (Graff & Tsai, 2013); however, it should be noted that the presence of HDACs
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in the brain is required for development. Research on the particular function of each
individual HDAC is underway, but the overall consensus is that increased acetylation
likely allows for more rapid gene expression of proteins necessary for learning (Rudenko
& Tsai, 2014).

Histone methylation is the best characterized histone modification to date (Kouzarides,
2007). While acetylation has been exclusively associated with transcriptional activation
of gene expression, the location and number of methyl groups on residues of histone
proteins ultimately determines their effect on gene expression. It is unclear how
methylation confers activation or repression, as methyl groups do not alter the charges of
histone proteins. However, it is thought that the methyl groups provide binding sites for
other proteins that may alter the nucleosome configuration (Arrowsmith et al., 2012); as
such, these “reader” proteins that respond to methylation of histones are likely
responsible for gene expression changes rather than the methyl group itself. Methylation
typically occurs on lysine residues, which can be mono-, di-, or tri-methylated and on
arginine residues, which can by mono-, symmetrically or asymmetrically di-methylated.
Arginine methylation on H3 and H4 occurs via the protein arginine methyltransferase
(PRMT) family in coordination with cofactor associated arginine methyltransferase
(CARM1). PRMT1 and CARM1 jointly catalyze methylation of mono and asymmetric
dimethylation of arginine for gene activation, while PRMT2 induces mono and
symmetric dimethylation for gene repression (Wang & Zhu, 2008). Both CARM1 and
PRMT1 have multiple targets, but the factors and associated outcomes of arginine
methylation are still relatively unexplored. Other histone methyltransferases (HMT),
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unlike HATs, are more specific and usually have one or two substrate specificities.
Additionally, at least for lysine residues, there are several HMTs that can methylate the
same residue with the same number of modifications. HMT proteins that contain SET
domain (suppressor of variegation enhancer of zeste trithorax) are responsible for
catalyzing methylation of lysine residues. Only one lysine HMT, DOT1, which
methylates H3 lysine 79, does not contain a SET domain; K79 lies within the histone
globular domain and not the N-terminal tail. SET HMTs transfer a methyl group from the
universal methyl donor S-adenosylmethionine. The SET HMT proteins of the mixed
lineage leukemia (MLL) family have been demonstrated to be important for brain
functioning. In particular, MLL1, which trimethylates H3K4, is important for
neurogenesis and allows for expression of Hox genes during development and during
proliferation in adult neural stem cells (Lim et al., 2009). H3K4 trimethylation has been
associated with gene activation almost exclusively, suggesting that the extent of
methylation of certain lysine residues determines whether transcriptional activation or
repression will occur. In addition to H3K4, methylation of H3K36 and H3K79 has been
correlated to gene activation, while H3K9, H3K27, and H4K20 methylation are
associated with gene repression. Several different proteins can impart each of these
histone marks; for example, methylation of H3K9 can occur via SUV39H1, SUV39H2,
G9A, or SETDB1 proteins (Wang & Zhu, 2008). Conversely, histone demethylase
proteins come in two categories: those that require either 2-oxyglutarate (Jumonji family)
or flavin (LSD or KDM family). LSD1 has been shown to be important for demethylation
of H3K4 trimethylation and functions in the REST complex to deactivate gene expression
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programs (Shi et al., 2005). There are several other lysine demethylase proteins in each
of the families, but their role in brain functioning is still uncertain.

1.4.4 Epigenetic mechanisms in psychiatric disorders
Every gene has underlying epigenetic components that mechanistically contribute to its
regulation. In the past few years, it has become evident that DNA methylation and
histone modifications interact with one another to confer epigenetic regulation of gene
expression. Histone modifications, for their part, are important for several developmental
and biological processes including learning and memory, adult neurogenesis, and recently,
their dysregulation has been implicated as part of the pathophysiology of psychiatric
disorders (Tsankova et al., 2007). Additionally, several lines of evidence suggest that
dysregulation of epigenetic processes may underlie some of depression’s etiology.

One insight into the role epigenetic dysregulation plays in the etiology of depression is
that antidepressant treatments have been demonstrated to impact histone modifications
and chromatin modifying proteins. Electroconvulsive seizure therapy (ECS) is one of the
most effect treatments for depression, although it is rarely used except for severe cases
(Berton & Nestler, 2006). In rodent models of stress-induced depression, seizure therapy
increases gene expression of both BDNF and CREB via increased H3 acetylation at both
promoter regions in the hippocampus concurrent with amelioration of depressive-like
symptoms (Tsankova et al., 2004). CREB regulates the expression of BDNF, and BDNF,
a neurotrophin, is critical for antidepressant efficacy and plays a role itself in the
pathophysiology of depression, as described by the neurotrophin hypothesis of depression.
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Additionally, several antidepressant medications function as inhibitors of chromatin
modifying proteins: these include valproate, an anticonvulsant used as a mood stabilizer
which also functions as an HDACi, and monoamine oxidase inhibitors, which in addition
to inhibiting the breakdown of monoamines, also inhibit the histone demethylase LSD1,
the enzyme responsible for trimethylation of H3K4, an activating HPTM (Sun et al.,
2013). Moreover, drugs originally intended as HDAC inhibitors have been demonstrated
to have antidepressant effects (Schroeder et al., 2007). Indeed, the use of chromatin
modifying protein inhibitors in the treatment of depression has gained traction over the
past few years with more studies demonstrating their efficacy.

The paradigms used to elicit depressive-like symptoms also induce altered chromatin
modifications, suggesting a role of epigenetics in psychiatric disorders. In one study,
chronic stress decreased histone acetylation, particularly in areas of the hippocampus,
along with increased HDAC expression of all three classes (Ferland & Schrader, 2011).
Interestingly, overexpression HDAC5 blocks the antidepressant actions of imipramine
and is increased in animals exposed to chronic social defeat stress (Tsankova et al., 2006).
In humans, patients with major depressive disorder (unmedicated) have increased
expression of HDAC2, HDAC5, HDAC6, and HDAC8, as measured in peripheral blood
(Hobara et al., 2010). Conversely, in one study, NAD-dependent SIRT HDACs,
particularly SIRT1, 2, and 6, were decreased in depressed patients but not in patients in
remission (Abe et al., 2011). As such, the complete picture for the role of HDACs in
depression is still not well characterized: it is currently thought that histone acetylation in
particular allows for the adaptation to stress and maladaptation to stress may include the
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increased expression of HDACs leading to greater susceptibility of depression (Sun et al.,
2013).

Some studies have demonstrated specific changes in other histone modifications that
reverse upon antidepressant administration. In one study, chronic defeat stress increased
H3K27 methylation at the P3 and P4 promoters of BDNF, leading to decreased
expression in the hippocampus; treatment with imipramine, a tricyclic antidepressant,
induced loss of K27 methylation, and increased H3K4 methylation and H3 acetylation at
the same promoter regions, leading to up-regulation of BDNF (Tsankova et al., 2006). As
compared with HAT and HDACs, less is known about the histone methyltransferase
proteins (HMT): one study demonstrated that in the nucleus accumbens, chronic social
defeat stress reduced expression of G9a, SUV39H1, and CoREST, while simultaneously
decreasing H3K9 methylation. Additionally, in another study, MLL and LSD1 were also
decreased in the nucleus accumbens of mice that are considered more susceptible to
developing depressive-like symptoms (Covington et al., 2011). In assessment of the
effect of stress for post-traumatic stress disorder, acute stress has been shown to increase
H3K9 trimethylation in the dentate gyrus and CA1 region of the hippocampus, while
chronic stress results in the opposite effect in both regions (Hunter et al., 2009). The
same research group subsequently performed ChIP-Seq analysis of H3K9 trimethylation
in the hippocampus of PTSD-stressed rats, which revealed global increases in H3K9me3
and increased occupancy of retrotransposable loci along with increased expression of
Suv39h2 mRNA expression (Hunter et al., 2012). Whether these effects are present in
animals with stress-induced depression is still not known.
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Overall, both histone acetylation and methylation along with their chromatin modifying
proteins likely play a role in the etiology of psychiatric disorders, including depression.
The brief discussion of the above studies demonstrates that the extent of aberrant histone
modifications is dependent on the type of modification (acetylation or methylation), the
location in the brain (nucleus accumbens, areas of the hippocampus, and other regions
implicated in depression), and the type of stress (acute or chronic) that is used to induce a
depressive-like phenotype. As such, more research on the epigenetic mechanisms of
psychiatric disorders and the use of epigenetic therapies is underway.
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Abstract
Arsenic toxicity is a worldwide health concern as several millions of people are exposed
to this toxicant via drinking water, and exposure affects almost every organ system in the
body including the brain. Recent studies have shown that even low concentrations of
arsenic impair neurological function, particularly in children. This review will focus on
the current epidemiological evidence of arsenic neurotoxicity in children and adults, with
emphasis on cognitive dysfunction, including learning and memory deficits and mood
disorders. We provide a cohesive synthesis of the animal studies that have focused on
neural mechanisms of dysfunction after arsenic exposure including altered epigenetics;
hippocampal function; glucocorticoid and hypothalamus-pituitary-adrenal axis (HPA)
pathway signaling; glutamatergic, cholinergic and monoaminergic signaling; adult
neurogenesis; and increased Alzheimer’s-associated pathologies. Finally, we briefly
discuss new studies focusing on therapeutic strategies to combat arsenic toxicity
including the use of selenium and zinc.

2.1 Introduction
Arsenic is ranked first among toxicants posing a significant potential threat to human
health based on known or suspected toxicity (Hughes et al., 2011). This naturally
occurring metalloid is a known poison, a co-carcinogen, and in lower concentrations has
been shown to increase susceptibility to cognitive dysfunction (Naujokas et al., 2013).
Currently, the permitted concentration of arsenic in water is 10 µg/L (10 ppb). Yet, an
estimated 100 million people worldwide are exposed to excessive amounts of arsenic via
drinking water (in the ppm range). Many of these individuals obtain drinking water from

51

unregulated sources (wells) or live in regions where arsenic levels are high, as in
Bangladesh. As arsenic leaches from rock formations into water sources as the water
table recedes, exposure to high amounts of arsenic will continue to persist as the demand
for clean water increases. This phenomenon particularly affects the Western region of the
United States, where it is estimated that certain areas contain up to 3100 µg/L arsenic (31
ppm) in drinking water, on par with levels reported in Taiwan and China (Naujokas et al.,
2013). While the World Health Organization (WHO) and the Environmental Protection
Agency (EPA) regulate water sources of arsenic, lack of strict regulations on food,
beverages, and air quality can lead to increased arsenic exposure (Wilson et al., 2012).
Ingestion of arsenic activates metabolic pathways for excretion, resulting in a number of
metabolites, some of which are more potent and toxic than the originally ingested
inorganic form of arsenic (iAs), including mono- and dimethylated arsenicals (Kligerman
et al., 2003; Gosse et al., 2013; Watanabe & Hirano, 2013), (Kruger et al., 2009;
Ventura-Lima et al., 2011).

All forms of arsenic, including inorganic and methylated arsenicals, accumulate in many
parts of the brain, with the highest accumulation in the pituitary (Sanchez-Pena et al.,
2010). Additionally, arsenic is a well-established teratogen that crosses the placenta
during development, and in high concentrations, induces growth delays and neural tube
defects (He et al., 2007; Vahter, 2009; Ahmed et al., 2011). Epidemiological studies
reviewed in this paper have investigated the neurological and cognitive effects of arsenic
on children and adults. Evidence presented suggests that chronic ingestion of arsenic
alters a number of intelligence measures and induces learning deficits and mood disorders
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like depression. Information on dose, concentration, extent, and method of exposure of
arsenic will be given for each study. We provide a detailed review of the mechanisms
involved in arsenic-induced toxicity in the brain. These include altered glucocorticoid
signaling, cholinergic and monoaminergic signaling, adult neurogenesis and other forms
of synaptic plasticity, and behavioral deficits including learning, memory, and
locomotion. The last section of this review discusses new studies on therapeutics used in
rodent models that may eventually be useful for remedying arsenic-induced neurological
deficits in human populations.

2.2 Epidemiological studies on arsenic exposure: Cognitive assessment of children
Over the past two decades, various epidemiological reports have shown that arsenic
exposure may alter cognitive function, particularly learning and memory during
childhood. A recently published meta-analysis focused on the impact of arsenic exposure
on intelligence measured by IQ tests (Rodriguez-Barranco et al., 2013). Researchers
concluded that arsenic exposure was associated with a 0.4 decrease in IQ in exposed
children (Rodriguez-Barranco et al., 2013). This appears to be a minor decrease in IQ,
but these changes could have cumulative effects later on in life. For our purposes, we will
provide a synopsis of epidemiological studies focusing on other neurobehavioral
measures in children.

Several studies have shown a relationship between low arsenic exposure (in the parts-perbillion range) and children’s intellectual performance on a battery of cognitive tests that
cover a number of skills and processes. For example, a 2007 study found a significant
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association between urinary arsenic concentrations greater than 50 µg/L and poor scores
on tests measuring visual-spatial reasoning, language and vocabulary, memory,
intelligence, and math skills in 6-8 year old (y.o.) children from Mexico (Rosado et al.,
2007). It should be noted that researchers found a sex-specific effect of arsenic: males
performed more poorly on all assessments compared to females. However, males had
higher arsenic concentrations (mean 11.85 µg/L) in their urine, which could account for
these differences. In another cohort of children in Mexico (6-7 y.o. with 55 µg/L urinary
arsenic), researchers reported poorer scores in arsenic-exposed children on measures of
language and vocabulary and a modest association with hyperactive behavior using the
attention deficit hyperactive disorder (ADHD) index (Roy et al., 2011). In India, a cross
sectional study on 351 children (5-15 y.o.) exposed to an average of 147 µg/L arsenic in
water throughout development and childhood found an association between arsenic
exposure and poor performance in several measures focusing on vocabulary, math skills,
memory, and overall cognition; however, confidence intervals and the age range of
participants in this study were broad (von Ehrenstein et al., 2007). When accounting for
age range and other covariates (education, levels of arsenic, socioeconomic status), there
was a dose-dependent relationship between arsenic levels in water and poor performance
scores on intelligence measures (Wasserman et al., 2004): children exposed to >50 µg/L
arsenic had poorer intellectual performance than those exposed to <5.5 µg/L arsenic
(Wasserman et al., 2004). While low exposures to arsenic (< 2 µg/L) resulted in no
measurable effects on IQ, moderate exposures (142 µg/L and 190 µg/L) resulted in
decreases of 5 and 10 IQ points, respectively (Wang et al., 2007). These findings, along

54

with other studies (See Table 2.1) support the association between moderate arsenic
exposure and deficits in cognitive skills in children exposed during development.

Table 2.1. The impact of arsenic exposure on the cognitive abilities of children and adults

As mentioned above, a common finding in these studies seems to be the differential
effect of arsenic among young males and females; while this has not received much
attention (Llop et al., 2013), some research suggests that arsenic impedes growth and
development in young females more than males, which in turn could impact cognitive
function (Gardner et al., 2013). In studies where urinary arsenic levels between males and
females are comparable, females aged 5-15 y.o. had a larger negative response to arsenic
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(Kang et al., 2007). Overall, in addition to poor cognitive assessments, children exposed
to arsenic in well water also have poor development scores (i.e. height), which correlates
with lower intellectual function; this effect may be more pronounced in females than
males (Wasserman et al., 2008).

2.2.1 In utero and cumulative arsenic exposure
Most epidemiological studies focusing on the effects of arsenic exposure in children, with
exposures occurring across several years, have reported impaired cognition regardless of
the concentration of arsenic. Conversely, studies evaluating the impact of arsenic
exposure only in utero fail to show consistent cognitive deficits. Analysis of arsenic in
cord blood one day after birth (1.33 µg/L) and subsequent behavioral assessment
(Brazelton Scale) showed an inverse correlation between arsenic levels and
neurodevelopment in newborns in Nepal (Parajuli et al., 2013). Yet, an early-life
longitudinal study of pre- and postnatal arsenic exposure reported no significant
correlations between maternal or child arsenic levels and psychomotor and mental
development index assessments, behavior, or the maternal report of language acquisition
in 18 month old children (Hamadani et al., 2010). Additionally, infants born to mothers
with urinary arsenic levels of 80 µg/L during pregnancy showed no cognitive impairment
when accounting for age, sex, and socioeconomic status (Tofail et al., 2009). Measurable
impaired cognition becomes evident later in life: a Bangladesh study from the same
group demonstrated a correlation between the mother’s and child’s urinary arsenic
content (80 and 51 µg/L respectively) and verbal IQ and full scale IQ but only in females
at 5 years of age (Hamadani et al., 2011). Research focused on the adolescent time period
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of development provides more insight, suggesting that long-term cumulative exposure is
more harmful for cognitive function including alterations in pattern memory, attention set
shifting (Tsai et al., 2003), full scale IQ, verbal IQ, and functional memory (Wright et al.,
2006). The levels of arsenic among these different cohorts of teens were highly variable,
ranging from 17.8 µg/L as assessed in hair (Wright et al., 2006) to 132 and 185 µg/L
arsenic in well water (Tsai et al., 2003); thus, conclusions determined from comparing
these studies are limited. Additionally, data from toxin assessment in hair has been
deemed somewhat insufficient to predict health outcomes as information of toxin content
varies according to gender, ethnicity, and pharmacokinetics (Harkins & Susten, 2003).
However, all groups in these studies had developmental exposure to arsenic. As with
other teratogens, the timing, dose, and duration of arsenic exposure seem to determine the
extent of neurological insults on children, and these insults may occur during
development to produce cognitive dysfunction in adolescence or adulthood.

Chronic moderate exposure to arsenic, more so than high acute exposure, may induce
greater harm on intellectual function in children. Several investigations by Wasserman
and colleagues showed that the relationship between arsenic exposure and cognition in
children might be age dependent. In a study of arsenic-exposed children aged 6 y.o.,
researchers found a negative association between arsenic and performance on the
Wechsler Preschool and Primary Scale of Intelligence (WPPSI-III) (Wasserman et al.,
2007); yet this association was not as substantive as the inverse association observed in
10 y.o. children, who had longer arsenic exposure (Wasserman et al., 2004). Both cohorts
of primary school children showed reduced intellectual function and performance,
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reduced processing speed, and lower full-scale raw scores with arsenic exposures
between 5-50 µg/L during development. Yet, the chronic nature of the exposure
combined with the concentration of arsenic had the most adverse effect on cognitive
ability and neurological functioning in children.

2.2.2 Factors comorbid with arsenic exposure
One difficulty in drawing conclusions of the effect of arsenic on cognitive ability is that
exposure is commonly associated with other factors that could affect the outcomes of
these studies (see Box 1). These include exposures to a mixture of metals, low
socioeconomic status, and poor nutrition.

2.2.2.1 Metal Mixtures
The presence of arsenic in water or the environment does not preclude the presence of
other elements; in fact, it is probable that a number of metals (Pb, Mn, Cd, Hg) are
comorbid in individuals with arsenic exposure in the studies provided here. Reports on
developmental exposures to heavy metal mixtures suggest that combined exposure is
associated with greater risk for cognitive dysfunction, including behavior and impaired
neurological (CNS) development (Rai et al., 2010). The incidence of mental retardation
is highly correlated with the presence of soil metals in rural areas (As, Cu, Pb, Mn, Hg),
and the probability of intellectual disability in children increases as the concentration of
arsenic and lead in the soil increases (Aelion et al., 2008), (McDermott et al., 2011). Yet,
determining the effect of one metal in isolation is quite difficult. In several studies, the
concentration of lead in blood, urine, or water (while low), still positively correlates with
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arsenic levels (Parajuli et al., 2013). Lead in particular is a known toxicant imparting
severe neurotoxic effects on the brain especially in children. Of the studies described here,
only a few discuss comorbid exposures and provide information about other metal
concentrations. Poor scores on cognitive assessments have been reported in children
exposed to both arsenic (slightly above and below the 10 µg/L EPA standard) and
manganese (500 µg/L) in well water, though the arsenic and manganese interaction was
not significant (Wasserman et al., 2011). Arsenic, in particular, was associated with poor
working memory and lower verbal comprehension scores as previously reported in a
smaller prospective study ((Wasserman et al., 2011)), although a significant manganese
arsenic interaction was found in this study (Wright et al., 2006). As such, further
investigation on developmental neurotoxicology of arsenic in combination with other
substances is warranted. The possibility that observations in epidemiological studies may
be induced by comorbid factors in addition to arsenic cannot be ignored.

2.2.2.2 Socioeconomic status
Overall, arsenic exposure is correlated with lower socioeconomic status (SES) (Rosado et
al., 2007), and SES correlates with lower measures on tests assessing infant development
and cognition (Tofail et al., 2009). The effects of poverty and parental stress due to low
SES are significant risk factors in neurodevelopment disorders (Drews-Botsch et al.,
2011), and parsing out these effects from arsenic exposure is quite difficult. Additionally,
control cases used for epidemiological work are typically from more affluent areas
without arsenic exposure. In China, cross-sectional analyses have shown that children
who live in rural areas have lower IQ scores than children who live in urban areas (Kang
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et al., 2007; Wang et al., 2007; Dong & Su, 2009). Children residing in poor rural areas
are more often exposed to arsenic, which may exaggerate the inverse associations found
between arsenic in drinking water and IQ scores (Rocha-Amador et al., 2007). Low SES
is often associated with less education, especially in developing countries; one study
reported that cognitive ability in children exposed to arsenic increased as maternal
education increased from primary to secondary school (von Ehrenstein et al., 2007).
However, many epidemiological studies that controlled for education as a covariate still
reported significant neurodevelopmental deficits imparted after arsenic exposure (Parajuli
et al., 2013).

2.2.2.3 Nutrition
Malnutrition can have a substantial negative impact on cognitive development and
performance even in the absence of arsenic or metal exposure. Children lacking proper
nutrition during development, such as iron deficiency, have deficits in neurological
function, including cognition (Beard, 2003). Arsenic exposure is thought to increase the
risk for anemia, which is a potential risk factor in blunted growth and development (Heck
et al., 2008). Current research has been focused on the possible connection between the
lack of proper nutrients in diet during development (methionine, cytosine, protein, folic
acid, vitamin B-12, choline, and betaine) and developmental delay (Heck et al., 2009;
Dominguez-Salas et al., 2013). These nutrients are important as they boost the body’s
methyl donor availability, which is critical in the metabolism of arsenic. Increased
consumption of methionine, cysteine, and protein aids in the methylation of arsenic, thus
enhancing excretion in individuals exposed to arsenic (Heck et al., 2009). The ability of
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the developing body to metabolize arsenic and to properly execute epigenetic
modifications could be impaired by the accumulation of arsenic. As such, understanding
the nutritional status of the children in these studies may be critical to interpreting the
effects of arsenic on cognition.

2.2.3 Summary of epidemiologic studies in children
Overall, we can ascertain certain patterns from the epidemiological literature on the
association between arsenic exposure and cognitive performance in children. A number
of studies have shown that arsenic induces cognitive deficits in children, even at low
concentrations. Arsenic water levels or urinary arsenic levels correlate with poorer
performance and scores on intelligence measures, and verbal IQ seems to be the most
affected cognitive skill. These effects persist into adolescence, such that cumulative
arsenic intake may be a greater factor than acute intake in cognitive dysfunction. Higher
concentrations of arsenic exposure can alter growth and development in children, leading
to neurological deficits, and females seem to be at greater risk than males, although few
studies have systematically evaluated sex differences. Potentially confounding factors in
these studies include the comorbidity of other metals with arsenic exposure, the
correlation between high arsenic exposure and poor socioeconomic status, and poor
nutrition in children exposed to arsenic (Calderon et al., 2001). Studies on cohorts from
around the world, including China, the U.S., Taiwan, Bangladesh, and Mexico, have all
provided significant research supporting the negative effects of arsenic on childhood
development and cognitive ability.
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2.3 Epidemiological studies on arsenic exposure: Cognitive assessment of adults
Most epidemiological research has focused on cognition in children, and reports on the
effect of arsenic exposure on adult cognition are limited. However, a series of studies has
recently revealed a significant correlation between arsenic exposure and altered adult
cognition, particularly for symptoms associated with Alzheimer’s disease. The
FRONTIER project is an ongoing cohort study focused on a group of West Texas
residents in an area that contains arsenic levels close to the EPA standard in groundwater
(3-15 µg/L). Long-term and continuing chronic exposure to low levels of arsenic via
drinking water significantly correlated with poorer scores in tests examining language,
visual and spatial skills, and executive function, all of which indicate cognitive
dysfunction (O'Bryant et al., 2011). Poorer scores in global cognition, processing speed,
and immediate memory were also found; these particular deficits have been associated
with Alzheimer’s disease (Gong et al., 2011; O'Bryant et al., 2011). Individuals exposed
to 10.6 µg/L arsenic scored significantly worse on global cognitive assessment compared
to those exposed to 6.5 µg/L arsenic, suggesting that 10 µg/L EPA standard may not be
sufficient to prevent arsenic-induced cognitive deficits (Gong et al., 2011).

There are several caveats to the FRONTIER studies. The Mini-Mental State Exam
(MMSE) used for cognitive assessment has been criticized for its bias against less
educated participants (Rosselli et al., 2006; Franco-Marina et al., 2010); indeed,
FRONTIER participants in the 10.6 µg/L group did have less education than controls
(Gong et al., 2011). Additionally, most of these assessments rely on verbal responses,
reading, and writing, while other tests require on proper auditory perception and visual
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acuity. The average age of the 434 FRONTIER participants in these studies was 62 years
old, thus if arsenic exposure affected sensory, perception, or communication, participants
may perform poorly even if no cognitive impairment exists. Finally, the arsenic
concentrations in both of these FRONTIER studies were determined using the ArcGIS
program based on ground water measurements made by the Texas Water Development
Board; direct measurement of arsenic was not performed. However, despite these
limitations, the findings presented here are important in supporting that cumulative, longterm exposure to low levels of arsenic, levels considered safe by the EPA, can impart
cognitive deficits in adults.

2.4 Epidemiological studies on arsenic exposure: Psychological assessment of adults
While the number of studies concerning cognitive and mental disorders after toxic
exposures has increased over the past ten years, specific characterization concerning
arsenic exposure and psychological health requires more epidemiological investigation.
Of the studies presented here, several point to a strong correlation between arsenic
toxicity and mental health status. These data are reported from all over the world
including China, Bangladesh, India, and the United States. Altered cognition is typically
concurrent with disturbances in mental health. As such, it is difficult to assess the validity
of studies primarily focused on psychological health in arsenic-affected individuals, as
the previous data we have presented shows a strong correlation between arsenic exposure
and cognitive deficits. However, despite the overlap between psychological and cognitive
disorders, there is substantial evidence to suggest that arsenic exposure increases the risk
of impaired cognition and enhanced susceptibility for mood disorders.
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2.4.1 Bangladesh
Bangladesh has one of the highest reported arsenic exposure rates in the world, and yet,
few studies have explored the relationship between arsenic exposure and mental health. A
recent cross-sectional study, published in 2012, found that patients with arsenic poisoning
reported a lower quality of life and scored lower on a validated mental health index
compared to individuals without arsenic exposure (Syed et al., 2012). Arsenic poisoning
has strong societal implications in Bangladesh, often resulting in individuals with arsenic
exposure ostracized from the community (Syed et al., 2012). This lack of social
acceptance could contribute to the lower quality of life and mental health scores in these
individuals; however, other studies on the effects of arsenic and mental health concur
with those reported in this study.

2.4.2 China
China accounts for approximately half of the world’s arsenic production and
consequently its pollution (Garelick et al., 2008), and there are many regions that contain
naturally high amounts of arsenic in soil deposits. Arsenic toxicity studies from China
typically focus on symptoms of neurotoxicity, including loss of hearing, loss of taste,
blurred vision, and tingling/numbness in the limbs (Guo et al., 2007). Altered mental
health is comorbid with these ailments, including a prevalence of insomnia (Guo et al.,
2007), anxiety and depression (Dang et al., 2008), and symptoms of distress (Fujino et al.,
2004a). Assessments of mental health were congruent with education levels of the
participants; however, as described above, exposure to metal mixtures is common, and
participants exposed to metals in one study showed significantly greater urine and hair
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concentrations of arsenic, lead, and cadmium than control participants (Dang et al., 2008).
Additionally, water in these villages contained between 15-1860 µg/L arsenic, much
higher than the Chinese Drinking Water Standard of 50 µg/L.

2.4.3 India
In India, over 1.5 million people have been exposed to high levels of arsenic with more
than 200,000 cases of arsenicosis. Cross-sectional analysis of over 1169 arsenicosis
patients between the ages of 18-65 y.o. revealed that 19% of patients developed some
type of psychiatric disorder, compared an average 7% prevalence of mental disorders in
India (Sen & Sarathi Biswas, 2012). Of the 19% of patients, most were categorized as
having depression and/or anxiety; yet, the prevalence of depression in India is only 3.7%.
The participants in this study were from seven different villages, 90% of which had
arsenic levels ranging from 25-900 µg/L. Most patients were males with low SES and a
25% rate of unemployment. As noted in the studies from Bangladesh, it is difficult to
determine if these patients exhibit depression due to the state of their overall health
(arsenicosis) or if depression is a manifestation of the arsenic toxicity. However, in
Indian society, arsenicosis patients are able to maintain their traditions, kinship, and cast
relations to cope with stress of the disease (Sen & Sarathi Biswas, 2012). Similar to
observations of the general population, anxiety and depression were the most common
psychiatric disorders in arsenicosis patients; however, lower SES, the diseases associated
with arsenic poisoning, body image, and low self-esteem are predisposing factors of
psychological issues in this population.
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2.4.4 United States
The US has more stringent standards of arsenic water quality than other countries (the
EPA limit is 10 µg/L), yet this concentration may not be low enough as suggested by the
literature on cognitive dysfunction. A 2004 cross-sectional study covered a wide range of
locations in areas with low concentrations of arsenic and revealed a significant
association between low arsenic exposure (2-10 µg/L) and poor mental health,
particularly depression. Individuals with cumulative, long-term exposure to low
concentrations of arsenic (2-10 µg/L) for more than twenty years were significantly more
likely to exhibit depressive symptoms than those drinking less than 2 µg/L arsenic
(Zierold et al., 2004). Interestingly, participants consuming more than 10 µg/L arsenic
were also more likely to have had cardiac bypass surgery, high blood pressure, and
circulatory issues than those drinking less than 2 µg/L arsenic in water (Zierold et al.,
2004). Unlike studies from India, Bangladesh, and China where low levels of arsenic
were not assessed, this study suggested that low exposure, under EPA limits of 10 µg/L,
is associated with higher rates of adverse mental health. However, evaluating the validity
of the conclusions from this study is difficult because of the lack of the critical
methodological information, (e.g., participant health status, and the type and analysis of
the assessment tools), which are all important in interpreting the findings.

2.4.5 Summary of epidemiologic studies in adults
There are several limitations to these studies, including some with small sample sizes, all
with variable levels of arsenic toxicity, and arsenic-affected individuals typically living in
rural areas and having lower SES. Additionally, assessment of dose-response
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relationships and mental health has not been determined: it would be useful to have high
and moderate arsenic exposures compared in the same study. While it is difficult to
disentangle the contribution of arsenic and that of general health in many of the studies
conducted in countries outside of the U.S., the findings presented thus far demonstrate a
correlation between arsenic exposure, cognitive dysfunction, and mental health. There is
clearly substantial evidence that arsenic exposure diminishes cognition and increases
mood disorders in human populations. Animal and invertebrate studies have replicated
many of these observations and aided in the search for the mechanisms for the adverse
health impacts of arsenic.

2.5 Mechanisms of Action
It is difficult to use the epidemiological literature to identify mechanisms, as long-term
exposures to arsenic are likely compounded with exposures to pollution, poor diet, and
low SES. Basic science research is poised to control for these confounding factors,
including extent and timing of exposure. This research has determined that arsenic
imparts its toxicity on the body via a number of mechanisms. These include the depletion
of methyl groups affecting epigenetic profiles, the uncoupling of oxidative
phosphorylation and increased reactive oxygen species, the inhibition of thiol-containing
enzymes and proteins (including the depletion of glutathione), altered signal transduction
and cell proliferation, and reduced DNA repair inducing genotoxicity (Hughes et al.,
2011; Watanabe & Hirano, 2013). As these mechanisms have been discussed in detail in
other reviews, we cover mechanisms particularly related to the brain. These include
hippocampal dysfunction; glutamatergic, glucocorticoid, cholinergic, and monoaminergic
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signaling; pathways associated with Alzheimer’s disease; and synaptic plasticity,
particularly neurogenesis. To begin, we briefly provide results from the few studies
focusing on neural epigenetic patterns altered after arsenic exposure.

2.5.1 Epigenetic patterns
Arsenic accumulation and subsequent toxicity is likely mediated through multiple
mechanisms of action. Of particular interest over the past few years is the impact of
arsenic on the epigenome. While there have been several studies determining the impact
of arsenic on epigenetic regulation in cancer cells, the liver, and other parts of the body,
very few have focused the brain. Exposure to 3 and 36 ppm arsenic throughout gestation
increased DNA methylation on two genes involved in neural plasticity in rat cortex and
hippocampus (Martinez et al., 2011). Hypomethylation of these genes in both regions
was observed after four months of cumulative exposure to arsenic; these animals also
displayed deficits in fear memory as well, although the link between hypomethylation
and memory was correlational. Since arsenic metabolism requires methyl groups derived
from S-adenosylmethionine (SAM) for excretion, it is plausible that arsenic depletes
SAM leading to alterations in DNA methylation. In vitro studies corroborate this
assertion: 25 µM arsenic exposure for 24 hours depleted SAM concentrations, increased
global DNA hypomethylation, and repressed DNMT1 and DNMT3a expression
(Reichard et al., 2007). Epidemiological work has shown that DNA methylation is
affected by arsenic in human populations as well, including umbilical cord blood, but
discussion of those studies is beyond the scope of this review (Reichard & Puga, 2010;
Kile et al., 2012; Bailey et al., 2013; Koestler et al., 2013). We can determine that
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exposure to arsenic does induce epigenetic modifications to the DNA, which may result
in aberrant gene expression even in the brain; however the link between DNA
methylation on particular genes and cognitive deficits has yet to be elucidated.

Other epidemiological studies have determined the impact of arsenic ingestion on histone
modifications. Arsenic compounds have been shown to alter gene expression and
posttranslational modifications (PTM) of histones in vivo; interestingly, researchers found
a differential effect of arsenic on global histone modifications among males and females
(Chervona et al., 2012c). In vitro assessment of low doses of arsenic on histone
modifications has also been performed; however, detailed discussion of this research is
beyond the scope of this review (Zhou et al., 2008; Zhou et al., 2009; Chervona et al.,
2012c). Rodent studies with prenatal exposure to 100 µg/L arsenic demonstrated reduced
global acetylion on lysine 9 of histone 3 (H3K9ac) in the cortex and hippocampus of
postnatal day (PND1) pups, which was correlated to altered learning in adulthood
(Cronican et al., 2013). Exposure to 3 and 36 ppm arsenic throughout development up to
four months reduced myelination (for which methylation is required) and dimethylation
of arginine residues on histones (Zarazua et al., 2010). This could result from the altered
expression and function of epigenetic modifiers or transcription factors, as arsenic
impacts zinc-finger protein expression and function (Zhou et al., 2011b).

These studies demonstrate that arsenic impacts DNA methylation and histone
modifications and alters the enzymes responsible for regulating these modifications. The
effects of arsenic on the epigenome are related to the dose and extent of arsenic exposure
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as seen before, but also type of histone methylation mark, gene, and sex. As such, in
determining mechanisms of arsenic toxicity it will be important to control for these
variables both in epidemiological and molecular studies in the future. Additionally,
cumulative low-level exposure to arsenic likely occurs over generations. The literature
suggests that females are differentially more affected by arsenic than males. Since
females are the key source of transgenerational effects (3rd generation ova are exposed to
the in utero environment), arsenic could be impacting transgenerational epigenetics,
including the imprinting of genes (from both males and females). This area of research
could provide an insight into the effects of arsenic on the brain and body, yet there are no
published reports on arsenic exposure and transgenerational epigenetic mechanisms to
date.

2.5.2 The hippocampus
Studies on the mechanisms of arsenic-induced toxicity have established that arsenic alters
learning and memory in behavioral assays and impacts multiple neurobiological
processes including those of neurogenesis and cholinergic, glutamatergic, and
monoaminergic signaling pathways. Recent work using animal models has revealed
potent alterations in hippocampal function, morphology, and signaling leading to altered
cognitive behavior after arsenic exposure. While the exposure paradigms and
concentrations of arsenic have been highly varied, the overall conclusions have been
congruent between studies (See Table 2.3).
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Table 2.2. The impact of arsenic on behavioral tasks in rodent studies

In particular, behavioral studies using hippocampal-dependent tasks, including the Morris
Water Maze and fear conditioning, have corroborated epidemiological evidence of
reduced cognition observed in humans with arsenic exposure. Table 2.3 details the
behavioral paradigms and arsenic exposures used in these studies. Results from this body
of literature suggest that regardless of dose, timing, or extent of exposure, arsenic induces
hippocampal-dependent behavioral deficits in rodent models, suggesting impaired spatial,
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working, long-term, and short-term memory (Martinez-Finley et al., 2009; Jing et al.,
2012; Cronican et al., 2013; Sharma & Sharma, 2013). Interestingly, the effect extends to
nonmammalian species as arsenic exposure in Danio rerio (zebrafish) induces deficits in
long-term memory as well (de Castro et al., 2009). Several of these behavioral deficits
can be ameliorated with treatment; for example, sodium butyrate, a histone deacetylase
inhibitor, attenuated deficits seen in the Radial Arm Maze after two weeks of arsenic
exposure of 100 µg/L during adulthood (Sharma & Sharma, 2013). More detail on
therapeutic interventions after arsenic exposure will be discussed in later sections of this
review. Overall, work with animal models has demonstrated that arsenic induces deficits
in multiple learning paradigms, particularly those relying on proper hippocampal function.
Yet, identifying the hippocampus as a sensitive area for arsenic’s effects does not
necessarily identify a molecular target. Alterations in multiple signaling pathways are
localized to the hippocampal formation, but it should be noted that mossy fiber terminals
in the hippocampus contain substantial amounts of zinc. Thus, the sensitivity of the
hippocampus may be due the effect of arsenic on zinc either via displacement or
substitution. To date, no studies investigating this mechanism have been published.

2.5.3 Glutamatergic signaling
Arsenic impacts the synaptic activity of neurons localized to the hippocampus. Slices
obtained from young and adult rats exposed to 100 µM arsenite in vitro had reduced
amplitudes of excitatory post synaptic potentials (EPSPs) in the Schaffer collateral/CA1
synapses. Exposure inhibited long-term potentiation (LTP), a form of synaptic plasticity,
in hippocampal slices from adult but not young rats; however, this effect was reversible
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after twenty minutes of washout. Arsenic exposure did not impair paired-pulse
facilitation, indicative of presynaptic activity, suggesting that acutely applied arsenic does
not affect presynaptic neurotransmitter release (Kruger et al., 2006). However,
components of NMDA receptors, specifically NR2A, were reduced after three months of
arsenic exposure (2.72, 13.6, 68 mg/L arsenic) in mice. Additionally, these mice
exhibited morphological changes in hippocampal neurons—reduced size with a
condensed nucleus and cytoplasm—along with capillary edema and irregular vascular
endothelial cell morphology (Luo et al., 2009a). Similar morphological changes in
hippocampal neurons were observed after a 3-month exposure of 8.2 mg/kg/day arsenic;
both the striatum and hippocampus contained abnormally myelinated nerve fibers, while
the hippocampus contained reduced mossy fiber terminals (Jing et al., 2012). Brief, two
week exposure to 100 µM arsenic also altered expression levels of mRNA for synapse
related genes, including increased Grin1, Syn2, and Stx6 expression, similar to results
from our studies (Cronican et al., 2013; Tyler & Allan, 2013).

In addition to altered synaptic activity and synapse-related gene expression, arsenic has
been shown to impart alterations in central pathways involved in mediating learning and
memory in the hippocampus. Using a three-month exposure model (from weaning until
four months), arsenic-exposed animals had decreased NR2A expression, PSD-95, and pCAMKIIa in the hippocampus with concurrent increased SynGAP expression, a known
negative regulator of the Ras-MAPK pathway (Luo et al., 2012). Reduced p-ERK1/2 in
the hippocampus was also observed in the arsenic-exposed animals. These findings
corroborate our own work demonstrating reduced ERK2 in the hippocampus after
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perinatal exposure to arsenic (Martinez et al., 2008). Thus, the Ras-MAPK/ERK pathway
appears to be sensitive to arsenic damage; interestingly, zinc has been shown to alter this
pathway as well (Klein et al., 2006). It is possible that arsenic is acting in a similar
fashion. Overall, altered Ras-MAPK/ERK signaling, LTP, and synaptic regulation in the
hippocampus could underlie behavioral deficits suggesting arsenic-induced alterations in
long-term episodic memory, associative learning, spatial learning, and working memory.

2.5.4 Glucocorticoid signaling
In addition to altered hippocampal-dependent behaviors, depressive-like symptoms have
been observed in arsenic-exposed mice. We have demonstrated increased immobility in
the forced swim task and increased latency for escape in the learned helplessness task,
along with increased plasma corticosterone levels (Martinez et al., 2008). Corticosterone
(CORT), the rodent equivalent of cortisol, is a stress hormone that plays a role in
mediating the effects of the hypothalamus-pituitary-adrenal (HPA) axis in response to
“stressful” events ranging from fear to learning. In humans, significant alterations in the
HPA axis have been connected to depressive-like symptoms, and patients with depression
typically report stress a major factor in the onset of their depression. Thus, decreased
behavioral ability and increased depressive-symptoms in arsenic-exposed animals
correlate with the epidemiological data on reduced cognition in humans; as such, arsenic
may be mediating not only cognitive impairments but also mood disorders in humans via
the glucocorticoid signaling pathway.
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CORT signaling is mediated through the corticosterone receptors, specifically the
mineralocorticoid (MR) and glucocorticoid (GR) receptors. When activated, MR and GR
translocate to the nucleus to allow for binding to response elements (MRE or GRE) on
genes for transcriptional activation or repression. CORT signaling, via its receptors in the
hippocampus, is responsible for imparting an inhibitory tone for the HPA axis. Our work
has demonstrated nuclear levels of GR are much lower in adult mice perinatally exposed
to arsenic than levels observed in controls in hippocampal tissue (Martinez-Finley et al.,
2009). Additionally, we have shown decreased GR binding to and expression of H-Ras
and Raf-1, genes involved in modulating the MAPK pathway with GRE binding sites
(Martinez-Finley et al., 2011). In vitro studies have demonstrated that various levels of
arsenic impact GR-mediated transcription in a bidirectional manner: high arsenic levels
(1-3 mM) induce an inhibitory effect, while low levels (0.05–1 mM) seem to produce a
stimulatory effect (Bodwell et al., 2004). Arsenic’s impact on GR is predicated on the
DNA binding domain (DBD) within the GR. Other steroid receptors, including the MR
and the progesterone receptor respond to arsenic in a similar biphasic manner as the GR
(Bodwell et al., 2006). Interestingly, arsenic’s effects on transcriptional regulation of the
estrogen receptor seem to be only inhibitory (Davey et al., 2007). A recent study
predicted that the GR pathway was a common mediator of metal-induced birth defects:
indeed, arsenic-induced deficits, specifically neurodevelopmental toxicity, were
prevented by inhibition of GR signaling in a chick embryo model (Ahir et al., 2013).
Oscillatory signaling of the HPA axis, in addition to proper GR localization for MAPK
activation, is paramount for proper learning and memory. This signaling may be impaired
in arsenic-exposed animals: while they have elevated circulating CORT, their ability to
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initiate a proper HPA response is blunted after a stressor (Goggin et al., 2012). Thus, the
susceptibility of the GR to arsenic may play an important role in hippocampal-related
deficits, including reduced learning and increased depressive-like symptoms (observed in
rodent models) and may underlie mood and cognitive deficits seen in human studies as
well.

2.5.5 Cholinergic signaling
Motor learning, cholinergic signaling, and locomotion are all affected by arsenic
exposure in rodent models. Early studies demonstrated impaired motor coordination and
delayed spontaneous alteration in rats chronically consuming arsenic (36 mg/L) for four
months (Rodriguez et al., 2002). However the increased locomotion reported in this study
has been challenged by more recent work: while altered locomotion is a common
behavior seen in arsenic-exposed mice, whether this behavior is hypo- or
hyperlocomotion seems to be dependent on sex and the arsenic exposure paradigm (see
Table 2.3 for studies). Low levels of arsenic exposure seem to induce hyperactivity in
male mice, while high levels induce hypoactivity (Bardullas et al., 2009), (Rodriguez et
al., 2010). Conversely, female mice consuming any level of arsenic display
hyperlocomotion (Bardullas et al., 2009). Subchronic exposures to arsenic increase
locomotion but impair motor coordination in both sexes (Yadav et al., 2009), but reports
on in utero exposure are conflicting, with some suggesting impaired neural reflexes and
others reporting no changes in locomotor behavior (Luo et al., 2013), (Gandhi et al.,
2012). A similar dose relationship between locomotion and arsenic level occurs in the
zebrafish model, where moderate arsenic levels reduced locomotion (line crossing) and
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high levels increased the distance travelled (Baldissarelli et al., 2012). Details on these
studies, including dose, timing of exposure, and age of behavioral assessment are
provided in Table 2.3. While parsing out verifiable locomotor actions from anxiety is
difficult and likely to impact these studies, we can ascertain that high concentrations of
arsenic induce hypolocomotion, moderate levels of arsenic induce hyperlocomotion, and
low concentrations may induce no change in locomotion.

Altered motor coordination and locomotion could arise from abberant cholinergic
functioning. Several reports have noted reduced acetylcholinesterase (AchE) activity and
choline acetyltransferase (ChAT) functioning after arsenic exposure. Female rats exposed
to 20 mg/kg arsenic for 28 days displayed deficits in the transfer latency of the passive
avoidance response and decreased labeling of muscarinic cholinergic receptors in the
hippocampus and frontal cortex (Yadav et al., 2011). These brain regions had reduced
AchE activity and ChAT labeling after arsenic exposure as well. Interestingly, treatment
with a bioactive component of the spice curcumin during arsenic exposure attenuated
these observed effects in female rats (Yadav et al., 2011). Exposure to less arsenic (5
mg/kg body weight) also inhibited AchE activity in the brain and was associated with
poorer performance in operant learning (Nagaraja & Desiraju, 1994); another study
demonstrated that AchE activity decreased with increasing arsenic concentrations in male
rats after five days of exposure (Patlolla & Tchounwou, 2005). Our analyses have shown
that mRNA of AchE is increased in the adult dentate gyrus after developmental arsenic
expoure to 50 µg/L arsenic, suggesting a compensatory mechanism for altered AchE
activity (Tyler & Allan, 2013). These studies provide support for arsenic in the etiology
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of Alzheimer’s disease, as more reports confirm reduced AchE and ChAT along with
degeneration of cholinergic neurons in AD pathology (Mufson et al., 2008).

2.5.6 Alzheimer’s disease
Global cognitive impairments assessed after arsenic exposure have been associated with
Alzheimer’s disease (AD) in the human population; for an in-depth assessment of the
relationship between arsenic and Alzheimer’s disease, see (Gong & O'Bryant S, 2010).
For the purposes of this review, we will discuss arsenic exposure in the context of
experimental studies. In vitro research using a cholinergic neuronal cell line has
demonstrated that sodium arsenite and dimethylarsenic acid (DMA) have different effects
on APP protein levels, b-amyloid formation, and altered activity of AchE and ChAT
(Zarazua et al., 2011). These findings corroborate our own: we have found altered mRNA
expression of genes associated with AD, including Appb1 and ApoE, and Ache in the
dentate gyrus of adult male mice after developmental exposure to 50 µg/L arsenic (Tyler
& Allan, 2013).

For hallmark pathologies associated with AD, cell culture studies have demonstrated
arsenic exposure increases b-amyloid protein and induces hyper-phosphorylation of tau
protein, oxidative stress, inflammation, endothelial cell dysfunction, and angiogenesis
(Giasson et al., 2002). Interestingly, zinc has also been shown to induce tau
phosphorylation through an ERK-sensitive mechanism (Kim et al., 2011a); again, this
effect may be due to a cation sensitive system (to zinc or arsenic) involving the RasMAPK/ERK pathway. In 2012, Piacentini and colleagues provided further evidence
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supporting the role of arsenic in the etiology of AD. The authors found a significant
correlation between a genetic polymorphism of the protein glutathione S-transferase
GSTO1-1 in a population of 120 AD patients compared to 114 healthy controls
(OR=3.70); this transferase has been linked to both Alzheimer’s and Parkinson’s disease
and is involved in arsenic metabolism, even in invertebrate systems (Whitbread et al.,
2005; Ortiz et al., 2009; Piacentini et al., 2012). While arsenic does not participate
directly in REDOX reactions, it can induce oxidative stress via depletion of glutathione
and impair REDOX reactions by inhibiting enzymes with sulfhydryl groups (Jomova &
Valko, 2011); and oxidative damage is strongly associated with AD. In rodent models,
arsenic exposure results in vascular endothelial dysfunction, impairment of learning and
memory, altered nitrogen levels, and oxidative stress; all of which have been associated
with symptoms of dementia (Sharma & Sharma, 2013). Treatment with a histone
deacetylase inhibitor, sodium butyrate, attenuated these cognitive and vascular deficits
observed in arsenic-exposed animals (Sharma & Sharma, 2013). Sodium butyrate has
been used in the treatment of depression and improves cognitive skills in the Alzheimer’s
mouse model (APP/PS1-21) (Govindarajan et al., 2011). Overall, we confidently state
that arsenic imparts cognitive deficits associated with AD in rodent studies of exposure;
however, very few epidemiological studies have investigated this relationship to date.

2.5.7 Monoaminergic signaling
Arsenic affects many transporter systems including the monoamines, dopamine (DA),
serotonin (5-HT), and norepinephrine (NE). We have demonstrated that very low doses
of arsenic (50 mg/L) during development increase 5-HT1A receptors in the dorsal
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hippocampus in adult offspring (Martinez et al., 2008). Exposure to moderate levels of
arsenic (1, 2, and 4 mg/L) in water for 60 days reduced levels of NE, DA, and 5-HT in
both the cerebrum and cerebellum of 7-week old mice in a dose-dependent manner.
mRNA levels of monoamine synthetases (including dopamine b-hydroxylase, tyrosine
hydroxylase (TH), and tryptophan hydroxylase) were also all reduced after exposure to 4
mg/L arsenic (Liu et al., 2013). Evidence from other studies using low to moderate doses
of arsenic suggest differential effects on monoaminergic signaling based on sex, as
observed in locomotion tasks. Four months of chronic exposure to 0.05, 0.5, 5.0 or 50
mg/L arsenic in drinking water decreased levels of DA in the striatum and hypothalamus
in females (who also exhibited increased locomotion) but not in males (Bardullas et al.,
2009). TH and thioredoxin (Trx-1 A) levels were reduced in the striatum of males but not
females; curiously, the opposite effect was observed in the nucleus accumbens where TH
and Trx-1A were reduced in females but not males (Bardullas et al., 2009). Conversely,
in a different study on rats ingesting 50 mg/L arsenic in water, DA content in the striatum
was increased in males, although no changes in DA, its metabolites, or serotonin were
found in the prefrontal cortex or the nucleus accumbens (Rodriguez et al., 2010). This
group also reported alterations in mRNA of several antioxidant genes including
superoxide dismutase (SOD), Trx-1, and NE and DA receptor genes in arsenic-exposed
animals dependent on dose and region of interest in the brain (nucleus accumbens,
prefrontal cortex, or striatum). Up-regulation of antioxidant factors (Trx-1 and SOD)
indicate compensatory mechanisms to overcome the oxidative byproduct effects of
arsenic toxicity on thiol containing enzymes related to arsenic metabolism (Rodriguez et
al., 2010). It is difficult to propose a mechanism of action for opposite effects based on
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sex for different brain regions. However, evidence from these studies, while conflicting,
suggest that arsenic may induce a complex dose-response relationship, which may not be
linear, on locomotion and the nigrostriatal dopaminergic system as seen in other studies.

High levels of arsenic exposure, which have been reviewed elsewhere, produce more
definitive deficits on dopaminergic and serotonergic signaling in the corpus striatum,
hippocampus, and frontal cortex (Yadav et al., 2009; Yadav et al., 2010). Interestingly,
treatment with curcumin in these studies attenuates deficits in monoamines and increases
nitric oxide (NO) and TH expression, in both sexes. More details on therapeutic strategies
to combat arsenic toxicity will be provided later.

2.5.8 Neurogenesis
Deficits in hippocampal-related behavioral tasks and increased depressive-like symptoms
suggest that arsenic exposure induces changes in hippocampal morphology. Recent
studies have demonstrated deficits in adult neurogenesis in the dentate gyrus of the
hippocampus in both developmental and adult exposures to arsenic. Treatment for four
months with 4 µg/L arsenic in drinking water reduced proliferation of neural progenitor
cells and the number of mature neurons (Liu et al., 2012). Developmental exposure of 50
mg/L arsenic (in utero and postnatal) altered differentiation but not proliferation of neural
progenitor cells in the adult hippocampus at PND63 (Tyler & Allan, 2013). In both
studies, deficits in adult neurogenesis were ameliorated either after cessation of the use of
arsenic in water (Liu et al., 2012) or with experience in an enriched environment (Tyler
& Allan, 2013). In vitro studies using P19 pluripotent cells cultured with varying
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concentrations of arsenic (7.5-75.0 µg/L) demonstrated that arsenic inhibited the
formation of muscle and neuronal cells during P19 cell differentiation in a dose
dependent manner. Deficits in neuronal differentiation may have resulted from reduced
expression of transcription factors including neurogenin1, neurogenin 2, and NeuroD as
compared to control P19 cultures. Further, Nanog expression increased during cell
differentiation, suggesting that arsenic impacts differentiation but not proliferation (Hong
& Bain, 2012a).

Altered hippocampal morphology in CA1, CA3 and the dentate gyrus was also observed
during postnatal development after I.P. injection of 1, 1.5, and 2.0 mg/kg arsenic from
PND4-11 (Kaler et al., 2013). Two weeks of 100 µM exposure to arsenic reduced GFAP
staining in the hippocampus in another study, indicative of less neural stem cells
(Cronican et al., 2013), while exposure to arsenic induced deficits in cell proliferation
and increased apoptosis in the brains of zebrafish (Li et al., 2009a). These studies suggest
many different types of exposures to arsenic, including brief, chronic, adult, or
developmental, can impact the morphology of the hippocampus. The effect of arsenic on
neurogenesis may be mediated through a signaling mechanism already discussed: altered
glucocorticoid and HPA axis function. Neurogenesis is particularly sensitive process in
the brain, and as such, is prone insults like stress activity. Recent in vitro studies done in
human hippocampal progenitor cells have demonstrated biphasic responses of adult
neurogenesis to cortisol; of particular interest is that increased cortisol levels inhibit
proliferation and differentiation possibly mediated by the GR (Anacker et al., 2013). But
the effect of the GR on adult neurogenesis is complex, as proposed by work showing
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antidepressants mediate an increase in adult hippocampal neurogenesis by activating the
GR (Anacker et al., 2011b) as well. Arsenic has an impact on adult neurogenesis and
hippocampal-dependent learning and memory and induces cognitive deficits and
depressive-like symptoms; altered HPA axis regulation, and particularly GR signaling in
the hippocampus could underlie all of these alterations seen in arsenic-exposed animals.

2.5.9 Summary of Mechanisms of Action
Arsenic can alter a multitude of systems in the brain. Of particualr interest is HPA axis
dysregulation that may underlie several behavioral deficits, particularly related to the
hippocampus including deficits in adult neurogensis and Ras-MAPK/ERK signaling.
Additionally, arsenic seems to have an impact on cholinergic and monoaminergic
signaling, though the mechanisms are not well understood at this point. Rodent studies
have provided useful corroboration of the epidemiological evidence suggesting that a
number of mechanisms could underlie cognitive deficits and mood disorders observed in
human populations. More research focused on the dynamics of epigenetics, particularly
on mechanisms of learning and memory and mood, will be important for understanding
the impact of arsenic on the brain. While it is unlikely one common unifying mechanism
for arsenic’s effects will be identifed, some clues on how naturally present cations, like
zinc, interact with the system, may provide insight.
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2.6 Therapeutics
2.6.1 Antidepressants
Some arsenic-induced deficits have been ameliorated with therapeutics. For example, in
rodent studies, deficits in adult neurogenesis can be attenuated either by abolishment of
exposure to arsenic water (Liu et al., 2012), experience in an enriched environment
(Tyler & Allan, 2013), or chronic antidepressant treatment (our unpublished
observations). Reduced expression of monoamines after arsenic exposure can be reversed
by treatement with curcumin (Yadav et al., 2009) or taurine (Liu et al., 2013). Studies
described here have demonstrated that use of selenium, zinc, arsenic chelators, and
environmental enrichment can attenuate systemic deficits due to arsenic exposure.

2.6.2 Selenium and zinc
The use of selenium as an anti-carcinogen and chemoprotective compound and its
interaction with arsenic has been extensively studied in the cancer field. Selenium forms
conjugates with arsenic using glutathione for excretion (Zeng et al., 2005). A study on
selenium concentrations in adults and children reported an inverse correlation between
blood concentrations of selenium and urinary concentrations of arsenic (George et al.,
2013). In rodent studies, selenium concentrations in the cerebrum and cerebellum are
reduced after exposure to 1-4 mg/L arsenic (Wang et al., 2013). Treatment with selenium
(Se) can attenuate some arsenic-induced deficits such as the inhibition of AchE in
arsenic-exposed fish (Channa punctatu), particularly if Se treatment precedes arsenic
exposure (Roy et al., 2006). Another naturally occurring metal, zinc, is an important
component of several enzymes involved in development and CNS function. Concurrent
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exposure to 40 mg/kg arsenic and 4% w/v zinc in drinking water during pregnancy
induced no teratological deficits or arsenic toxicity in male offspring, as seen in arseniconly exposure. No changes were observed in sensory reflexes, glutathione, or motor
behavior, suggesting that zinc treatment attenuated arsenic-induced deficts in mice
(Ahmad et al., 2013). Zinc has also been shown to be protective against arsenic-induced
apoptosis in neurons in vitro (Milton et al., 2004). The mechanism by which zinc
prevents arsenic-induced toxicity has not be eluciated, but we hypothesize that the RasMAPK/ERK pathway is involved.

2.6.3 Arsenic chelators
In India, where efforts for intervention of arsenic-induced toxicity are at the forefront of
research, the use of chelators has been suggested for attenuating the effects of chronic
arsenic exposure, including thiol chelators that form insoluble complexes with arsenic
(Flora

&

Pachauri,

2010).

One

such

chelator

is

monoisoamyl

meso-2-3-

dimercaptosuccinic acid (MiADMSA), a lipophilic analog of DMSA and a strong thiol
chelator. Five days of MiADMSA was provided for treatment of male rats after 10 weeks
of exposure to 2 mg/kg arsenic. Compared to control animals, arsenic-exposed rats
displayed decreased locomotor activity, fore and hind limb strength, reduced exploration,
and impaired learning in the MWM. Additionally, reduced levels of malodialdehyde
(MDA) and oxidative stress markers including superoxide dismutase, glutathione
peroxidase, glutathione reductase, and glutathione transferase were measured in the
cerebellum, hippocampus, and most notably, the frontal cortex. Treatment with
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MiADMSA attenuated all of these effects but failed to restore performance back to
control levels (Ram Kumar et al., 2013).

Other notable interventions include high protein diet, antidepressants, curcumin, and
exposure to enriched envrionments. Casein and pea protein, both of which have
antioxidant proteins, protected against the effects of arsenic on reproductive measures in
female rats (Mondal et al., 2013), while curcumin in the diet attenuated the effects of
arsenic on malonaldehyde (MDA), glutathione, and superoxide dismutase in several key
brain regions, including decreased TH expression in the striatum (Yadav et al., 2009).
Our own studies of treatment with fluoxetine (Prozac) or exposure to an enriched
environment after developmental arsenic exposure suggests that the insults arsenic
imparts can be ameliorated (Tyler & Allan, 2013). Research on therapeutic approaches
will become more pronounced as the number of people exposed to arsenic increases.
However, efforts to implement safe water programs have been successful in reducing
arsenic exposure in some parts of the world (Seow et al., 2012). Arsenic remediation
endeavors remain the most effective method for reducing exposure to this insidious toxic
metalloid.

2.7 Conclusions concerning arsenic dysregulation in the brain
The most recent report provided by the ATSDR (Agency for Toxic Substances and
Disease Registry) has suggested that toxic exposures to arsenic may result in memory
loss and emotional instability in humans. Epidemiological studies from the past decade
have provided a wealth of information supporting a strong correlation between arsenic
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exposure and neurological and cognitive dysfunction in children and adults. These
deficits seem to be dependent on concentration, timing, and duration of exposure, with
cumulative arsenic inducing more severe insults. Developmental exposure to arsenic may
impart damage on critical processes involved in programming in the brain. Research in
rodent models has provided sufficient evidence to suggest that arsenic toxicity affects
multiple systems and specific pathways involved in several aspects of learning, memory,
movement, decision making, and mood. The next phases of research will delve deeper
into mechanisms of action including epigenetics and specifically focus on therapeutics
for the treatment of arsenic toxicity on the brain. More information on health and
exposure during the intrauterine period could be helpful in ascertaining the true impact of
arsenic exposure on the central nervous system. Additionally, more epidemiological
studies, particularly in the United States, would be useful in determining if the current
standard (10 µg/L) will be sufficient enough to block arsenic-induced neurotoxicity, and
if not, what can be done, either legislatively or pharmaceutically to alleviate arsenicmediated cognitive deficits.
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3. Research Rationale, Hypothesis, and Specific Aims

3.1 Research Rationale
Major depressive disorder (MDD; depression) is the leading cause of disability
worldwide, affecting more than 350 million people (Hyman et al., 2006). A combination
of factors, including genetic predisposition, individual experience, and environmental
exposures contribute to the etiology of depression. Epidemiological studies in the United
States and Bangladesh have shown that the incidence of depression in humans correlates
with arsenic levels in drinking water. Arsenic, a common environmental contaminant, is a
deadly toxin in high doses, a co-carcinogen in moderate doses and has been shown to
negatively impact human cognition in low doses. Reports focusing on low doses of
arsenic exposure demonstrate that even minimal amounts, previously considered safe by
the Environmental Protection Agency (EPA), can have long-lasting cognitive
consequences in adults and children. Prior work in our laboratory has demonstrated that
perinatal exposure (during three trimester equivalents) to 50 parts-per-billion (ppb)
arsenic induces deficits in the molecular constituents of the hypothalamic-pituitaryadrenal (HPA) axis, depressive-like symptoms, and deficits in hippocampal-dependent
cognitive measures. The mechanism by which arsenic induces these alterations is still
under investigation.

One particular mode of action may be aberrant adult neurogenesis. Patients with
depression typically have hippocampal atrophy, and antidepressant treatment reverses
this atrophy by increasing adult hippocampal neurogenesis (Boldrini et al., 2013). It is
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unclear if developmental insults, such as arsenic exposure, lead to depression due to
impaired adult neurogenesis. Additionally, the regulation of adult neurogenesis is
mediated by transcription factors and epigenetic modifications, which alter gene
expression programs for either maintaining the neurogenic niche or stimulating
maturation and integration of newborn neurons. Long-term exposure to arsenic has been
shown to change the epigenome by reducing methyl donors (Zhao et al., 1997), altering
DNA methylation patterns in the hippocampus (Martinez et al., 2011), and altering
posttranslational modifications including histone methylation and acetylation in humans
(Chu et al., 2011; Chervona et al., 2012b). Yet, the epigenetic link between
developmental arsenic exposure and adult onset depression has not been elucidated to
date.

3.2 Hypothesis
Based on this rationale, the overall goal of this dissertation has been to test the hypothesis
that perinatal arsenic exposure induces epigenetic dysregulation of adult hippocampal
neurogenesis leading to increased susceptibility to depression in adulthood.

3.3 Specific Aims
To test this hypothesis, I developed two specific aims with two sub aims to characterize
the epigenetic and neurogenic link between arsenic exposure and depression. The first
aim focuses on characterizing the impact of arsenic on the hippocampus, particularly
molecular and morphological damage, and the potential reversibility of that damage. The
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second aim focuses on determining the contribution of epigenetic dysregulation in the
dentate gyrus as a potential molecular mechanism of action for arsenic exposure.

3.3.1 Aim 1: Determine the extent and reversibility of hippocampal damage induced by
perinatal arsenic exposure in the adult mouse. My working hypothesis is that perinatal
arsenic exposure results in deficits in adult neurogenesis and hippocampal-dependent
behavioral tasks, both of which can be rescued by chronic antidepressant treatment. This
first aim was developed to establish depression as an endophenotype of perinatal arsenic
exposure by demonstrating etiologic and predicative validity of the behavior.

Aim 1A: Characterize depression as a behavioral endpoint after perinatal arsenic
exposure with and without antidepressant treatment.
•

Determine the stress response and behavioral outcomes of arsenic-exposed
animals in the learned helplessness task and forced swim task after a mild stressor.

•

Develop a chronic antidepressant treatment regime to increase neurogenesis.

•

Determine the impact of chronic antidepressant treatment on the stress response
and behavioral outcomes in each of the previous tasks.

Aim 1B: Assess adult neurogenesis in the hippocampus with and without
antidepressant treatment.
•

Determine the effect of a perinatal arsenic exposure on proliferation,
differentiation, and survival of neural progenitor cells in the dentate gyrus using
immunohistochemistry, confocal microscopy, and unbiased stereology.
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•

Determine the impact of an antidepressant on these components of hippocampal
neurogenesis using the previously established treatment regime.

•

Characterize the effect of perinatal arsenic exposure on a neurogenesis-dependent
behavioral task and the potential amelioration of arsenic-induced deficits in this
task.

3.3.2 Aim 2: Determine the impact of perinatal arsenic exposure on the epigenetic
programming of neurogenesis-related genes. My working hypothesis is that perinatal
arsenic exposure alters histone methylation and acetylation patterns on neurogenesisrelated genes specifically in the dentate gyrus. This second aim was developed to
determine if perinatal arsenic exposure induced long-lasting effects on the epigenome
leading to altered gene regulation in adulthood.

Aim 2A: Characterize the effect of perinatal arsenic exposure on genetic programs
associated with neurogenesis.
•

Measure changes in gene expression of neurogenesis-related genes using qRTPCR after perinatal arsenic exposure in the adult dentate gyrus.

•

Determine the potential reversibility of genetic alterations by measuring the effect
of a treatment regime that enhances neurogenesis (using qRT-PCR).

Aim 2B: Characterize the effect of perinatal arsenic exposure on the epigenetic
landscape of the dentate gyrus.
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•

Determine the effect of perinatal arsenic exposure on histone posttranslational
modifications by measuring global histone modifications specifically in the
dentate gyrus via Western blot.

•

Determine the effect of perinatal arsenic exposure on the protein expression of
chromatin modifying proteins that impart histone modifications specifically in the
dentate gyrus via Western blot.

•

Assess the impact of perinatal arsenic exposure on the epigenetic regulation of
neuronal genes by measuring the (histone) occupancy on genes expressed in the
dentate gyrus (ChIP-Seq).

The expected outcomes from these aims include the identification of the molecular and
morphological effects of development arsenic exposure and possible identification of
novel epigenetic mechanisms that may be useful as therapeutic targets for treatment of
depression. By evaluating the contribution of aberrant epigenetic regulation of adult
neurogenesis to adult onset depression after a developmental environmental insult of
arsenic, these studies will not only forward our understanding of environmental
influences on epigenetics but also provide knowledge as to the impact developmental
toxins have on adult depression, which may help to inform environmental toxin policy.
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Abstract
Arsenic is a common and pervasive environmental contaminant found in drinking water
in varying concentrations depending on region. Exposure to arsenic induces behavioral
and cognitive deficits in both human populations and in rodent models. The
Environmental Protection Agency (EPA) standard for the allotment of arsenic in drinking
water is in the parts-per-billion range, yet our lab has shown that 50 ppb arsenic exposure
during development can have far-reaching consequences into adulthood, including
deficits in learning and memory, which have been linked to altered adult neurogenesis.
Given that the morphological impact of developmental arsenic exposure on the
hippocampus is unknown, we sought to evaluate proliferation and differentiation of adult
neural progenitor cells in the dentate gyrus after 50 ppb arsenic exposure throughout the
perinatal period of development in mice (equivalent to all three trimesters in humans)
using a BrdU pulse-chase assay. Proliferation of the neural progenitor population was
decreased by 13% in arsenic-exposed mice, but was not significant. However, the number
of differentiated cells was significantly decreased by 41% in arsenic-exposed mice
compared to controls. Brief, daily exposure to environmental enrichment significantly
increased proliferation and differentiation in both control and arsenic-exposed animals.
Expression levels of 31% of neurogenesis-related genes including those involved in
Alzheimer’s disease, apoptosis, axonogenesis, growth, Notch signaling, and transcription
factors were altered after arsenic exposure and restored after enrichment. Using a
concentration previously considered safe by the EPA, perinatal arsenic exposure altered
hippocampal morphology and gene expression, but did not inhibit the cellular neurogenic
response to enrichment. It is possible that behavioral deficits observed during adulthood
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in animals exposed to arsenic during development derive from the lack of differentiated
neural progenitor cells necessary for hippocampal-dependent learning. This study is the
first to determine the impact of arsenic exposure during development on adult
hippocampal neurogenesis and related gene expression.

4.1 Introduction
Arsenic is a naturally occurring essential trace element found in soil deposits and water.
Both natural and human sources contribute to the ubiquitous presence of arsenic in the
environment; as such, several millions of people are exposed to this toxic metalloid in
varying concentrations depending on location. Consistent exposure to arsenic results in a
myriad of problems associated with almost every organ system in the body, including
problems with renal, cardiovascular, reproductive, hepatic, and neurological systems
(Brinkel et al., 2009). It’s well established that arsenic is a toxin in high doses and a cocarcinogen in moderate doses; the last decade of research has shown arsenic to be a
neurotoxin in low doses. The current EPA standard for arsenic in water is 10 parts per
billion; however, many people in rural areas and developing countries, where arsenic is
not regulated, are exposed to much higher levels of arsenic in their water. Developmental
and continuous arsenic exposure induces significant deficits in long-term memory in
children, as measured by the Wechsler Intelligence Scale for Children (WISC) (Calderon
et al., 2001). Other research has revealed considerable deficits in learning and memory
after several methods of arsenic exposure in both rodent models and in humans (Nagaraja
& Desiraju, 1994; Calderon et al., 2001; Chattopadhyay et al., 2002; Rodriguez et al.,
2002; von Ehrenstein et al., 2007; Wasserman et al., 2007; Martinez-Finley et al., 2009;
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O'Bryant et al., 2011). Additionally, developmental arsenic exposure alters cerebellar
morphology in the brain and disrupts cell cycle dynamics of neuroepithelial cells in vitro
(Sidhu et al., 2006; Dhar et al., 2007). Recently, we have demonstrated that
developmental exposure to arsenic alters components of the hypothalamus-pituitaryadrenal (HPA) axis (Goggin et al., 2012) including increased hypothalamic
corticotrophin releasing hormone (CRH), altered corticosterione (CORT) secretion (both
at baseline and in response to a stressor), decreased hippocampal 11β-HSD 1, and altered
subcellular glucocorticoid receptor (GR) distribution in the hypothalamus. We have also
reported deficits in learning tasks, including 8-way radial arm, novel object exploration,
learned helplessness, and forced swim tasks, some of which are hippocampal-dependent
(Martinez et al., 2008; Martinez-Finley et al., 2009). The underlying mechanism
responsible for these behavioral outcomes in adulthood after developmental exposure to
arsenic has not been elucidated to date.

Of the two neurogenic regions of the brain capable of continual mitosis, adult
neurogenesis in the dentate gyrus of the hippocampus has been implicated as an integral
component of hippocampal-dependent learning and memory (Shors et al., 2002; Deng et
al., 2010; Sahay et al., 2011). Adult neurogenesis involves proliferation of a neural
progenitor cell (NPC) population comprised of neural stem cells left over from
development and transient amplifying cells, differentiation of daughter cells from NPC
into either glia or neurons, and survival and integration of these new cells into the
hippocampal circuitry. Research conducted over the last decade has shown that ablation
of adult neurogenesis in the hippocampus results in substantial deficits in learning and
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memory and that these new neurons are required for integration of new memories
(Jessberger et al., 2009; Shors et al., 2012). This budding population of cells seems
particularly sensitive to environmental factors, as evidenced by decreased adult
neurogenesis after exposure of several different neurotoxins, including adult or fetal
exposure to alcohol (Nixon & Crews, 2002; Klintsova et al., 2007; Gil-Mohapel et al.,
2011) or nicotine (Abrous et al., 2002; Shingo & Kito, 2005), and fetal exposure to lead
(Gilbert et al., 2005; Jaako-Movits et al., 2005; Verina et al., 2007) or methylmercury
(Faustman et al., 2002; Falluel-Morel et al., 2007). This sensitivity in the hippocampus
coupled with the vulnerability of the brain during development may result in an
environment that is susceptible to damage even with low concentrations of toxin.
However, the neurogenic environment shows plasticity to extrinsic factors like
antidepressants, exercise, novelty, and environmental enrichment with toys and social
interaction, all of which increase adult neurogenesis and learning (Kempermann et al.,
1997; van Praag et al., 1999a; Malberg et al., 2000). Environmental enrichment also
enhances cognitive performance, decreases depression and anxiety, and increases
proliferation and differentiation of adult neural progenitor cells (Malberg et al., 2000;
Koh et al., 2007; Zhao et al., 2008; Fabel et al., 2009).

Based on our previously published behavioral data and research supporting the link
between learning and memory and adult neurogenesis, we hypothesized that our
environmentally relevant perinatal arsenic exposure model induces deficits in
proliferation and differentiation of neural progenitor cells in the dentate gyrus of exposed
animals. This deficit may be responsible for the behavioral outcomes we observe in these
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animals (Martinez et al., 2008; Martinez-Finley et al., 2009). We found that
developmental exposure to a low concentration of arsenic (50 parts per billion, ppb) over
the first three trimester equivalents significantly decreased the number of differentiated
neural progenitor cells but did not affect proliferation of these cells in adult mice.
Additionally, perinatal arsenic exposure altered 31% of target neurogenesis-related genes
as well, including several involved in growth and differentiation in adult animals. Brief
exposure to an enriched environment increased both proliferation and differentiation of
neural progenitor cells in both control and arsenic-exposed animals and significantly
reversed mRNA expression of aberrantly expressed neurogenesis genes. Thus, it is
possible that impaired hippocampal adult neurogenesis is a candidate mechanism by
which developmental arsenic exposure induces deficits in learning and memory seen in
adulthood.

4.2 Methods
Note: Arsenic is a known human carcinogen, and all arsenicals were handled with caution
according to MSDS standards.

4.2.1 Ethics Statement
All experiments were performed in accordance with protocols approved by the University
of New Mexico Institutional Animal Care and Use Committee (Protocol number: 11100679 HSC).
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4.2.2 Perinatal Arsenic Exposure Paradigm
The arsenic exposure paradigm was performed as previously described (Martinez et al.,
2008). Briefly, C57BL/6J mice (Jackson Laboratories, Bar Harbor, ME) were bred and
maintained in the University of New Mexico (UNM) Animal Research Facility on a 12hour reverse light/dark cycle with lights off at 0800 hr. Animals had ad libitum access to
food and water in a temperature controlled (22°C) room. Female mice were assigned to
either control (arsenic-free) or arsenic exposure groups and acclimated for seven days
prior to mating. Fifty parts per billion (ppb) arsenic-treated water was prepared from
sodium arsenate (Sigma-Aldrich, St. Louis, MO) and ultra pure water from a Milli-Q Plus
purification system (Millipore, Billerica, MA). Dams were provided ad libitum access to
50 ppb arsenic (equivalent to 50 µg/L) or normal tap water during breeding and
pregnancy until pups were weaned at approximately PD23–25. After weaning, pups were
group housed, four per cage, with ad libitum access to food and normal tap water (Figure
4.1).

Figure 4.1. Arsenic exposure paradigm and subsequent BrdU injection strategy and experience in
environmental enrichment
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Male mice were used for all studies with only one animal from each litter to eliminate
litter effects, n = 7–9 mice per group. The UNM Health Sciences Center Institutional
Animal Care and Use Committee approved all the procedures described in these studies.
As described in our previous papers, the arsenic concentrations were 56 ppb in the
arsenic-treated water and 6 ppb in standard tap water (Martinez et al., 2008; MartinezFinley et al., 2009). Average daily water consumption is not significantly different
between arsenic-exposed and control groups. We have previously assessed total arsenic
concentration in whole brains of animals: perinatal arsenic exposure results in 2.24 ± 0.2
ppb arsenic in whole brains at PD35, which is significantly greater than 1.0 ± 0.24 ppb
arsenic determined in age-matched control animals on tap water (Martinez et al., 2008;
Martinez-Finley et al., 2009).

4.2.3 Enriched Environment Paradigm
For enrichment studies, PD35 male mice were separated into two groups: one with daily
exposure to enrichment (enriched environment, EE) and one without exposure to
enrichment (no enrichment, NE). Mice used for proliferation assessment were exposed to
an enriched environment (EE) for 2–4 hours per day for five days after which
proliferation was assessed at PD40 for both EE and NE groups. Mice used for
differentiation assessment were exposed to an enriched environment for 2–4 hours per
day for 28 days (approximately one month post last-BrdU injection) after which
differentiation was assessed at PD63 for EE and NE groups. No enrichment control
groups consisted of both perinatally arsenic-exposed animals and unexposed animals in
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which neither group had exposure to enrichment. The enriched environment consisted of
toys (ladder, plastic house, chew toys) and a running wheel in a large housing container
(48 cm × 27 cm × 20 cm). Toys were exchanged every other day, but the running wheel
was kept throughout the exposure paradigm. The location of all the objects was changed
every other day. All NE control groups (perinatal arsenic or control) and all enriched
groups (perinatal arsenic or control) were maintained in standard housing (28 cm × 18 cm
× 13 cm). Each standard housing cage contained two to three mice, while the enrichment
cages contained four to six mice; the same four to six mice were exposed to enrichment
together each day. All groups were given ad libitum access to food and tap water while in
the enriched environment and in their own standard housing.

4.2.4 Histological Evaluation of Neurogenesis
To analyze adult neurogenesis, 5-bromo-2’-deoxyuridine (97% Sigma-Aldrich, St. Louis,
MO) BrdU was used to label neural progenitor cells (NPC) in the dentate gyrus (DG) of
the hippocampus of PD34 male mice for all groups. To reduce BrdU toxicity and double
labeling of neural progenitor cells, a 12-hour, 4-injection paradigm was used with a low
concentration of BrdU (50 mg/kg made in 0.9% sterile NaCl) (Hayes & Nowakowski,
2002). Assessment of proliferation or differentiation was performed either 12 hours
(PD35) or 4 weeks (PD63) following the final BrdU injection, respectively. Brain slices
were obtained according to an earlier published protocol (Guo et al., 2011). Briefly, mice
were euthanized with an i.p. injection of sodium pentobarbital followed by transcardiac
perfusion with 4% PFA. Brains were dissected and post-fixed overnight in 4% PFA
followed by equilibration in 30% sucrose for 48 hours. Brains were frozen in 30%
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sucrose and 40 µm coronal sections were obtained using a sliding microtome; tissue was
stored at –20°C in 96-well plates with cryoprotectant (1:2:2 by volume glycerol, ethylene
glycol, and 0.1M PBS, pH 7.4). Immunohistological analysis for every 1-in-6 serial,
floating, 40 µm section (240 µm apart) for the rostral-caudal extent of the hippocampus
was performed. Free-floating sections were washed with 0.1 M TBS (0.15 M NaCl, 3
mM KCl, 30 mM Tris-base, pH 7.4) for 15 minutes. Sections were incubated for 30
minutes in 1 N HCl at 37°C, rinsed in 0.1 M borate buffer for 30 minutes, and rinsed
several times in 0.1 M TBS. After one hour incubation in TBS-T (0.1 M TBS,
0.1%Triton X, and 3% normal goat serum), sections were incubated in primary
antibodies BrdU (rat, 1:100, Abcam), Ki67 (mouse, 1:200, Vector), NeuN (mouse, 1:500,
Millipore), doublecortin (rat, 1:500, Cell Signaling), and DAPI (1:1000, Sigma) in TBS-T
for 72 hours at 4°C. Sections were washed in 0.1 M TBS and incubated for one hour in
appropriate fluorescent secondary antibodies (Alexa 488; Cy5; Cy3). Sections were
mounted, coverslipped with DABCO, and maintained at 4°C in the dark until analysis; a
minimum of n = 7 was analyzed for each group.

4.2.5 Stereology
StereoInvestigator software (Microbrightfield, Wiliston, VT) was used for assessment of
adult neurogenesis. Both proliferation and differentiation were scored for at least 10, 1in-6 serial sections throughout the rostral-caudal extent of the granule cell layer of the
dentate gyrus for at least seven animals per group. BrdU with Ki67 positive cell counts
were limited to the granule cell layer and subgranular zone next to the hilus; this was
accomplished using StereoInvestigator to outline digital contours around each dentate
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gyrus for each section using a 10X objective. BrdU positive cells that were more than
three nuclear diameters from the base of the granule cell layer or more than two nuclear
diameters into the hilus were not counted, as only progenitor cells lie within this region.
A two-micron guard zone was used with a 25 µm optical fractionator probe and a 40X
objective for counting cells. As arsenic has been shown to induce DNA damage (Piao et
al., 2005), proliferation was assessed via colocalization of BrdU positive cells (BrdU+)
with Ki67 positive (Ki67+) cells using unbiased stereology. Cells expressing only BrdU
or only Ki67 were not counted; although, very few cells had BrdU+ labeling only. One
month after the final BrdU injection, differentiation of progenitors was assessed via BrdU
colocalized with either doublecortin (DCX) or BrdU colocalization with NeuN positive
cells. Counts for both types of differentiated cells (immature DCX+ and mature NeuN+)
were pooled together to determine the total impact of arsenic exposure on the
differentiation capacity of NPC. Results are presented as cell counts directly from the
StereoInvestigator analysis for the total number of cells throughout the entire dentate
gyrus per animal. This assessment takes into account the section sampling fraction (SSF),
the area subfraction (ASF), the thickness subfraction (TSF) and the total number of cells
counted (Q): N=Q/(SSF×ASF×TSF). Phenotype analysis was performed for 100
randomly selected BrdU positive cells per animal for differentiation studies. Phenotypes
were counted as BrdU+, Brdu+DCX+, or BrdU+NeuN+.

4.2.6 Confocal Microscopy
Images used for stereological analysis were collected using an Olympus DSU spinning
disk confocal inverted IX-81 microscope endowed with argon and HeNe lasers. A Z-
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stack composite was obtained using a 40X objective throughout the orthogonal plane
with appropriate filters for each secondary antibody for 10 slices per brain. A guard zone
of 2 µm was used along with a probe of 25 µm. Cell bodies within the guard zone were
not counted. Images for publication were acquired using a Zeiss LSM510 META
confocal microscope endowed with a laser diode, one argon laser, and two HeNe lasers.
Colocalization was visualized using a 63X oil objective (Figure 4.2A, 4.3A), while
maximum intensity projections of Z-stacks were acquired with a 20X objective.

4.2.7 Real-time PCR analysis
The dentate gyrus of the hippocampus in PD70 male mice was isolated, microdissected as
described by Hagihara and colleagues, snap frozen in liquid nitrogen, and stored at –80°C
until use (Hagihara et al., 2009; Brady et al., 2013), n = 6 litters/group, where one mouse
is used per litter to eliminate litter effects. Total RNA was extracted from homogenized
frozen tissue using the QIAshredder homogenizer (Qiagen, Valencia, CA) and the
RNeasy Mini Kit (Qiagen, Valencia, CA). The concentration of mRNA was assessed
using a NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington,
DE); the 260/280 absorbance ratio for all RNA was ~ 2.0. Isolated 750 ng mRNA was
converted to cDNA using the RT2 First Strand Kit (SABiosciences, Frederick, MD).
Real-time PCR analysis was performed using the RT2 Profiler Mouse Neurogenesis PCR
Array (PAMM-404Z, SABiosciences) according to the manufacturer’s instructions on an
ABI 7300 Real-Time PCR System (Applied Biosystems). No template controls and RT
controls were on the microarray. Gene of interest (GOI) CT values were normalized to
the average CT value of four housekeeping genes (β-actin, B2m, GAPDH, Hsp90ab1),
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and subsequent ΔCT values were assessed using the comparative CT method (ΔΔCT)
(Livak & Schmittgen, 2001). Results are expressed as fold change, 2-ΔCT(GOI-T)/2-ΔCT(GOI-C),
where GOI-T refers to the gene of interest in a particular treatment group and GOI-C to
the same gene of interest but in the control group. Fold change was measured as the ratio
of the 2-ΔCT of the GOI under exposure conditions (e.g. arsenic or enrichment) to the 2-ΔCT
under control conditions (e.g. tap water or no enrichment) for a particular GOI. Fold
regulation was calculated as -1/2-ΔCT for all fold changes less than one.

4.2.8 Statistical Analysis
Neurogenesis data was analyzed using one-way ANOVA (SPSS, v.19; Chicago, IL) with
post-hoc analysis performed as needed and corrected for multiple comparisons with
Bonferroni, n = 7–9 mice per group. Gene expression data was analyzed using the
Student’s t-test, n = 6 mice per group with Bonferroni corrections when multiple
comparisons were performed.

4.3 Results
4.3.1 Perinatal arsenic exposure did not alter proliferation of neural progenitor cells
Proliferation of neural progenitor cells (NPC) was measured using colocalization of BrdU,
an exogenous S-phase marker, and Ki67, an endogenous cell proliferation marker (Figure
4.2A). The use of two markers was necessary, as arsenic has been shown to induce DNA
damage, and BrdU may label cells with DNA damage; thus, as Ki67 expression mimics
that of BrdU within the proliferative zone, it was used to confirm the BrdU+ cell counts,
validate the pulse chase assay, and to ensure measurement of an actively proliferating
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population of neural progenitors. While it is more common to label with one or the other
marker, BrdU+ only cell counts may overestimate proliferation of NPC and Ki67+ only
cell counts do not give an accurate birthdate for cells. However, the disadvantage of
double labeling with both BrdU and Ki67 is that cell counts do not include the very small
quantity of BrdU+ labeled cells that exit the cell cycle within 12 hours of the injections;
we found this amount to be negligible compared to the total counts of BrdU+Ki67+ for
proliferation. The labeling method used here provides a depiction of a population of cells
that includes neural stem cells and their progeny, transient amplifying cells, which can
give rise to neurons. Four injections of 50 mg/kg BrdU (n = 7–9 mice/group) were given
over a 12-hour period to PD34 male mice. Twelve hours after the last BrdU injection, the
animals were sacrificed and adult neurogenesis was measured. Labeling with BrdU+ and
Ki67+ resulted in an average of 3973 ± 497 NPC in the DG of control animals and 3465 ±
372 NPC in the arsenic-exposed animals (Figure 4.2B, 4.2C). Thus, arsenic-exposed mice
have 13% less NPC than their control counterparts. Cells that were only labeled with
BrdU or Ki67 or more than three nuclei away from the subgranular zone of the dentate
gyrus were not counted as proliferating progenitor cells. One-way analysis of variance
(ANOVA) assessing the effect of treatment (arsenic water versus tap water) on
proliferation showed that average cell counts are not significantly different from one
another. As such, perinatal exposure of 50 ppb arsenic (throughout all three trimester
equivalents in mice) did not alter the proliferation of NPC in the DG of the hippocampus
at PD35 (Figure 4.2D).
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Figure 4.2. Perinatal arsenic exposure does not alter proliferation at PD35 in adult male mice.
Representative images of neural progenitor cell (NPC) proliferation at PD35 in the dentate gyrus: (A)
Colocalization of Ki67 (endogenous mitotic marker) and BrdU (exogenous S-phase marker) determine the
proliferating pool of neural progenitor cells in (B) control and (C) arsenic-exposed animals. (D) There was
no significant effect of treatment on the proliferation of neural progenitor cells, n = 7–9 mice per group
(each from different litters). Results are expressed as the mean 6 SEM. DAPI (blue), BrdU (green), Ki67
(red).
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4.3.2 Perinatal arsenic exposure reduced the number of differentiated neural progenitor
cells
Differentiation of NPC was measured using colocalization BrdU with either doublecortin
(DCX), a marker of neuroblasts and immature neurons, or NeuN, a marker of mature
neurons (Figures 4.3A, 4.3B). Since the impact of arsenic on the differentiation capacity
of NPC is not known, we assessed overall differentiation, including the generation of
neuroblasts and immature neurons (DCX+) and mature neurons (NeuN+). Differentiation
was measured four weeks after the last BrdU injection to allow for maturation of BrdUlabeled cells (n = 7–9 mice/group). Figures 4.3A and 4.3B show representative images of
colocalization of BrdU with DCX (BrdU+DCX+) and BrdU with NeuN (BrdU+NeuN+):
both types of cell counts were used for assessment of total differentiation. Analysis of
phenotype indicated that the relative amounts of each cell type were unchanged between
groups: BrdU+ labeling (~25%), BrdU+DCX+ (~15%), and BrdU+NeuN+ (~60%). From
the proliferation data, a significant quantity (approximately 3500) of NPC was labeled in
both control and arsenic-exposed animals. In control animals, there were 1997 ± 178
BrdU+/DCX+ and BrdU+NeuN+ labeled cells (Figure 4.3C), while in the arsenic-exposed
animals, there were 1178 ± 252 BrdU+DCX+ and BrdU+NeuN+ labeled cells. This
translates into a 41% decrease in the number of differentiated cells in arsenic-exposed
animals as compared to their control counterparts (Figure 4.3D). One-way ANOVA
revealed a significant effect of arsenic exposure on differentiation of NPC in the DG
(F(1,13)=7.311, p=.018). Thus, perinatal exposure of 50 ppb arsenic (throughout all three
trimester equivalents in mice) reduced the number of differentiated NPC in the DG of the
hippocampus at PD63 (Figure 4.3E).
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Figure 4.3. Perinatal arsenic exposure decreases the number of differentiated neural progenitor cells
at PD63 in adult male mice (A) Colocalization of doublecortin (immature neuron marker DCX) or NeuN
(mature neuron marker) and BrdU determine differentiated neurons derived from labeled neural progenitor
cells. (B) Colocalization of BrdU with NeuN in the dentate gyrus reveals mature daughter cells of BrdUlabeled progenitor cells, (BrdU, green; DAPI, pink; NeuN blue). Arrows indicate colocalization of marks
and cells that were counted. Representative images of neural progenitor differentiation at PD63 in the
dentate gyrus of (C) control and (D) arsenic-exposed animals. (E) There was a significant effect of
treatment on differentiation of neural progenitor cells; BrdU+DCX+ and BrdU+NeuN+ were significantly
decreased after perinatal arsenic exposure, n = 7–9 mice per group (each from different litters). Results are
expressed as the mean ± SEM. BrdU (green), DCX (red), NeuN (blue). *p<.05.
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4.3.3 Exposure to an enriched environment increased proliferation of neural progenitor
cells in control animals
Using the same BrdU injection paradigm, NPC were labeled in four sets of PD34 mice:
control and arsenic-exposed animals that were exposed to enrichment and control and
arsenic-exposed animals that were not exposed to enrichment. After five days of daily,
brief (2–4 hours) exposure to enrichment after which animals were returned to their home
cages, proliferation of NPC was assessed via BrdU and Ki67 colocalization in the
subgranular zone of the dentate gyrus of PD40 animals (n = 7–9 mice/group). Figure
4.2A shows a representative image of colocalization of BrdU with Ki67 for proliferation
assessment. Assessment of proliferation resulted in 6753.64 ± 1372.1 BrdU+Ki67+
labeled cells in control animals exposed to enrichment: this constitutes a 70% increase
over control animals not exposed to enrichment. In arsenic-exposed animals exposed to
enrichment, there were 5312.96 ± 1935.95 BrdU+Ki67+ labeled cells: this constitutes a
53% increase over arsenic-exposed animals not exposed to enrichment and a 33%
increase over control animals not exposed to enrichment (Figure 4.4A, 4.4C). Figure
4.4A shows a representative image of the DG from an arsenic-exposed animal with
experience in enrichment. One-way ANOVA indicated a significant effect of enrichment
on proliferation regardless of perinatal treatment (F(1,21)=13.87, p=.001). Using a
Student’s t-test with Bonferonni correction, brief exposure to enrichment slightly
increased proliferation for arsenic-exposed animals but was not significant (Figure 4.4C,
p=.061); however, exposure to enrichment did significantly increase proliferation for
control mice (Figure 4.4C, p=.008). There is no statistically significant difference in the
average cell counts between both groups exposed to enrichment. Regardless of perinatal
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exposure, NPC proliferation in the DG is enhanced after five days of brief exposure to
enrichment, though this increase is only statistically significant in control animals.

Figure 4.4. Brief, daily exposure to enrichment increases proliferation and differentiation in control
and arsenic-exposed male mice. Representative images of increased (A) proliferation after brief exposure
to enrichment for five days in arsenic-exposed animals at PD40 (BrdU (green), Ki67 (red), DAPI (blue))
and increased (B) differentiation after brief, daily exposure to enrichment for one month in arsenic-exposed
animals atPD63 (BrdU (green), DCX (red), NeuN (blue)). (C) Perinatal arsenic exposure did not affect
proliferation of NPC; exposure to enrichment for five days increased NPC proliferation at PD40 in both
arsenic-exposed and control mice but was only significant in controls. (D) Perinatal arsenic exposure
decreased the total number of differentiated cells (BrdU+DCX+ and BrdU+NeuN+); brief, daily exposure
to enrichment for one-month increased differentiation in both arsenic-exposed and control animals at PD63,
n=7–9 mice per group, each from different litters. (**p<.01, *p<.05).
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4.3.4 Exposure to an enriched environment increased the number of differentiated neural
progenitor cells in all animals
Using the same BrdU injection paradigm, NPC were labeled in four sets of PD34 mice:
control and arsenic-exposed animals that were exposed to enrichment for one month and
control and arsenic-exposed animals that were not exposed to enrichment (n = 7–9
mice/group). After brief (2–4 hours), daily enrichment for 28 days, colocalization of
BrdU with DCX (BrdU+DCX+) and BrdU with NeuN (BrdU+NeuN+) in the DG was
assessed at PD63 in all four groups (Figure 4.3A, 4.3B). One-way ANOVA showed a
significant effect of enrichment on differentiation for both controls and arsenic-exposed
animals regardless of perinatal exposure (F(1,21)=14.710, p=.001). Analysis of
phenotype indicated no significant difference in the percent of cell types between the two
groups exposed to enrichment (data not shown), similar to that seen in groups with no
exposure to enrichment. For animals exposed to enrichment, colocalization revealed 2778
± 232 BrdU+DCX+ and BrdU+NeuN+ labeled cells in control mice, a 39% increase over
control animals without exposure to enrichment. In arsenic-exposed mice with exposure
to enrichment, colocalization revealed 2613 ± 294 BrdU+DCX+ and BrdU+NeuN+ labeled
cells, a 121% increase over arsenic-exposed animals without exposure to enrichment and
a 31% increase over control animals not exposed to enrichment (Figure 4.4B, 4.4D).
Figure 4.4B shows a representative image of the DG from an arsenic-exposed animal
with one month of exposure to enrichment. Using a Student’s t-test with a Bonferroni
correction, brief exposure to enrichment significantly increased differentiation for
arsenic-exposed mice (Figure 4.4D, p=.006) and control mice (Figure 4.4D, p=.027).
These results show that regardless of perinatal exposure, the number of differentiated
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NPC in the DG significantly increased after one month of brief exposure to enrichment in
both control and arsenic-exposed animals.

4.3.5 Perinatal arsenic exposure altered mRNA expression of neurogenesis-related genes
To analyze several genes associated with neurogenesis, we compared gene expression
profiles between control and arsenic-exposed animals using a microarray on
microdissected dentate gyrus tissue from PD70 animals (n = 6 mice/group). All CT
values of genes of interest (GOI) were normalized to the average CT value of four
housekeeping genes (b-actin, B2m, GAPDH, Hsp90ab1), and subsequent ΔCT values
were assessed using the comparative CT method (ΔΔCT) (Livak & Schmittgen, 2001).
Fold change was measured as 2-ΔCT(arsenic or enrichment)/2-ΔCT (control or no
enrichment) for each GOI. Fold regulation is expressed as the negative inverse for
negative fold changes. A Student’s t-test was used to compare exposure conditions to
control conditions. Table 4.1 shows gene expression of arsenic-exposed adult males
compared to age-matched control animals. Of the 82 genes on the microarray, 13.4%
were significantly up-regulated (p<.05): these included Apbb1, Apoe, Ntn, Ache, and
Adora1, which are involved in apoptosis and in Alzheimer’s disease. Perinatal arsenic
exposure resulted in down-regulation (p<.05) of 18.3% of the genes on the array. These
included genes involved in axonogenesis and neurite growth (Dcx, Tnr, Robo1, Mtap2),
growth factors (Ptn, Odz, Fgf2), transcription factors (Pax6 and Creb1), synaptic
signaling molecules (Nf1 and Chrm2), and Notch and TGFb signaling molecules (Ascl1,
Hey2, Nrg1, and Tgfb1) as seen in Figure 4.5.
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Table 4.1 Aberrant expression of neurogenesis-related genes in perinatal arsenic-exposed mice
compared to control age-matched animals.
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Figure 4.5. Perinatal arsenic exposure alters genes involved in several different pathways important
in neurogenesis. Each box contains genes that have altered expression in the dentate gyrus derived from
adult male mice exposed to 50 ppb arsenic during development. Arrows indicate direction of expression,
while red asterisks indicate genes with reversed expression after exposure to environment enrichment for
one month. Genes altered include those involved in Alzheimer’s disease, apoptosis, axonogenesis, growth,
transcription, and Notch, synaptic, and TGFβ signaling. In each set of genes at least one aberrantly
expressed gene has a reversal of expression after enrichment indicating restoration.
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4.3.6 Exposure to an enriched environment reversed altered mRNA expression in arsenicexposed animals
After one month of brief, daily exposure (2–4 hours per day) to an enriched environment,
mRNA expression for neurogenesis-related genes was analyzed on dentate gyrus tissue
derived from adult male mice aged PD70 (n = 6 mice/group). Genes that were
significantly altered (p<.05) after this enrichment paradigm are displayed in Table 4.2 for
control animals and Table 4.3 for arsenic-exposed animals. Enrichment induced several
changes in both sets of animals in genes involved in growth; axonogenesis; cell cycle
dynamics; transcription factors; and Notch, WNT, and TGFb signaling. Enrichment in the
arsenic-exposed mice compared to their arsenic-exposed counterparts without exposure
to enrichment included significant up-regulation of 23 genes (Table 4.3); 12 of those 23
genes were previously down-regulated in arsenic-exposed animals prior to enrichment,
indicating a reversal of expression due to the enrichment exposure (Table 4.4 column 2).
These same 12 genes were up-regulated in control animals with exposure to enrichment
to a greater extent than in the arsenic-exposed animals (Table 4.4). Figure 4.6 shows all
genes that had altered expression after exposure to environmental enrichment in arsenicexposed animals and control animals, including those genes that were common to both
groups. Complete data sets for gene expression from the array are provided in Table 4.5
(arsenic-exposed), Table 4.6 (control animals with exposure to enrichment), and Table
4.7 (arsenic-exposed animals with exposure to enrichment).
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Table 4.2. Exposure to enrichment for one month altered gene expression in control adult male mice
compared to age-matched animals without exposure to enrichment, p<.05.

Table 4.3. Exposure to enrichment for one month altered gene expression in arsenic-exposed adult
male mice compared to arsenic-exposed age-matched animals without exposure to enrichment, p<.05.
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Table 4.4. Reversal of altered gene expression after one month exposure to an enriched environment
compared to arsenic-exposed animals without exposure to enrichment, p<.05.

Figure 4.6 One month of brief, daily exposure to enrichment alters gene expression in both arsenicexposed and control animals.
A Venn diagram depicts gene expression alterations after brief, daily exposure to enrichment for one month
in control animals (right) and in arsenic-exposed animals (left). Fold changes of displayed genes include up
and down regulation, p<.05 (Tables 4.2, 4.3). Gene expression changes common to both sets of animals are
displayed in the middle. These include genes involved in cell signaling, axonal growth, histone
maintenance, receptors, and cell cycle dynamics.
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Table 4.5. Expression of neurogenesis-related genes in arsenic-exposed adult male mice compared to
control age-matched animals, entire data set including non-significant changes.
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Table 4.6. Expression of neurogenesis-related genes in control adult male mice after brief, daily
exposure to enrichment for one month compared to control age-matched animals without exposure
to enrichment
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Table 4.7. Expression of neurogenesis-related genes in arsenic-exposed adult male mice after brief,
daily exposure to enrichment for one month compared to arsenic-exposed age-matched animals
without exposure to enrichment
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4.4 Discussion
It is widely recognized that high levels of arsenic produce deleterious effects on the brain.
The results presented here demonstrate that our developmental arsenic exposure model,
which represents a low and environmentally relevant concentration previously considered
safe, significantly impacts adult neurogenesis, specifically the number of differentiated
NPC in the SGZ. Given that our labeling method is more likely to underestimate the total
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degree of neurogenesis (Hayes & Nowakowski, 2002) (as it does not include BrdU+ only
cells that have exited the cell cycle after 12 hours for proliferation assessment), the fact
that we were able to discern a difference of 13% for proliferation (though not significant)
and 41% for differentiation after perinatal arsenic exposure in the adult animal is
substantive. Our subsequent studies will further elucidate arsenic’s impact on the
immature cells (DCX+) and mature cells (NeuN+) separately and on NPC survival.
Because adult neurogenesis has been shown to be integral for certain forms of learning
and memory, the hippocampal damage measured in this study may be responsible for the
cognitive deficits previously observed in this arsenic exposure model.

Other heavy metals similar to arsenic have been implicated in reduced adult neurogenesis
and deficits in cognition. A single injection of 5 µg methylmercury per gram body weight
at PD7, resulting in 500 ppb concentration in the brain, was enough to reduce adult
neurogenesis and hippocampal size and induce hippocampal-dependent learning and
memory deficits specifically in a spatial learning task (Falluel-Morel et al., 2007). Using
tritiated thymidine incorporation at PD7, the authors were also able to show inhibited
hippocampal DNA synthesis, degradation of cyclin E, and reduced cyclin D1 and D3
during postnatal development in which neurogenesis is highly active in the hippocampus
(Falluel-Morel et al., 2007). Mercury is a potent neurotoxin and elevated exposures may
lead to mental retardation; yet, this brief exposure resulted in significant morphological
changes and learning deficits similar to the results we report here using an arsenic
concentration an order of magnitude lower than that used in the methylmercury study.
Similarly, postnatal exposure to low levels of lead (0.2% lead acetate resulting in 6 ng
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Pb/g brain by PD80) from PD1 to PD30 results in increased anxiety behavior, deficits in
contextual fear conditioning, reduced adult neurogenesis (specifically differentiation),
and preferential astroglial lineage in PD80 Wistar rats (Jaako-Movits et al., 2005).
Another study using the same low level of lead acetate exposure from GD16 to PD21,
resulting in 35-40 ppm Pb in blood, showed altered differentiation of adult neurogenesis
at PD110 but no learning deficits in the Morris water maze (Gilbert et al., 2005). Chronic
exposure during development using an environmentally relevant dose of lead (1500 ppm
lead acetate resulting in 258 ppm Pb in blood) results in significantly decreased
proliferation and survival of granule cells and reduced mossy fiber input into CA3 region
of the hippocampus from the dentate, possibly accounting for the deficits in synaptic
plasticity and learning seen in lead-exposed animals (Verina et al., 2007). Our results
reveal that like mercury and lead, developmental arsenic exposure can induce potent
morphological damage in the adult hippocampus even at a low concentration, and these
deficits may be linked to altered behavioral changes seen in our model as we have
previously reported (Martinez et al., 2008; Martinez-Finley et al., 2009).

In vitro studies investigating the effects of developmental arsenic exposure in the parts
per billion range (up to 4 µM) have shown altered cell cycling including reduced viability,
minimal apoptosis, and an increase in caspase 3/7 resulting in inhibition of cell cycle
progression in primary embryonic rat midbrain neuroepithelial cells (Sidhu et al., 2006).
Other in vitro work with P19 mouse embryonic stem cells (ESC) has demonstrated that
low concentrations of arsenic in the ppb range (0.1 up to 1.0 µM sodium arsenite)
suppress the differentiation, but not proliferation, of ESC into neurons indicated by
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reduced Tuj1, neurogenin 1, neurogenin 2, and NeuroD expression in arsenic-treated cells
(Hong & Bain, 2012a). The results from these studies concur with our in vivo
developmental model of arsenic exposure and the work presented here, suggesting that
arsenic impacts the number of differentiated cells among several cell types both in vivo
and in vitro.

Exposure to higher concentrations of arsenic (ppm range up to 68 mg/L) during
adulthood results in changes in synaptic plasticity components, including the expression
of the NMDA receptor subunit NR2A, PSD-95, and pCaMKIIa in the hippocampus, all
of which are important for learning and memory (Luo et al., 2012). In accordance with
our own previous results (Martinez-Finley et al., 2011), increased SynGAP, a negative
regulator of Ras/MAPK activity, along with decreased pERK1/2 activity is also seen after
chronic low dose arsenic exposure in the adult. Two months of 4.0 mg/L As2O3 (ppm
range) exposure beginning at four months of age decreases both proliferation and
differentiation of newly labeled cells in the dentate gyrus in mice (Liu et al., 2012). This
deficit was ameliorated after two months of drinking distilled water, suggesting that the
effects of arsenic are transient. Our model indicates that significant changes in
differentiation can be measured several weeks after developmental 50 ppb arsenic
exposure, suggesting that the effect is not transient. It is possible that because arsenic is
present during development of the brain, arsenic’s effects are much longer lasting than
those seen during adulthood exposure due to arsenic-induced molecular changes. For
example, low concentrations of arsenic during development impact the epigenetic status
of histones and DNA, which play an important role in gene expression regulation; these
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epigenetic changes are concurrent with learning deficits seen in certain behavior tasks
(Reichard & Puga, 2010; Martinez et al., 2011). Thus, we hypothesize that behavioral
deficits seen during adulthood of mice developmentally exposed to arsenic are due, in
part, to lack of differentiated cells necessary for hippocampal-dependent learning.

To support the differences in adult neurogenesis we observed in arsenic-exposed animals,
we sought to elucidate if there was transcriptional dysregulation of genes involved in
adult neurogenesis in the dentate gyrus. In accordance with our morphological findings,
arsenic exposure during the perinatal period resulted in down-regulation of 15 target
genes (18%) and up-regulation of 11 target genes (13%) in adult animals.

Up-regulation of genes included those involved with apoptosis (Ntn1, Adora1, and Ache)
and Alzheimer’s disease (ApoE, Apbb1). In particular, acetylcholinesterase (Ache) is an
important regulator of apoptosis; increased expression, while not initiating apoptosis, has
been correlated with apoptotic cells (Xie et al., 2011). Adult arsenic exposure (20 mg/kg
body weight for 28 days in rats) results in decreased activity of acetylcholinesterase in the
hippocampus, but also decreased binding of (3)H-QNB, a label of muscarinic-cholinergic
receptors (Yadav et al., 2011). While the increase in Ache mRNA is not indicative of
greater activity of the enzyme, it could be overcompensating for a disruption in
cholinergic signaling as suggested by the significantly reduced Chrm2 mRNA, a
muscarinic cholinergic receptor (Table 4.1). The hippocampus receives several
cholinergic inputs that may contribute to the formation of new neurons; additionally,
cholinergic transmission is important for learning and memory and altered acetylcholine
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levels have been associated Alzheimer’s-related cognitive deficits (Veena et al., 2011).
Thus, aberrant cholinergic transmission induced by arsenic could play a part in reduced
adult neurogenesis seen in our studies, along with up-regulation of the genes Apbb1 and
ApoE, both of which are associated with Alzheimer’s disease and have been shown to
impair adult neurogenesis (Ghosal et al., 2010).

Additionally, while adult exposure to low concentrations of arsenic does not induce
apoptosis in the hippocampus (Liu et al., 2012), developmental exposure to arsenic
increases apoptosis in conjunction with decreased Nissl body staining in neuronal bodies
in the hippocampus (Fan et al., 2013). In addition to increased apoptosis after
developmental arsenic exposure, a study demonstrated significant down-regulation of
nerve growth factor (NGF) and GAP-43 mRNA (Fan et al., 2013) in response to arsenic,
similar to the results from our arrays showing significant down-regulation of mRNA from
Ptn, Odz1, and Fgf2. These growth factors are also involved in axonogenesis and neurite
outgrowth, which arsenic exposure can impair (Aung et al., 2013). Similarly, several
important genes responsible for proper maturation and axonal growth including
doublecortin, tenascin R, Mtap2, and Robo1 are all significantly down-regulated in
arsenic-exposed animals (Table 4.1). This further supports the notion that arsenic is
impacting the ability of NPC to develop into mature neurons, possibly leading to the
decrease in differentiated neurons in the dentate gyrus. It should be noted that the number
of surviving neural progenitors does affect the number of differentiated cells as well;
however, NPC survival was not assessed after four weeks. Thus, it is unclear whether this
lack of differentiated cells is due to deficits in the surviving NPC population or issues
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with differentiation program; however, the gene expression data do suggest that arsenic
exposure is impacting neurogenesis programs in the dentate gyrus.

Several pathways, including Notch, TGFb, and WNT, all had factors that were aberrantly
expressed in the arsenic-exposed animals (Table 4.1). Interestingly, arsenic induced an
up-regulation of Dll1, a ligand that promotes Notch signaling, which enhances
proliferation of progenitor cells.

However, increased Dll1 also drives the down-

regulation of Ascl1, which was also down-regulated in arsenic-exposed animals. Ascl1,
or Mash1, is a basic helix-loop-helix (bHLH) transcription factor that increases
expression of neurogenins to promote neuronal differentiation programs (Ables et al.,
2011). Thus, the Notch signaling program may be enhanced at the expense of the
differentiation of progenitors as reflected in the deficits in differentiation of NPCs in
arsenic-exposed animals (Shimojo et al., 2011). Arsenic exposure resulted in downregulation of other factors important for differentiation including Odz and Nrg1 (also
involved in Notch signaling) and a trend toward down-regulation of neurogenins 1 and 2,
though not significant. Thus, all of these changes in genes important for proper
differentiation could be contributing to the lack of differentiated cells we observed after
developmental arsenic exposure.

It’s well established that exposure to an enriched environment can lead to increased adult
neurogenesis, thereby enhancing certain forms of learning and memory (Kempermann et
al., 1997; Zhao et al., 2008). Yet, our previous publications have demonstrated that
developmental toxins, such as alcohol, reduce the ability of the neurogenic environment
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in the hippocampus to respond to a continuous enrichment paradigm (Choi et al., 2005).
Other studies reveal that brief exposure to enrichment is adequate to improve behavior
and adult neurogenesis (Rampon et al., 2000; Frick & Fernandez, 2003; Veena et al.,
2009). To reduce the likelihood that animals habituate to the enriched housing
environment, we decided to use a “playground” enrichment paradigm in which animals
spend two to four hours per day in the enrichment cages (with toys, ladders, running
wheels, housing, and other animals) and are subsequently returned to their standard home
cages. We found that this model of brief, daily exposure to enrichment sufficiently
increased both proliferation and differentiation in both control and arsenic-exposed
animals regardless of perinatal exposure. The effect on control animals was as expected:
significantly increased proliferation of 70%, likely due to exercise from use of the
running wheel as suggested by work from van Praag, and significantly increased
differentiation of 39%, likely due to exposure to novelty, other animals, and toys (van
Praag, 2008). The use of both a running wheel and toys for enrichment has additive
effects on adult neurogenesis and may likely account for the robust increase seen in both
sets of animals (Fabel et al., 2009). While the increase in proliferation of arsenic-exposed
animals after enrichment was not significant, we consider a 53% increase to be
considerable. Qualitative evidence suggests that a substantial difference exists even if not
statistically significant (Figure 4.4C). Two reasons for this lack of significance include 1)
the inherent variability in measuring neurogenesis and 2) the fact that, while arsenic may
influence NPC proliferation, this impact may only be observed as the lack of significant
neurogenic response to the enrichment, as seen in other studies using teratogens (e.g.,
alcohol) (Choi et al., 2005). Surprisingly, we found that brief exposure to enrichment led
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to increased differentiation (121%) in perinatal arsenic-exposed animals compared to
their arsenic-exposed counterparts without exposure to enrichment. Cell counts show that
arsenic-exposed animals have increased levels of differentiation after enrichment similar
to those seen in control animals without exposure to enrichment. As expected, exposure
to enrichment also increased mRNA levels of genes involved in proliferation and
differentiation, including several growth and transcription factors (Table 4.3, 4.4; Figure
4.5). However, in control enriched animals versus control, no enrichment animals (Table
4.2), enrichment induces suppression of factors like Noggin, Cdkr1, Notch1, and Sox3,
suggesting a shift from proliferation to differentiation in response to enrichment (Fabel et
al., 2009). Exposure to enrichment significantly reversed aberrant gene expression in
arsenic-exposed animals (Tables 4.3, 4.4; Figure 4.5), inducing up-regulation of several
genes important for axonogenesis, cell cycle dynamics, Notch signaling, and transcription
factors. These results suggest that even though arsenic interferes with the number of
differentiated cells in the dentate gyrus, the neurogenic morphological and genetic
response to enrichment both is not impaired when using this particular playground model.

Evidence elucidating the importance of intact adult neurogenesis suggests that it is crucial
for some types of hippocampal-dependent learning and memory, and ablation of adult
neurogenesis results in learning and memory deficits similar to those observed in our
arsenic model. We have demonstrated that exposure to 50 ppb arsenic, which is
metabolized more efficiently in the mouse (and more closely models an exposure of 10
ppb arsenic in humans), during all three trimesters of gestational and postnatal
development induces hippocampal-dependent learning and memory deficits (Martinez et
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al., 2008; Martinez-Finley et al., 2009). Results presented here indicate it is likely that
altered neurogenesis is one mechanism responsible for these deficits. This study is the
first to show that developmental exposure to a low concentration of arsenic induces
changes the number of differentiated adult neural progenitors in the subgranular zone of
the hippocampus and aberrant expression of neurogenesis-related genes. Further studies
are needed to elucidate mechanisms that produce these genetic and morphological
changes we have observed.
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Abstract
Several epidemiological studies have reported an association between arsenic exposure
and increased rates of psychiatric disorders, including depression, in exposed populations.
We have previously demonstrated that developmental exposure to low amounts of arsenic
induces depression in adulthood along with several morphological and molecular
aberrations, particularly associated with the hippocampus and the hypothalamic-pituitaryadrenal (HPA) axis. The extent and potential reversibility of this toxin-induced damage
has not been characterized to date. In this study, we assessed the effects of fluoxetine, a
selective serotonin reuptake inhibitor antidepressant, on adult animals exposed to arsenic
during development. Perinatal arsenic exposure (PAE) induced depressive-like symptoms
in a mild learned helplessness task and in the forced swim task after acute exposure to a
predator odor (2,4,5-trimethylthiazoline, TMT). Chronic fluoxetine treatment prevented
these behaviors in both tasks in arsenic-exposed animals and ameliorated arsenic-induced
blunted stress responses, as measured by corticosterone (CORT) levels before and after
TMT exposure. Morphologically, chronic fluoxetine treatment reversed deficits in adult
hippocampal neurogenesis (AHN) after PAE, specifically differentiation and survival of
neural progenitor cells. Protein expression of BDNF, CREB, the glucocorticoid receptor
(GR), and HDAC2 was significantly increased in the dentate gyrus of arsenic animals
after fluoxetine treatment. This study demonstrates that damage induced by perinatal
arsenic exposure is reversible with chronic fluoxetine treatment resulting in restored
resiliency to depression via a neurogenic mechanism.

135

5.1 Introduction
In a recent report by the ATSDR (Agency for Toxic Substances and Disease Registry),
arsenic was singled out as a considerable threat to human health compared to other
toxicants, outranking even mercury and lead. While the World Health Organization
standard remains at 10 parts per billion (ppb), it is estimated that over 100 million people
worldwide are exposed to arsenic in amounts that well exceed this standard (in the ppm
range) (Tyler and Allan, 2014). Research over the past few decades has identified
pathologies resulting from chronic arsenic exposure, demonstrating that this metalloid
disrupts many organ systems in the body, including the brain (Brinkel et al., 2009; Farzan
et al., 2013). Epidemiological studies report that cumulative long-term exposure to low
doses of arsenic correlates with learning and memory deficits in children and increased
rates of depression in adults (Zierold et al., 2004; Rosado et al., 2007; O'Bryant et al.,
2011; Roy et al., 2011). Additionally, in almost every country assessed, individuals
residing in arsenic-affected areas report a poorer quality of life, poorer mental health, and
are more likely to have a mood disorder, such as anxiety or depression, than individuals
without significant arsenic exposure (Fujino et al., 2004b; Sen & Sarathi Biswas, 2012;
Syed et al., 2012).

Research investigating the role of environmental factors, including toxin exposure, in the
etiology of depression has gained momentum, as heritability studies report high
discordance of the disorder and individual variability in gene expression (Byrne et al.,
2013). The early environment during development has been demonstrated to exert
profound effects on the modulation behavior and susceptibility to psychiatric disorders in
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adulthood (Hochberg et al., 2011). In several rodent studies, pre- and postnatal toxin
exposure results in the behavioral endophenotypes of anxiety and depression (Johansson
et al., 2007; Onishchenko et al., 2008; Haider et al., 2013). These toxin-induced
behaviors are often accompanied by concurrent abnormalities in the regulation of the
hypothalamus-pituitary-adrenal (HPA) axis (Hellemans et al., 2008; Hellemans et al.,
2010; Bolton et al., 2013). Individuals with robust homeostatic responses to stress are
often considered resistant to depression (Krishnan & Nestler, 2008), thus dysregulation of
the HPA axis after toxin exposure may be a mechanism by which toxins, like arsenic,
increase susceptibility to psychiatric disorders. Indeed, we have previously demonstrated
that perinatal (pre- and postnatal developmental) arsenic exposure (PAE) alters
glucocorticoid signaling within the HPA axis, blunts stress responses, increases stress
reactivity (Goggin et al., 2012), and results in depressive-like behavior in adulthood
(Martinez et al., 2008, Martinez-Finley et al., 2009). In addition to these aberrations, we
have also observed altered hippocampal morphology and deficits in adult hippocampal
neurogenesis after PAE (Tyler & Allan, 2013). Yet, the pathophysiology of arsenicinduced depression and the response to antidepressants after arsenic exposure has not
been fully explored.

Fluoxetine, selective serotonin reuptake inhibitor (SSRI) antidepressant, is the most
commonly prescribed treatment for depression. In addition to attenuation of stressinduced depressive-like behaviors, fluoxetine contemporaneously increases adult
hippocampal neurogenesis (AHN) in rodents (Wang et al, 2008, Malberg and Duman,
2003, David et al., 2009, Rainer et al., 2009, (David et al., 2009; Mahar et al., 2014).
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Impaired AHN has been intimately linked with the onset of depression: recent clinical
research reported that depressed patients treated with fluoxetine do not exhibit
hippocampal atrophy or reduced cell numbers as those patients without treatment, further
supporting the “neurogenic hypothesis of depression” (Boldrini et al., 2013). Fluoxetine
treatment has also been shown to normalize the corticosterone (CORT) response
associated with aberrant HPA signaling after prenatal stress (Ishiwata et al., 2005);
restoration of HPA axis function is associated with robust increases in neurogenesis in
cell culture as well (Anacker et al., 2013). However, the molecular and behavioral
responses to fluoxetine in a rodent model with arsenic-induced hippocampal
morphological and behavioral deficits have not been determined to date.

To investigate the reversibility of arsenic-induced damage, we evaluated the effect of
chronic fluoxetine treatment on behavioral, morphological, and molecular impairments
resulting from PAE. To this end, we measured survival and differentiation of neural
progenitor cells (NPCs) along with expression of several proteins involved in
neurogenesis specifically in the dentate gyrus to determine fluoxetine’s mechanism of
action in arsenic-exposed animals. We further characterized the vulnerability to stressinduced depression generated by arsenic exposure by evaluating behavior and
corticosterone (CORT) before and after brief exposure to a predator odor. Chronic
fluoxetine treatment reversed deficits in the learned helplessness task; attenuated blunted
stress responses and immobility after predator exposure; increased NPC survival and
differentiation; and increased expression of brain-derived neurotrophic factor (BDNF),
the glucocorticoid receptor (GR), histone deacetylase 2 (HDAC2), and cAMP response
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element binding protein (CREB) in the DG of arsenic-exposed animals but not in controls.
This study suggests that impairments induced by developmental exposure to an
environmental toxin like arsenic may be altered with pharmacological intervention in
adulthood, leading to normalized hippocampal morphology and behavior.

5.2 Materials and Methods
5.2.1 Perinatal arsenic exposure paradigm
All procedures were conducted in accordance with protocols approved by the
Institutional Animal Care and Use Committee at the University of New Mexico. Animals
were maintained in a 22°C vivarium on a 12-hour reverse light/dark cycle with lights off
at 0800 and ad libitum access to water and food. Exposure to arsenic during all three
trimesters of brain development was performed as previously described (Tyler & Allan,
2013). Briefly, singly housed female C57BL/6J mice aged 55 days (Jackson Laboratories,
Bar Harbor, ME) were acclimated to drinking 50 ppb arsenic-laced water (sodium
arsenate, Sigma-Aldrich, St. Louis, MO) for seven to ten days prior to mating. Dams
were provided either 50 ppb arsenic water or tap water during breeding and pregnancy
until offspring were weaned (Figure 5.1A). Offspring were housed two per cage with tap
water for the remainder of the study. The number of dams used in this study is reflected
in the number of litters provided for each experimental analysis (i.e. n = 8-10 indicates
that only one animal was used from each of 8-10 litters from 8-10 different dams.) Adult
male offspring (postnatal day 70) from dams drinking arsenic water were euthanized by
rapid decapitation for tissue dissection or by overdose with sodium pentobarbital
followed by transcardiac perfusion with 4% paraformaldehyde for neurogenesis
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assessment.

5.2.2 Fluoxetine treatment paradigm and plasma analysis
Fluoxetine hydrochloride (Sigma-Aldrich, St. Louis, MO) was provided for 35 days in
drinking water containing 0.066% saccharin to mask any taste of the drug beginning at
postnatal day (PD) 35. Male offspring from dams drinking arsenic or tap water were
separated into three groups: those drinking 50 mg/L fluoxetine, 100 mg/L fluoxetine, and
control (only 0.066% saccharin) as seen in Figure 5.1A. Fluoxetine solutions were
shielded from the light and changed every other day. Weight gain and fluoxetine
ingestion were monitored weekly.

5.2.3 Predator odor exposure and stress response
Exposure to 2,3,5-trimethyl-3-thiazoline (TMT) (Contech, Victoria, BC, Canada;
#300000368) was performed as previously described (Goggin et al., 2012). Animals were
individually transferred to an exposure cage containing filter paper saturated with 100 µL
of 3% (v/v) TMT for ten minutes. Group-housed animals were exposed concurrently in
parallel and returned to home cages for twenty minutes after the ten-minute exposure.
Several cohorts of animals were exposed to TMT, some of which were placed into the
forced swim task 20 minutes after exposure, while others were rapidly decapitated for
trunk blood collection using Safe-t-Fill EDTA capillary tubes. Samples were centrifuged
at 1000 × g for 10 min at 4°C. Plasma was removed and stored at −80°C. Corticosterone
(CORT) levels in plasma were determined using the DetectX Corticosterone EIA Kit
(Arbor Assays, K014-H1) per manufacturer instructions with a 1:100 dilution of plasma
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prior to analysis. Optical density absorbance was determined by an Infinite M200
instrument and data were analyzed using 4PLC ReaderFit online software.

5.2.4 Open field
Adult male mice (PD70) were permitted to explore a novel open arena, measuring 40 cm
× 40 cm × 35 cm and constructed of white Plexiglas, for fifteen minutes for two
consecutive days. Dim red overhead lighting was used along with white spotlights to
illuminate the corners of the open field at 45-60 lumen and the center at 75-90 lumen.
Total distance traveled was measured with the aid of an Ethovision video tracking system
using the coordinates of the animal’s center of mass image compared against a template
of the arena dimensions. Locomotor activity in a novel environment was assessed the first
day, and locomotor activity in a familiar environment was assessed on the second day.

5.2.5 Forced swim
The forced swim task (FST) was conducted essentially as previously described (Caldwell
et al., 2008; Martinez et al., 2008) with a critical difference in the time of behavior
assessment. Our prior studies used a conventional light/dark cycle (lights on at 0800);
however, our current studies use a reverse light/dark cycle (lights off at 0800). Thus, all
behavioral assessments occurred during the nocturnal (active) phase of the animals’
circadian cycle (Kelliher et al., 2000). Adult male mice (PD70) were placed in a clear
Plexiglas cylinder (46 cm height × 30 cm diameter) filled with warm water (27°C) to a
depth such that the animal’s tail did not touch the bottom of the container. Both latency to
cease active swimming and total immobility (cessation of escape directed movement)
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were scored for five minutes by an experimenter blind to group designations (Porsolt et
al., 1977). The forced swim test was conducted with and without exposure to predator
odor in separate cohorts of animals 20 minutes after cessation of the TMT exposure.

5.2.6 Learned helplessness
The learned helplessness (LH) task was conducted essentially as previously described
(Caldwell et al., 2008; Martinez et al., 2008) with critical differences including the time
of behavioral assessment and a more mild inescapable shock training. As previously
stated, all behavioral assessment were performed during the nocturnal (active) phase of
the animals’ circadian cycle, as this has been shown to affect stress-related behavior.
Animals were trained in the Coulbourn™ Habitest© shuttle box apparatus with 20
unpredictable foot shocks (0.5 mA, 2-sec) over the course of ten minutes for one session.
Twenty-four hours later, animals were placed in the shuttle box and given 28 trials of
shocks with a 30-second intertrial interval. Escape latency was measured as the time
between opening and closing of the shuttle box door. The criterion for determining the
number of trials to acquisition was set as three consecutive escape latencies of 10 seconds
or less. Failure to escape after 24 seconds resulted in shock termination and door closure.

5.2.7 Assessment of adult neurogenesis and confocal stereology
Differentiation and survival of neural progenitor cells (NPC) in the dentate gyrus was
assessed as previously described (Tyler & Allan, 2013). Briefly, 5-bromo-2’deoxyuridine (97% Sigma-Aldrich, St. Louis, MO) BrdU was used to label NPCs in a
pulse-chase assay using four injections (I.P.) of 50 mg/kg BrdU over a 12-hour period at
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PD40. Thirty days later, coronal sections (40 µm) of the rostral-caudal extent of the
hippocampus were obtained from 4% paraformaldehyde perfused adult male mice
(PD70). Immunohistochemistry was performed for 1:6 serial sections over the dorsal
extent of the dentate gyrus. Free-floating sections were incubated for 72 hours in primary
antibodies for BrdU (1:300; Abcam, ab6326) and NeuN (1:1500; Millipore, MAB377)
and subsequently incubated in secondary antibodies Alexa 488 (1:500; Invitrogen,
A11006) and Alexa 647 (1:500; Invitrogen, A21236) and DAPI (1:300 nM; Sigma) for 2
hours at room temperature. Colocalization of BrdU and NeuN was determined for
measurement of differentiated NPCs, while BrdU-only labeled cells were indicative of
survival of NPCs. While it should be noted that some BrdU cells might be of glial origin
(Steiner et al., 2004), this approach is congruent with other recent studies assessing
differentiation and survival (Klempin et al., 2010; Hamilton et al., 2014; Jiang et al.,
2014). Confocal stereology was performed used an Olympus DSU spinning disk inverted
IX-81 microscope; a 40X objective through the orthogonal plane of the tissue was used to
visualized colocalization of markers. Quantification of the number of cells with
colocalization for 10 slices per brain was performed using StereoInvestigator software;
specifications include a guard zone of 2 µm and a probe of 20 µm. Images for publication
were acquired using a Zeiss LSM510 META confocal microscope with a 100X oil
objective or a 10X objective to obtain maximum intensity projections of Z-stacks.

5.2.8 Protein expression quantification via immunoblotting
Immunoblotting was conducted essentially as previously described using established
protocols (Caldwell et al., 2014). Microdissected dentate gyrus tissue derived from one
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animal (Hagihara et al., 2009) was homogenized in a Biomasher II disposable
microhomogenizer (Kimble Chase) with homogenization buffer containing 20 mM TrisHCl, 1 mM EDTA, 320 mM sucrose, protease inhibitor cocktail (1:1000; Sigma, P8340),
and 200 µM sodium orthovanadate, pH 7.4. The nuclear fraction was obtained via
centrifugation at 1000 × g for 6 minutes at 4°C followed by resuspension in
homogenization buffer and further centrifugation at 1000 × g for 10 minutes; the
supernatant was collected as the post-nuclear lysate and stored at -80°C. The nuclear
pellet was resuspended in homogenization buffer containing 1% (v/v) Triton X-100, 75
mM NaCl, and 75 mM KCl; the nuclear envelope was lysed via sonication and
centrifuged at 15,000 × g for 10 minutes. The supernatant was collected as the nuclear
fraction and stored at -80°C. Target proteins were assessed in the nuclear (CREB: 20 µg,
GR: 10 µg, HDAC2: 10 µg) and post-nuclear (BDNF: 21 µg) subcellular fractions of the
dentate gyrus. Samples from each of four groups (arsenic and control animals drinking
only 0.066% saccharin solution or 100 mg/L fluoxetine and 0.066% saccharin solution)
were run on the same blots for each target protein. Samples (n = 7-10 per group) were
loaded in NuPAGE 4 to 12% Bis-Tris gels (Invitrogen, NP0336), separated by
electrophoresis, and transferred to PVDF membranes (Millipore Corporation,
IPFL00010). Membranes were incubated overnight using the following primary
antibodies in 1:1000 dilutions: anti-CREB (Cell Signaling, 9104), anti-GR (Santa Cruz,
sc-1004), anti-HDAC2 (Santa Cruz, sc-81599), and anti-BDNF (Santa Cruz, sc-546). All
primary antibodies were diluted in PBS-T (1.06 mM KH2PO4, 2.97 mM Na2HPO4, 155
mM NaCl, 0.1 % (v/v) Tween-20, pH 7.4). Membranes were incubated for 45 minutes in
respective secondary antibodies dilute to 1:15,000 in PBS-T: IRDye 680RD (LiCOR
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Biosciences, 926-68073) and IRDye 800CW (LiCOR Biosciences, 926-32212).
Quantification of immunoreactivity was performed using two-channel infrared detection
Odyssey® Imaging System (LI-COR Biosciences); Image Studio (LI-COR Biosciences,
version 3.1) was used for quantification assessment. For normalization, all blots were
stained with IRDye® Blue Protein Stain (LI-COR Biosciences, 3343C056); Coomassie
staining was demonstrated to be linear within the range of protein concentrations used in
these studies. All blots were normalized to their respective Coomassie stain for
quantification.

5.2.9 Statistical Analysis
Global analysis of variance (ANOVA) for two factors (arsenic, fluoxetine) was used to
assess all data; further analysis of significant main effects was performed using post hoc
Student’s t-test with Bonferonni correction. Homogeneity of variance was confirmed
using Levene’s test. Data are presented as mean ± SEM, and P value <.05 was deemed
statistically significant for all experiments. The reported n refers to the number of litters
used in each experiment, with only one animal per litter used in each experimental group
to avoid litter effects. Separate animals were used for each behavioral experiment, and
tissue derived from animals without behavioral assessment was used for all molecular
and neurogenesis studies. All studies contain at least three different breeding rounds per
assay; n = 7−11 and is reported for each assay.
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5.3 Results
5.3.1 Perinatal arsenic exposure does not interfere with consumption of fluoxetine in
adulthood
Fluoxetine consumption was monitored every other day for five weeks (Figure 5.1A)
beginning on PD35. Average intake was calculated for each group: 9.79 ± 0.21 and 9.97
± 0.21 mg/kg/day for arsenic and control groups consuming 50 mg/L fluoxetine, and 16.6
± 0.66 and 17.1 ± 0.47 mg/kg/day for arsenic and control groups consuming 100 mg/L
fluoxetine. No differences among exposure groups in consumption of fluoxetine were
found (Figure 5.1B). Weight gain was monitored weekly in all animals; no differences in
weight were observed among exposure or treatment groups (Figure 5.1C). Average
weight gain per week was 1.44 ± 0.13 mg/week/animal. (n = 8-10 animals per group
where n = number of litters)

146

Figure 5.1. Perinatal arsenic exposure paradigm followed by chronic fluoxetine treatment.
(a) Dams were provided water with 50 parts-per-billion (ppb) arsenic 10 days prior to and throughout
breeding and pregnancy until weaning of offspring at postnatal day 23 (PD23). Offspring were placed on
tap water until PD35. Male offspring were split into 6 groups: arsenic-exposed or control animals
consuming either 50 mg/L fluoxetine with 0.066% saccharin, 100 mg/L fluoxetine with 0.066% saccharin,
or 0.066% saccharin only for 35 days (approximately PD35-PD70). BrdU (5-bromo-2’-deoxyuridine) was
used to label neural progenitor cells in a pulse-chase assay using four injections (I.P.) of 50 mg/kg BrdU
over a 12-h period at PD40. Assessments of neurogenesis, behavior, and protein expression were conducted
at PD70. (b) Male offspring from either the arsenic-exposed or control groups consume the same quantities
of fluoxetine in drinking water. Average consumption for the arsenic-exposed offspring was 9.79 ± 0.21
mg/kg/day and 16.6 ± 0.66 mg/kg/day for the 50 mg/L and 100 mg/L fluoxetine groups, respectively.
Average consumption for the control groups was not significantly different from arsenic-exposed groups:
9.97 ± 0.21 mg/kg/day and 17.1 ± 0.47 mg/kg/day for the 50 mg/L and 100 mg/L fluoxetine groups,
respectively. (c) Fluoxetine consumption did not alter weight gain in the exposure groups; weight gain was
monitored weekly. All animals were approximately the same weight (after week 4) during assessments.
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5.3.2 Fluoxetine treatment prevents depressive-like symptoms induced by perinatal
arsenic exposure in a mild learned helplessness task
We have previously demonstrated that arsenic induces depressive-like symptoms in a
robustly stressful learned helplessness (LH) task consisting of one hour of training with
120 uncontrollable foot shocks. In this experiment, we sought to assess the response to
mild stress, which does not result in depressive-like symptoms in control animals. To
validate the construct validity of such a task, chronic fluoxetine treatment (for one month
prior to the LH task) was used to assess if depressive-like symptoms could be prevented.
A mild learned helplessness task consisting of 20 uncontrollable foot shocks given over
10 minutes and subsequent assessment of latency 24 hours later, revealed a significant
main effect of arsenic (F(1,47) = 6.58; p = .01) and of fluoxetine (F(2,47) = 9.19; p = .0004)
with a significant interaction (F(2,47) = 7.24; p = .002). Results are provided graphically in
Figure 5.2A for average escape latency and in Figure 5.2B for trials to acquisition.
Average escape latency for arsenic-exposed animals was 10.4 ± 1.8 seconds which was
reduced by 52% with fluoxetine treatment (4.9 ± 0.6 seconds), (p<.001) independent of
dose (50 mg/L versus 100 mg/L). Average escape latency for control animals was 5.4 ±
0.4 seconds (a 48% reduction compared to arsenic-exposed animals, p<.01) with no
effect of fluoxetine consumption, suggesting lack of depressive-like symptoms.
Assessment of trials to acquisition suggests a similar pattern: significant main effects of
arsenic (F(1,47) = 4.39; p = .03) and of fluoxetine (F(2,47) = 8.77; p = .0006) with a
significant interaction (F(2,47) = 4.28; p = .02) yet no differences among fluoxetine
treatment groups in control animals. Due to a lack of dose-dependent effects, all
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subsequent treatments used 100 mg/L fluoxetine in drinking water. (n = 8-10 animals per
group where n = number of litters)

Figure 5.2. Chronic fluoxetine treatment enhances the resiliency to stress-induced depression and
restores the stress response in arsenic-exposed animals at PD70. (a) Perinatal exposure to arsenic
increases escape latency in the learned helplessness (LH) task at PD70 (p < .01). Chronic treatment with 50
mg/L or 100 mg/L fluoxetine decreases latency in arsenic-exposed animals (p < .001) in a doseindependent manner. Escape latency of control animals with and without fluoxetine treatment was not
altered in this mild LH task. (b) Perinatal arsenic exposure increases the number of trials to criteria in the
LH task at PD70 (p < .01). The criterion for determining the number of trials to acquisition was set as three
consecutive escape latencies of 10 s or less. Chronic treatment with 50 mg/L or 100 mg/L fluoxetine
decreases the number of trials to acquisition in arsenic-exposed animals (p < .01) in a dose-independent
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manner. Average number of trials to acquisition for control animals with and without fluoxetine treatment
was not altered in this mild LH task. (c) Total immobility in the forced swim test (FST) of arsenic-exposed
animals is increased compared to controls (p < .01) 30 min after the onset of a 10-min predator odor
exposure (TMT). Chronic treatment with 100 mg/L fluoxetine decreased immobility time of arsenicexposed animals (p < .001), but had no effect on immobility time of control animals. (d) Latency to
immobility in the FST is decreased in arsenic-exposed animals compared to controls 30 min after the onset
of a 10-min predator odor exposure (TMT) with a significant main effect of arsenic (F(1,28) = 12.7; p
= .001). Chronic treatment with 100 mg/L fluoxetine increased latency to immobility of arsenic-exposed
animals (p < .05), but had no effect on the latency duration in control animals. (e) Basal corticosterone
(CORT) levels in serum are elevated in arsenic-exposed animals at PD70 compared to controls (p < .05).
Chronic treatment with 100 mg/L fluoxetine had no effect on basal CORT levels in either perinatal
exposure group. (f) The percent CORT response, measured as CORT levels 30 min post- onset of the 10min exposure to TMT divided by the basal CORT levels, was reduced by perinatal arsenic exposure (p
< .01). Chronic treatment with fluoxetine restored the percent CORT response (p < .01) in arsenic-exposed
animals, but had no effect on control animals. ***p < .001, **p < .01, *p < .05.

5.3.3 Fluoxetine treatment prevents depressive-like behavior induced by perinatal arsenic
exposure after TMT predator odor exposure in the forced swim task
We sought to assess stress-induced depressive-like behavior during the active nocturnal
cycle in a forced swim task (FST) using warm water (25-27°C) to prevent the
hypothermia confound observed in several FST paradigms (Petit-Demouliere et al., 2005).
We have previously shown adult males perinatally exposed to arsenic exhibit depressivelike behaviors during the diurnal cycle. To determine the resiliency of arsenic-exposed
animals and the efficacy of fluoxetine, we assessed depressive-like symptoms in the
forced swim task 20 minutes after a 10-minute exposure to a predatory odor
(trimethylthiazoline, TMT, the main component of fox urine) for which we have
previously shown arsenic-exposed animals do no respond appropriately. Results are
provided graphically in Figure 5.2C for total immobility and in Figure 5.2D for latency.
Analysis of immobility revealed no significant main effects; however, post hoc analysis
indicates that arsenic exposure increases immobility (p<.01) and treatment with 100 mg/L
fluoxetine ameliorates this depressive-like behavior in the arsenic-exposed group
(p<.001). Measurement of latency to cease active swimming revealed a significant main
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effect of arsenic (F(1,28) = 12.7; p = .001), no significant main effect of fluoxetine, and an
interaction (F(1,28) = 10.99; p = .0025), suggesting that arsenic reduces resiliency in the
FST. Fluoxetine treatment (100 mg/L) significantly increased latency in arsenic-exposed
animals (p<.05) indicating restoration of resiliency, but had no effect on control animals.
(n = 8-10 animals per group where n = number of litters)

5.3.4 Neither perinatal arsenic exposure nor fluoxetine treatment alters locomotion in the
open field task
To determine if altered behavior in the LH and FST behavioral tasks was due to
impairment of locomotion, we assessed total movement in the open field test (OFT). Data
analysis indicated no significant main effects of arsenic or fluoxetine at PD70 on Day 1
of the OFT. Total movement decreased in all groups on Day 2 of the OFT as expected
(data not shown). (n = 8-10 animals per group where n = number of litters)

5.3.5 Fluoxetine treatment restores the blunted stress response to predator odor induced
by perinatal arsenic exposure
We have previously demonstrated that arsenic-exposed mice fail to activate a normal
corticosterone (CORT) response to TMT (Goggin et al., 2012); to determine if fluoxetine
attenuates this effect, CORT levels at baseline and after TMT exposure were determined
in all animals. As seen in Figure 5.2E, perinatal arsenic exposure increases the baseline
levels of CORT: 45.3 ± 3.2 ng/ml compared to 28.8 ± 5.6 ng/ml in control animals
(p<.05) as expected. Fluoxetine treatment did not alter baseline CORT levels in arsenicexposed animals or in control animals. Plasma was obtained 30 minutes after the onset of
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a 10-minute TMT exposure; subsequent analysis of change in CORT levels was
determined using average baseline amounts (CORTTMT − CORTBaseline) as seen in Figure
5.2F. Two-way ANOVA analysis indicated no significant main effects of arsenic or
fluoxetine, but a significant interaction (F

(1,27)

= 10.97, p=.003). Perinatal arsenic

exposure decreased the CORT response compared to controls (p<.01). Treatment with
fluoxetine did not impact control animals and increased the CORT response in arsenicexposed animals up to levels measured in the control animals (p<.01). These data suggest
that arsenic-exposed animals have a blunted but prolonged response to TMT (stress) and
fluoxetine treatment attenuates this effect. (n = 7-10 animals per group where n = number
of litters)

5.3.6 Fluoxetine treatment ameliorates deficits in survival and differentiation of neural
progenitor cells after perinatal arsenic exposure
To determine if chronic treatment with 100 mg/L fluoxetine induces alterations in adult
neurogenesis in adult males perinatally exposed to arsenic, the number of BrdU+ and
BrdU+NeuN+ cells were measured four weeks after a pulse chase BrdU assay. Figure 3A
shows triple staining (DAPI+BrdU+NeuN+) used for assessment of the number of
differentiated neural progenitor cells (NPCs). All cells containing BrdU were counted for
assessment of survival of NPCs. Figures 5.3D and 5.3F are representative images from
arsenic-exposed animals at PD70 with and without five weeks of fluoxetine treatment,
respectively. Figures 5.3E and 5.3G are representative images from control animals at
PD70 with and without five weeks of fluoxetine treatment, respectively. For the number
of BrdU+NeuN+ cells, two-way ANOVA data analysis indicates significant main effects

152

Figure 5.3. Chronic fluoxetine treatment restores deficits in adult hippocampal neurogenesis in
arsenic-exposed animals at PD70. (a) Representative images of the dentate gyrus were taken with 100_
objective to demonstrate colocalization of markers to identify neurons (BrdU+NeuN+) and neural
progenitor cells (BrdU+). NeuN (red) mature marker of neurons; DAPI (blue) nuclear counterstain; BrdU
(green) exogenous mitotic marker; Merge, all three markers (b). Perinatal arsenic exposure decreases the
number of BrdU+NeuN+ cells in the dentate gyrus compared to controls at PD70 (p < .01). Chronic
treatment with 100 mg/L fluoxetine increases the number of BrdU+NeuN+ cells in arsenic-exposed animals
(p < .05) but not in controls. (c) Perinatal arsenic exposure decreases the number of BrdU+ cells in the
dentate gyrus compared to controls at PD70 (p < .05). Chronic treatment with 100 mg/L fluoxetine
increases the number of BrdU+ cells in arsenic-exposed animals (p < .05) but not in controls. ***p < .001,
**p < .01, *p < .05. The following representative images were taken with 10_ objective on a META
confocal microscope. NeuN (red) mature marker of neurons; DAPI (blue) nuclear counterstain; BrdU
(green) exogenous mitotic marker; Merge, all three markers represented. (d) Representative image of the
dentate gyrus at PD70 from an arsenic-exposed animal. (e) Representative image of the dentate gyrus at
PD70 from a control animal. (f) Representative image of the dentate gyrus at PD70 from an arsenicexposed animal chronically treated with 100 mg/L fluoxetine. (g) Representative image of the dentate gyrus
at PD70 from a control animal chronically treated with 100 mg/L fluoxetine.

of arsenic (F(1,26) = 9.675; p = .005) and fluoxetine (F(1,26) = 9.82; p = .004) but no
significant interaction. Arsenic-exposed animals had 654 ± 60 BrdU+NeuN+ labeled
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cells; fluoxetine exposure resulted in 1016 ± 37 BrdU+NeuN+ labeled cells, a significant
increase of 55% (p<.05). Control animals had 1014 ± 52 BrdU+NeuN+ labeled cells (also
a 55% increase over arsenic-exposed animals p<.01); fluoxetine resulted in 1167 ± 144
BrdU+NeuN+ labeled cells in control animals which was not a significant increase. A
similar trend was observed for BrdU+ cells: two-way ANOVA analysis revealed a
significant main effect of arsenic (F(1,28) = 8.33; p = .007) and fluoxetine (F(1,28) = 13.9; p
= .001) but no significant interaction. Arsenic-exposed animals had 843 ± 68 BrdU+
labeled cells, significantly 53% less than the 1240 ± 78 BrdU+ labeled cells in control
animals (p<.05). Fluoxetine treatment in arsenic-exposed animals resulted in a 57 %
increase (p<.001), 1325 ± 36 BrdU+ labeled cells. Fluoxetine treatment increased the
number of BrdU+ cells by 22% (1511 ± 169 BrdU+ labeled cells) in control animals but
this effect was not significant. (n = 7-9 animals per group where n = number of litters)

5.3.7 Fluoxetine treatment increases expression of several proteins associated with
neurogenesis in the dentate gyrus after perinatal arsenic exposure
To determine the mechanism by which fluoxetine rescues deficits in survival and
differentiation of NPCs in perinatally arsenic exposed animals, protein expression of
several factors that contribute to adult neurogenesis was assessed in dentate gyrus tissue.
As we have previously demonstrated reduced expression of the glucocorticoid receptor
(GR) in the hippocampus of PD35 arsenic-exposed animals (Martinez-Finley et al., 2009),
GR expression in the nuclear fraction of the dentate gyrus at PD70 was assessed.
Representative blots and data are shown in Figure 5.4A for the GR. There were no
significant main effects of arsenic but a significant main effect of fluoxetine (F(1,38) = 8.5;
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p = .006) and no significant interaction; however, treatment with fluoxetine increased
expression of the GR in both arsenic-exposed and control groups ( (p<.05, Figure 5.4A).
Histone deacetylase 2 (HDAC2) has been implicated in depression and has a known GR
response element in its promoter. Perinatal arsenic exposure did not alter protein
quantification of HDAC2 in the nuclear fraction of the dentate gyrus (Figure 5.4B);
however, there was a significant main effect of fluoxetine treatment (F(1,36) = 6.1; p = .02)
with significantly increased expression of HDAC2 in arsenic-exposed animals (p<.05)
but not in control animals. Brain derived neurotrophic factor (BDNF) is regulated by the
GR, HDAC2, and cAMP response element binding protein (CREB); both BDNF and
CREB are paramount to proper maturation and differentiation of neural progenitor cells
(Gass & Riva, 2007). Protein quantification of the mature form of BDNF in the postnuclear lysate fraction of the DG and of CREB in the nuclear fraction of the DG was
determined. Representative blots and data are shown in Figure 5.4C for BDNF and
Figure 5.4D for CREB. A significant main effect of fluoxetine on BDNF was determined
(F(1, 36) = 6.2; p = .012). While PAE did not alter BDNF expression, arsenic-exposed
animals treated with fluoxetine had higher immunoreactivity to BDNF than their nontreated counterparts (p<.05), with no effect on control animals. A similar pattern was
observed for CREB protein expression: a significant main effect of fluoxetine was
determined (F(1,31) = 8.5; p = .0065), with a significant difference among arsenic-exposed
animals with and without fluoxetine treatment (p<.05) but not among control animals. (n
= 8-11 animals per group where n = number of litters)
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Figure 5.4. Chronic fluoxetine treatment increases expression of proteins associated with
neurogenesis in the dentate gyrus of arsenic-exposed animals at PD70. (a) In (A)–(D), representative
images of immunoblots are shown for arsenic-exposed and control animals consuming 0.066% saccharin or
100 mg/L fluoxetine with 0.066% saccharin. The immunoreactivity for each protein antibody was
normalized to its respective Coomassie stain for quantification (see Supplementary Figure). (b) Perinatal
arsenic exposure does not alter the protein expression of the glucocorticoid receptor (GR) in the nuclear
fraction of the dentate gyrus at PD70 compared to controls. Chronic treatment with 100 mg/ L fluoxetine
increases expression of the GR in both arsenic exposed animals (p < .05) and control animals (p < .05) at
PD70. (c) Perinatal arsenic exposure does not alter the protein expression of histone deacetylase 2
(HDAC2) in the nuclear fraction of the dentate gyrus at PD70 compared to controls. Chronic treatment with
100 mg/L fluoxetine increases expression of HDAC2 in arsenic-exposed animals (p < .05) but not in
control animals at PD70. (d) Perinatal arsenic exposure does not alter the protein expression of the mature
form of brain-derived neurotrophic factor (BDNF) in the post-nuclear lysate fraction of the dentate gyrus at
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PD70 compared to controls. Chronic treatment with 100 mg/L fluoxetine increases expression of mature
BDNF in arsenic-exposed animals (p < .05) but not in control animals at PD70. (e) Perinatal arsenic
exposure does not alter the protein expression of cAMP responsive element binding protein (CREB) in the
nuclear fraction of the dentate gyrus at PD70 compared to controls. Chronic treatment with 100 mg/L
fluoxetine increases expression of CREB in arsenic-exposed animals (p < .05) but not in control animals at
PD70. ***p < .001, **p < .01, *p < .05.

5.4 Discussion
Toxins such as lead, methylmercury, organophosphates, and arsenic have been associated
with psychiatric disorders, including depression, in a number of epidemiological studies
(Zierold et al., 2004; Sen & Sarathi Biswas, 2012; Beard et al., 2013; Freire & Koifman,
2013; Malekirad et al., 2013; Ojo et al., 2013; Weisskopf et al., 2013). Yet, the impact of
environmental factors, particularly toxins, on the susceptibility to depression has not been
investigated in great detail. We have previously shown several behavioral deficits,
morphological abnormalities, and molecular aberrations induced by developmental
arsenic exposure in adult mice (Martinez et al., 2008; Martinez-Finley et al., 2009;
Martinez-Finley et al., 2011; Tyler & Allan, 2013). In the present study, we determined
the extent to which chronic fluoxetine treatment was able to reverse these effects and
restore resiliency to stress-induced depression in arsenic-exposed animals.

Animals perinatally exposed to arsenic likely exhibit depressive-like symptoms and
negatively process congruent information due to hyperactivity of the HPA axis, as
observed in depressed patients and other rodent models (Vollmayr & Gass, 2013). Here,
we have demonstrated that exposure to mild stress on the first day of a learned
helplessness (LH) task was sufficient to induce depressive-like symptoms in arsenicexposed mice, but not in controls, suggesting a lack of resiliency to stress. This particular
LH paradigm is minimal (low foot shock and few inescapable exposures) such that it is

157

unlikely to induce depressive-like behaviors in controls as other LH paradigms do.
Additionally, arsenic-exposed mice exhibit depressive-like behavior in the forced swim
task (FST) after a 10-minute exposure to predator odor, while control animals do not.
This effect may be mediated through alterations in the HPA axis signaling leading to an
aberrant stress response. To support this assertion, we determined that corticosterone
(CORT) levels are elevated under basal conditions in arsenic-exposed animals; and while
hyperlocomotion due to elevated CORT can confound activity measured in depression
tasks (Strekalova et al., 2005), we found no difference in total locomotor activity in the
open field test (data not shown). The blunted CORT response we measured after predator
odor exposure in arsenic-exposed animals is conceivably due to the elevated CORT
before the stressor and the lack of sufficient CORT activation. Reduced HPA axis
responses have been observed in animals prenatally exposed to stress with behavioral
deficits in adulthood due to HPA hyperactivity (Darnaudery & Maccari, 2008).
Furthermore, abnormal HPA axis function has been measured in depressed patients,
along with increased release of cortisol and blunted HPA axis feedback; these alterations
are diminished after chronic treatment with antidepressants, typically preceding
alleviation of behavioral symptoms (Wainwright & Galea, 2013). Thus, perturbation the
HPA axis may be required to elucidate distinctions in depressive-like behavior between
arsenic and control animals, yet these behaviors may be impermanent as resiliency to
depressive-like symptoms was restored after chronic treatment with fluoxetine in a doseindependent manner.
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Recent studies have demonstrated a link between the early environment, development of
HPA axis feedback, and adult hippocampal neurogenesis (Loi et al., 2014). Results
presented here suggest that perinatal arsenic exposure induces unambiguous but
reversible deficits in adult neurogenesis by reducing the survival (BrdU+ cells; 53% less)
and differentiation (BrdU+NeuN+; 55% less) of neural progenitor cells four weeks after
BrdU injection at PD70. Chronic treatment with 100 mg/L fluoxetine, resulting in 17
mg/kg/day consumption, attenuated these deficits in the arsenic-exposed animals: we
measured a 57% increase in survival of BrdU+ cells and a 55% increase in the number of
differentiated BrdU+NeuN+ cells. Region specificity was not determined; however all
measurements occurred in the dorsal hippocampus. Additionally, BrdU+ cells may
include a small population of glial cells, but this effect may be negligible (Steiner et al.,
2004). These results concur with our previous observations of the robust effect of
intermittent interval exposure to enrichment on neurogenesis after arsenic exposure
(Tyler & Allan, 2013). This increase in adult neurogenesis coincident with restored
resiliency to stress-induced depression suggests that fluoxetine is ameliorating arsenicinduced deficits via a neurogenic mechanism.

Recent genomic analysis has demonstrated that genes associated with adult hippocampal
neurogenesis are impacted by SSRI treatment (Malki et al., 2012). Additionally, HPA
axis stress responses in the dentate gyrus are mediated in part through the glucocorticoid
receptor (GR) and can impact gene expression (de Kloet et al., 2005). For its part, arsenic
exposure induces deficits in mRNA expression of neurogenesis-related genes, including
Nrc31 (gene for GR protein), Creb1, and Hdac2 (Goggin et al., 2012; Tyler & Allan,
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2013), though the mechanism by which this damage occurs is unclear. Thus to determine
the pathways involved in fluoxetine’s neurogenic actions and in arsenic-induced
morphological damage, we assessed expression of proteins involved in AHN, including
the GR, CREB, HDAC2, and BDNF. We would have expected all of these proteins to be
reduced in arsenic-exposed animals, but arsenic exposure did not result in altered levels
for any of these proteins. Our results may be specific to the dentate gyrus: studies
demonstrating reduced CREB and BDNF, in response to either prenatal stress or toxins
such as lead or mercury, have done so using mRNA expression in the dentate gyrus
(similar to our previous observations) or protein quantification in the whole hippocampus,
but never protein expression in the dentate gyrus (Onishchenko et al., 2008; Feng et al.,
2012; Boersma et al., 2013; Guan et al., 2013; Sanchez-Martin et al., 2013; Boersma et
al., 2014). While arsenic exposure in the parts-per-million range has been shown to
reduce CREB and associated proteins (Wang et al., 2009), the arsenic concentration in
our study is in the parts-per-billion range, closer to the levels humans are exposed to, and
likely too low to impair CREB signaling. Additionally, reduced Nr3c1 and Hdac2 mRNA
levels in the hippocampus or reduced Creb1 mRNA in the dentate gyrus may not
translate to reduced protein levels, as seen in several other studies. While these proteins
may not be altered, their downstream signaling, including ERK from the BDNF pathway,
may lead to deficits in AHN or lead to greater susceptibility to stress-induced depression
(Numakawa et al., 2013). Thus, reduced AHN in arsenic-exposed animals does not derive
from alteration of these target proteins, and elucidating an arsenic-specific mechanism
requires further investigation.
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While arsenic does not impact the expression of CREB, HDAC2, GR, or BDNF, chronic
fluoxetine treatment increases expression of all target proteins, particularly in the arsenicexposed animals. These results suggest that the mechanism by which fluoxetine enhances
AHN is separate from the pathways damaged by arsenic exposure. Increased signaling of
5-HT receptors after fluoxetine administration ultimately leads to a steady increase in
cAMP, protein kinase A, and CREB (Pinnock et al., 2010). CREB, a histone
acetyltransferase, then allows for increased transcription of BDNF, which has
antidepressant effects when released and feedback on CREB. Thus, increased BDNF and
CREB expression in the dentate gyrus after fluoxetine treatment was expected in these
studies, as others have demonstrated similar results, particularly in rodent models with
impaired stress responses (Blom et al., 2002; Vinet et al., 2004). Fluoxetine also
enhances functionality of the GR (Pariante et al., 2003) allowing for termination of HPA
signaling via improved negative feedback (Sapolsky et al., 1984), as seen in studies
presented here using the predator odor and FST challenge. This enhanced GR signaling
directly increases AHN (Pariante et al., 2003; Anacker et al., 2011b) and uses
neurogenesis-dependent

mechanisms

to

restore

control

over

the

HPA

after

dexamethasone administration (Surget et al., 2011). The GR has also been demonstrated
to increase expression of HDAC2 via the Hdac2-GRE (Graff et al., 2012), while others
have shown HDAC2 is necessary for GRE-mediated gene activation (Luo et al., 2009b).
However, HDAC2 negatively regulates BDNF (Guan et al., 2009), though we are the
first to show these alterations specifically in the dentate gyrus; as such, the interaction
among these proteins after fluoxetine treatment remains to be elucidated. Overall,
fluoxetine treatment is ameliorating depressive-like behavior after PAE by enhancing
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AHN in the dentate gyrus likely mediated by these increased proteins. This effect is
particularly robust in arsenic-exposed animals, as neither protein expression nor AHN
was significantly increased in control animals after fluoxetine treatment.

A recent study reported that fluoxetine does not increase BDNF levels in males after
chronic psychosocial isolation stress (Mitic et al., 2013), and several others have
demonstrated that in control animals not exposed to stress, BDNF does not increase after
fluoxetine treatment (Nibuya et al., 1995; Dias et al., 2003; De Foubert et al., 2004).
While we anticipated increased protein expression and AHN in control animals after
fluoxetine treatment, our results are consistent with these studies and the lack of altered
behavior and stress response we observed in control animals. However, AHN is a
sensitive system easily influenced by experience, stress, and pharmacological
manipulation. As such, it is likely that our findings for control animals can be attributed
to the method of fluoxetine administration. A similar pattern was reported in animals
consuming fluoxetine via drinking water after developmental methylmercury exposure:
three weeks of chronic fluoxetine treatment (80 mg/L) ameliorated deficits in total
neuronal number in exposed animals but did not significantly impact cell numbers in
unexposed control animals (Bose et al., 2012). Other delivery methods of fluoxetine
generate different results: animals given 18 mg/kg fluoxetine via gavage for 28 days
exhibit increased proliferation and maturation of cells in the hippocampus (Wang et al.,
2008a), while interperitoneal (IP) administration of 5 or 10 mg/kg/day fluoxetine for 28
days increases survival of neural progenitor cells one month (Malberg et al., 2000) and
24 hours after BrdU injection (Santarelli et al., 2003) in control animals, respectively.
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Both the IP and the gavage procedures provide instant delivery of the antidepressant,
which should accelerate the time to achieving peak blood levels and may affect
downstream mechanisms. It should also be noted that both methods of administration
(injection and gavage) are stressful and may reduce AHN in the vehicle control animals
not provided antidepressants. Similarly, fluoxetine increases proliferation of NPCs after
mild chronic stress (Surget et al., 2011) and survival and maturation of NPCs after
corticosterone injection (David et al., 2009) but this effect is not observed in control
animals without exposure to stress. Since arsenic-exposed animals have alterations in the
hypothalamic-pituitary-adrenal-axis (HPA) resulting in aberrant stress signaling (Goggin
et al., 2012), we sought to provide the antidepressant using the least stressful method.

The evidence provided here strengthens the connection between AHN and depression, as
arsenic-exposed mice have decreased AHN and depressive-like symptoms; however, this
association is correlational. It is unknown if alterations in the HPA axis result in deficits
in AHN that ultimately lead to the onset of depression or if altered AHN is a byproduct of
stress-induced depression (David et al., 2009; Anacker et al., 2013). In this study,
increased AHN via fluoxetine in arsenic-exposed animals is concurrent with increased
resiliency to stress-induced depression in the mild stressor LH task and in the FST
following predator odor exposure. This effect may be mediated by increased AHN,
possibly via increased nuclear GR in the dentate gyrus, as demonstrated in the
hippocampus in other studies (Anacker et al., 2011b), or via reduced basal levels of
CORT and a subsequent proper response to stress. The serotonergic system may also
contribute to the efficacy of fluoxetine: arsenic-exposed mice have decreased serotonin
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levels and increased 5HT1A receptors in the dorsal hippocampus (Martinez et al., 2008),
and these receptors have been implicated in the efficacy of fluoxetine as an
antidepressant (Riad et al., 2004). It is likely that fluoxetine alters morphology, behavior,
and molecules in the arsenic-exposed animals via all of these pathways: increased AHN,
restored stress response, and serotonergic signaling via 5HT1A receptors, although we
have yet to measure the latter.

5.5 Conclusion
Several epidemiological and rodent studies have demonstrated a correlation between
exposures during gestation or early development and increased risk for developing
psychiatric disorders (Hellemans et al., 2010; Davis et al., 2013; Talati et al., 2013);
indeed, arsenic exposure has been associated with depression in epidemiological studies
(Zierold et al., 2004). While it is unclear if the damage resulting from developmental
exposures is amenable to intervention, we have provided evidence that arsenic-induced
deficits can be reversed with fluoxetine treatment. Using a perinatal arsenic exposure
model in mice, we have demonstrated that arsenic reduces resiliency to stress-induced
depression, induces a blunted CORT response, and decreases adult hippocampal
neurogenesis. These effects were ameliorated and behavior restored with chronic
fluoxetine treatment, along with increased levels of proteins associated with neurogenesis
in the dentate gyrus. Based on these findings, fluoxetine restores resiliency to depression
via a neurogenic mechanism. However, the mechanisms through which arsenic exposure
reduces AHN are likely not the same mechanism by which fluoxetine reverses these
effects. While fluoxetine increases expression of neurogenesis-related proteins, deficits in
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these proteins were not found after arsenic exposure. Thus, fluoxetine is likely bypassing
arsenic-induced damage to increase AHN. As such, while alterations in morphology and
behavior after PAE are ameliorated by chronic fluoxetine treatment, the mechanism by
which arsenic produces deficits in AHN is still under investigation.
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Abstract
Epidemiological studies have demonstrated that arsenic exposure has a profound effect
on the epigenetic landscape, particularly on histone posttranslational modifications
(HPTMs), which are critical for programming of cellular function. We have previously
shown that exposure to a low level of arsenic (50 parts-per-billion) during the perinatal
period (three trimester equivalent) induces deficits in adult neurogenesis, depressive-like
symptoms, and alterations in gene expression. As epigenetic processes control these
outcomes, we assessed the influence of our developmental arsenic exposure paradigm
(DAE) on global HPTMs and the expression of associated chromatin-modifying proteins
in the dentate gyrus (DG) and frontal cortex (FC) of adult male and female mice using
western blotting techniques. DAE preferentially altered histone methylation levels
dependent on sex, with increased levels of trimethylation of histone 3 lysine 4
(H3K4me3) in both the FC and DG of adult males and decreased H3K4me3 levels in the
female DG. The chromatin-modifying protein responsible for this modification, MLL,
exhibited a similar expression profile in arsenic-exposed animals. Conversely, DAE
influenced histone acetylation dependent on both tissue type and sex, with increased
H3K9ac levels in the male and female DG and decreased levels in the male FC.
Associated histone acetyltransferase expression of GCN5 and PCAF was similarly
impacted by DAE without alterations in CREB-binding protein (CBP). Levels of H3,
H3ac, H3K9me3 were not influenced by DAE in either brain region of either sex.
Surprisingly, arsenic exposure reduced expression of CREB and p-CREB in the male
frontal cortex with concurrent increased expression of the repressive complex proteins
REST/NRSF and Co-REST. These findings suggest that developmental exposure to a

167

very low level of arsenic leads to long-lasting changes in histone methylation, acetylation,
and associated chromatin modifying proteins in a region- and sex-dependent manner in
the adult mouse brain.

6.1 Introduction
Arsenic exposure continues to be a worldwide health concern as several millions of
people are exposed to this environmental toxicant via natural and anthropogenic sources
(Naujokas et al., 2013). The Environmental Protection Agency (EPA) and World Health
Organization (WHO) have deemed 10 µg/L (parts-per-billion, ppb) arsenic in drinking
water safe for consumption; however, in several countries around the world (including in
the U.S. prior to 2006) 50 ppb arsenic remains the standard allotment in drinking water
(WHO, 2008). Additionally, there are places where access to drinking water containing
arsenic within the WHO limits is simply not possible, and populations within these
regions are exposed to excessive arsenic, bordering on mass poisoning (Jiang et al., 2013).
Exposure to arsenic can also occur via consumption of arsenic-contaminated food, which
is also a significant problem. It is well established that high levels of arsenic exposure (in
the parts-per-million range) can induce disease states (including cancer) in almost every
organ in the body including the heart, lungs, liver, and brain (Bustaffa et al., 2014).
Epidemiological studies have demonstrated that even low levels of arsenic exposure can
negatively impact the body, including increasing the propensity toward developing a
psychiatric disorder and cognitive dysfunction (Zierold et al., 2004; Brinkel et al., 2009).
Importantly, in utero and developmental arsenic exposure results in learning and memory
deficits in children and may underlie long-lasting susceptibility to disease later in life
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(reviewed in (Tyler & Allan, 2014). However, relatively little is known about the longterm influence of low levels of arsenic exposure, particularly in the brain.

Research over the past decade has provided evidence demonstrating that arsenic alters the
epigenetic landscape in various cell types. The epigenome consists of DNA methylation
and histone modifications that collectively constitute chromatin structure and ultimately
chromatin function, conferring regulation of gene expression (Kouzarides, 2007). Of
particular interest are studies on histone posttranslational modifications (HPTM), as
histone modifications can be dynamic in response to the extrinsic environment and are
paramount for proper differentiation of neural stem cells in the brain (Hsieh & Eisch,
2010; Day & Sweatt, 2011). Indeed, epigenetic dysregulation HPTMs has been
postulated as a molecular mechanism underpinning psychiatric disorders such as
depression (Mateus-Pinheiro et al., 2011; Sun et al., 2013). However, the impact of
arsenic on the epigenetic status of the brain has not been thoroughly investigated,
particularly in the context of developmental exposure. To date, there are three studies on
the effects of developmental exposure to arsenic in the brain, suggesting an impact of
arsenic on histone acetylation and DNA methylation with concurrent deficits in proteins
that may underlie learning and memory deficits (Zarazua et al., 2010; Martinez et al.,
2011; Cronican et al., 2013). Conversely, the literature on the effect of arsenic on the
epigenome is quite extensive in the context of cancer. In vitro studies have demonstrated
arsenic exposure influences histone methylation, acetylation, and phosphorylation along
with the expression chromatin modifying proteins that impart these modifications in
human carcinoma cell lines (Zhou et al., 2008; Ren et al., 2011; Chervona et al., 2012a).
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Additionally, a prospective epidemiological study reported an effect of arsenic exposure
(via drinking water) on HPTMs in peripheral blood monocular cells from exposed
individuals, demonstrating a particularly strong correlation between arsenic exposure and
histone methylation and acetylation, with a differential influence of arsenic dependent on
sex (Chervona et al., 2012b). To our knowledge, there have been no reports on the longterm epigenetic consequences of developmental arsenic exposure in the brain,
particularly of HPTMs and their associated chromatin modifying enzymes.

We are interested in the mechanisms that potentially mediate the long-lasting toxicity of
developmental arsenic exposure into adulthood when the presence of arsenic is quite low.
Using a perinatal exposure paradigm to 50 ppb sodium arsenate (through all three
trimesters of fetal/neonatal development), we have previously demonstrated that arsenic
reduces adult hippocampal neurogenesis (AHN) leading to greater susceptibility to
developing stress-induced depressive-like symptoms in adult male mice (Tyler & Allan,
2013; Tyler et al., 2014). Adult neurogenesis is comprised of several processes that
include the continual mitotic activity of dentate gyrus neural progenitor cells and their
subsequent maturation and integration into the hippocampal circuitry (Ming & Song,
2005). These processes are finely orchestrated by several epigenetic factors, including
histone modifications (Ma et al., 2010). We have provided evidence that developmental
arsenic exposure (DAE) alters the expression of many neurogenesis-related genes in the
adult dentate gyrus (Tyler and Allan, 2013); however, the mechanism by which arsenic
induces this damage is currently not known. Based on the extensive literature
investigating the effects of arsenic on the epigenome in relation to cancer, we hypothesize
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that DAE leads to altered epigenetic processes, specifically histone modifications, in the
dentate gyrus of adult male mice.

Here, we report an influence of perinatal arsenic exposure on levels of trimethylation of
H3K4 and acetylation of H3K9 and on expression of associated chromatin-modifying
proteins including MLL, GCN5, PCAF, CREB, p-CREB, and REST/NRSF, and CoREST in a sex- and region-dependent manner. No changes in total H3, H3K9me3, total
H3 acetylation or CBP expression in either tissue of either sex were observed. This is the
first report to demonstrate that low-level arsenic exposure during development imparts
damage on the epigenetic landscape of the brain in adulthood.

6.2 Materials and Methods
Chemical Hazards. Arsenic is classified as a human co-carcinogen; all arsenicals were
handled with caution in accordance with MSDS standards.

6.2.1 Perinatal arsenic exposure paradigm
The Institutional Animal Care and Use Committee at the University of New Mexico
(UNM) approved the animal protocols, including the arsenic exposure paradigm, used in
this study. C57BL/6 mice obtained from Jackson Labs were maintained on a reverse
light/dark cycle (lights off at 0800) with ad libitum access to food and water in the
Animal Resource Facility at UNM. Arsenic exposure was performed as previously
described (Tyler et al., 2014), as depicted in Figure 1. Briefly, singly-housed female mice
aged 55 days were acclimated to drinking 50 ppb arsenic water (sodium arsenate, Sigma
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Aldrich) for 10 days prior to mating. Arsenic water was prepared weekly using standard
tap and MilliQ water. Control mice were administered tap water from UNM, which
contains approximately 2-5 ppb arsenic. Mating occurred for five days; dams continued
to drink arsenic-laced water throughout pregnancy until offspring were weaned at
postnatal day (PD) 23. Offspring were group housed, four per cage, with ad libitum
access to food and tap water. At PD70, animals were euthanized via rapid decapitation,
and the frontal cortex and dentate gyrus from both male and female animals were
microdissected and snap frozen and stored at -80°C until further analysis. Female animals
were exposed to male bedding prior to euthanizing. Synchronicity of cycle was
confirmed via vaginal cytology, and only brain tissue from females in the proestrus phase
was used, as some biochemical and behavioral measures are impacted by the phase of the
estrous cycle (Warren & Juraska, 1997). Multiple rounds of breeding were performed for
sufficient numbers of litters for arsenic or control groups. For each experiment, at least 6
different litters from different dams were used; e.g. n = 6 represents the number of
different litters used with one animal per litter to avoid litter effects.

Figure 6.1. Perinatal Arsenic Exposure Paradigm
Exposure to 50 parts-per-billion arsenic via drinking water occurs throughout the perinatal period, which
includes all three trimesters of development in rodents. The arsenic exposure paradigm is initiated 10 days
prior to mating, and arsenic consumption is monitored. Control dams drink tap water from UNM, which
contains approximately 2-5 ppb arsenic. Dams drink arsenic-laced water until pups are weaned at
approximately postnatal day (PD) 23. Both control and arsenic-exposed offspring are group housed with ad
libitum access to food and tap water; brain tissue is retrieved via microdissection at PD70 for analysis.
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6.2.2 Evaluation of histone methylation and acetylation
Histone extraction. For preparation of extracted histones, tissue derived from one animal,
either the dentate gyrus or the frontal cortex, was homogenized in a Biomasher II
disposable microhomogenizer (Kimble Chase) using PBS buffer containing 0.5% TritonX 100 (v/v), 2 mM phenylmethylsulfonyl fluoride (PMSF), 0.02% (w/v) sodium azide
(NaN3), 5 mM sodium butyrate (NaB), and 1 µg/µl protease inhibitor cocktail (Sigma,
#P8340). Tissue homogenates were centrifuged at 6500 × g for 10 minutes at 4°C; nuclei
were washed and centrifuged as before. The pellet was resuspended in 1 N HCl and acid
extraction was allowed to occur overnight at 4°C; 1 N NaOH was added the following
day to neutralize the acid. Lysates were centrifuged as before and the supernatant saved
for protein quantification. Bradford assays were performed to determine the
concentration of histone protein. Aliquots were stored at -80°C until further use.

Histone assessment. Approximately 8-12 µg histone protein, determined by antibody
optimization, was separated using NUPAGE 10% bis-tris gels (Invitrogen, NP0316) and
transferred to a PVDF membrane (Millipore Corporation, IPFL00010). Membranes were
incubated overnight at 4°C using the following primary antibodies diluted in PBS-T: H3
(1:1000 in DG and FC; Cell Signaling, 3638), H3K4 trimethyl (1:1000 fin DG and FC;
Abcam, ab8580), H3 acetyl (1:1000 in DG and FC; Millipore, 06-599), H3K9 trimethyl
(1:2000 in DG; 1:1000 in FC; Epigentek, A-4036), H3K9 dimethyl (1:2000 in DG;
1:1000 in FC; Epigentek, A-4035), H3K9 acetyl (1:500 in DG and FC; Epigentek, A4022), or H3K27 trimethyl (1:2000 in DG; 1:1000 in FC; Epigentek, A-4039).
Membranes were incubated for 45 min in their respective secondary antibodies

173

(1:15,000) from LiCOR: rabbit IRDye 680RD and mouse IRDye 800CW. Quantification
of protein expression was performed using Image Studio, and values are expressed as
each individual histone mark normalized to H3. Evaluation of each histone mark was
performed on separate gels and blots to avoid confounds. The n = 6-10 litters depending
on histone mark and will be expressed for each individual blot in the results.

6.2.3 Evaluation of chromatin modifying proteins
Immunoblotting for chromatin-modifying proteins was conducted as essentially described
using our established protocols (Goggin et al., 2012; Tyler et al., 2014). Dentate gyrus or
frontal cortex tissue lysates from one animal were prepared and the nuclear fraction was
isolated for protein expression analysis. Total protein concentration was determined by
Bradford assay. Antibody and protein optimization was performed for each target protein
in both types of tissues. Membranes were incubated overnight at 4°C using the following
primary antibodies diluted in PBS-T: MLL (1:1000 in DG, 1:500 in FC; Santa Cruz, sc20153); GCN5 (1:000 in DG and FC; Santa Cruz, sc-20698); PCAF (1:000 in DG and
FC; Santa Cruz, sc-13124); CREB binding protein, CBP (1:500 in DG, 1:1000 in FC;
Cell Signaling, cs-9104); CREB (1:1000 in FC; Cell Signaling, cs-9104), phosphorylated
CREB, p-CREB (1:1000 FC; Cell Signaling, cs-9198), REST/NRSF (1:500 in DG and
FC; Santa Cruz, sc-15118); Co-REST (1:500 in DG and FC; Santa Cruz, sc-23449), and
KDM5B (1:500 in DG and FC; Abcam, ab-181089). Membranes were incubated for 45
min in their respective secondary antibodies (1:15,000) from LiCOR: rabbit IRDye
680RD and mouse IRDye 800CW. Quantification of protein expression was performed
using Image Studio; Coomassie staining was demonstrated to be linear for all protein
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concentrations used. Values are presented as protein expression normalized to Coomassie
and renormalized to controls.

6.2.4 Statistical Analysis
H3 expression levels were determined to be similar among exposure groups in males and
females in both tissue types and was normalized to Coomassie staining. Histone
expression levels, as measured via western blotting, were normalized to H3 levels for
each sample, and each histone mark was run on a separate gel. Chromatin modifier
protein expression was normalized to the average of total protein expression evaluated by
Coomassie staining. All data are presented as mean ± SEM normalized to control values,
and a p value of <.05 was set for statistical significance. All data were analyzed by t-test
using GraphPad software (GraphPad Software, v. 6.0; San Diego, CA). The number of
litters is reported for each experiment, with only one animal per litter used to avoid litter
confounds. All studies contain at least three different breeding rounds per assay, with at
least n = 6 per assay.

6.3 Results
6.3.1 Validation of H3 for normalization of histone proteins
To validate histone 3 as a proper control, we evaluated the impact of perinatal arsenic
exposure on H3 levels in dentate gyrus and frontal cortex tissue derived from adult male
and female mice. We observed no effect of arsenic exposure on H3 levels (Figure 2A:
Male DG, t(11) = .4555, p = .6576; Fig 2B: Male FC, t(10) = .2597, p = .8003; Fig 2C:
Female DG, t(11) = .2950, p = .7735; Fig 2D: Female FC, t(12) = .7512, p = .4670). H3
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expression was used to normalize expression for all subsequent histone modifications. (n
= 6-7 per assay)

Figure 6.2. Developmental arsenic exposure does not impact H3 in the adult mouse brain.
To establish validity as a control for immunoblotting, H3 levels were assessed in PD70 control and arsenicexposed male and female offspring in both tissue types. Perinatal arsenic exposure does not alter the
expression levels of total histone protein 3 in either the dentate gyrus (A and C) or the frontal cortex (B or
D) in male or female adult mice, respectively.

6.3.2 Perinatal arsenic exposure does not influence methylation of H3K9
To determine the long-term epigenetic consequences of perinatal arsenic exposure
(Figure 1), we assessed histone methylation at postnatal day (PD) 70 in the dentate gyrus
(DG) and the frontal cortex (FC) of both male and female mice. Perinatal arsenic
exposure did not alter levels of histone 3 lysine 9 trimethylation (H3K9me3), a repressive
posttranslational modification, in either brain region of either sex (Figure 3A: Male DG,
t(14) = .056, p = .956; Fig 3C: Female DG, t(16) = .2288, p = .822; Fig 3D: Female FC,
t(12) = .5396, p = .5994), although there was a modest increase of expression in the adult
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male frontal cortex, though this was not significant (Fig 3B: Male FC, t(14) = 1.596, p
= .13). (n = 7-10 per assay)

Figure 6.3. Developmental arsenic exposure does not impact H3K9me3 in the adult mouse brain.
Global analysis of trimethylation of histone 3 lysine 9 (H3K9me3) indicated that perinatal arsenic exposure
does not significantly alter the levels of H3K9me3 in the (A) male dentate gyrus, (B) male frontal cortex,
(C) female dentate gyrus, or (D) female frontal cortex at PD70.

6.3.3 Perinatal arsenic exposure alters methylation of H3K4 dependent on sex
Perinatal arsenic exposure differentially influenced the level of histone 3 lysine 4
trimethylation (H3K4me3), an activating HPTM, in adult mice (Figure 4). We observed
increased expression of H3K4me3 in the dentate gyrus and the frontal cortex of adult
male mice (Figure 4A: Male DG, t(14) = 2.24, p = .04; and Figure 4B: Male FC, t(14) =
2.408, p = .027), and decreased expression of H3K4me3 in the dentate gyrus of adult
female mice (Figure 4C: Female DG, t(15) = 2.184, p = .045) with no change in the
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female frontal cortex (Figure 4D: Female FC, t(12) = 0.8357, p = .4197). (n = 7-10 per
assay)

Figure 6.4. Developmental arsenic exposure alters H3K4me3 levels based on sex and brain region.
Global analysis of trimethylation of histone 3 lysine 4 indicated that perinatal arsenic exposure alters levels
of H3K4me3 in a sex-specific manner. DAE increases H3K4me3 levels in the (A) male dentate gyrus,
p<.05 and (B) male frontal cortex, p<.05 and decreases H3K4me3 levels in the (C) female dentate gyrus,
p<.05, with no effect on (D) the female frontal cortex, p>.05. *p<.05

6.3.4 Perinatal arsenic exposure alters H3K9 acetylation dependent on brain region and
sex
Histone acetylation at PD70 in the DG and FC of both male and female mice was
assessed. Overall histone acetylation was not impacted by perinatal arsenic exposure in
either brain regions of either sex (Figure 5A: Male DG, t(11) = .3730, p = .7162; Fig 5B:
Male FC, t(18) = .3777, p = .7101; Fig 5C: Female DG, t(12) = .4905, p = .6326; Fig 5D:
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Female FC, t(12) = .3675, p = .7197). (n = 7-11 per assay) Perinatal arsenic exposure
differentially impacted specific lysine acetylation based on brain region and sex: we
observed an increased in histone 3 lysine 9 acetylation (H3K9ac) in the dentate gyrus of
adult male mice (Figure 6A: Male DG, t(13) = 2.215, p = .05) and decreased H3K9ac in
the frontal cortex of adult male mice (Figure 6B: Male FC, t(14) = 2.474, p = .0268). We
did measure a modest increase in H3K9ac in the female dentate gyrus, but this effect was
not significant (Figure 6C: Female DG, t(6) = 1.659, p = .1483); H3K9ac in the female
frontal cortex was unaffected by perinatal arsenic exposure (Figure 6D: Female FC, t(11)
= .9750, p = .3505). (n = 7-9 per assay)

Figure 6.5. Developmental arsenic exposure does not impact total acetylation of H3 in the adult
mouse brain.
Global analysis of total histone acetylation indicated that perinatal arsenic exposure does not impact levels
of H3ac in the (A) male dentate gyrus, (B) male frontal cortex, (C) female dentate gyrus, or (D) female
frontal cortex, p>.05 for all assessments.
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Figure 6.6. Developmental arsenic exposure alters H3K9ac based on brain region.
Global analysis of acetylation of histone 3 lysine 9 indicated that perinatal arsenic exposure alters levels of
H3K9ac in a sex- and region-specific manner. DAE increases H3K9ac levels in the (A) male dentate gyrus,
p<.05, but decreases levels in the (B) male frontal cortex, p<.05. There is a slight, but not significant trend
of increased H3K9ac in the (C) female dentate gyrus, p=.1, but DAE has no effect on (D) the female frontal
cortex, p>.05. *p<.05

6.3.5 Perinatal arsenic exposure influences expression of epigenetic machinery in a
similar pattern to their respective histone modifications

6.3.6 Histone methyltransferase modifier: MLL1
To determine the effect of arsenic on the enzymes responsible for imparting histone
modifications, we assessed the expression several chromatin-modifying proteins in the
same brain regions in which we found altered histone modifications. The MLL family
(mixed lineage leukemia factor) is comprised of several histone methyltransferase
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enzymes responsible for imparting three methyl groups on H3K4. Perinatal arsenic
exposure increased expression of MLL1 in both the dentate gyrus (Figure 7A: Male DG,
t(19) = 2.123, p = .0471) and the frontal cortex of adult male mice (Figure 7B: Male FC,
t(22) = 2.732, p = .0122). Conversely, we observed a decrease in MLL1 expression in the
dentate gyrus of female mice (Figure 7C: Female DG, t(15) = 3.092, p = .0074), and no
influence of perinatal arsenic exposure in the female frontal cortex (Figure 7D: Female
FC, t(12) = .01323, p = .9897). Thus, perinatal arsenic exposure impacts the expression
of the MLL1 protein similar to the pattern observed for the H3K4me3 modification in
both sexes and brain regions. (n = 9-12 per assay)

Figure 6.7. Developmental arsenic exposure alters expression of the histone methyltransferase,
MLL1, based on sex and brain region.
Assessment of the chromatin-modifying protein, MLL1, which is responsible for the trimethylation of
H3K4me, indicated that perinatal arsenic exposure alters levels of this enzyme in a similar pattern as levels
of H3K4me3, in a sex-specific manner. DAE increases MLL1 expression the (A) male dentate gyrus, p<.05
and (B) male frontal cortex, p<.05 and decreases expression in the (C) female dentate gyrus, p<.01, with
no effect on (D) the female frontal cortex, p>.05. *p<.05, **p<.01
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6.3.7 Histone Acetyltransferase Modifiers: GCN5, PCAF, CBP, and CREB
There are three groups of histone acetyltransferase enzymes responsible for imparting
acetyl HPTM; these include the GNAT, MYST, and CBP/p300 families (Bannister &
Kouzarides, 2011). Exposure to high concentrations of arsenic has been shown to alter
expression of chromatin-modifying proteins responsible for histone acetylation and
deacetylation, including members of the GNAT family, specifically GCN5 (Nelson et al.,
2009). GCN5 and PCAF are also responsible for H3K9 acetylation. Members of the
CBP/p300 family of histone acetyltransferases are paramount for proper learning and
memory and have been implicated in the response to stress and depressive-like behaviors
(Maurice et al., 2008). As such, expression of three histone acetyltransferase enzymes,
GCN5, PCAF, and CREB binding protein (CBP) and the transcription factor, CREB, was
assessed. Perinatal arsenic exposure increased GCN5 expression (Figure 8A: Male DG,
t(18) = 2.461, p = .0242) but did not impact expression of PCAF or CBP in the dentate
gyrus of adult males (Figure 8C: Male DG PCAF, t(23) = .4144, p = .6924; Fig 8E: Male
FC CBP, t(22) = .4370, p = .6664). The impact of arsenic exposure on CREB and
phospho-CREB in the dentate gyrus of adult males has previously been assessed; we
reported no effect of arsenic exposure (Tyler et al., 2014). Conversely, perinatal arsenic
exposure decreased expression of the following proteins in the adult male frontal cortex:
GCN5 (Figure 8B: Male FC, t(20) = 2.279, p = .0338), PCAF (Figure 8D: Male FC, t(24)
= 3.607, p = .0014), with no impact on CBP (Figure 8F: Male FC, t(22) = .6452, p
= .5255).
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Figure 6.8. Developmental arsenic exposure alters the expression of some histone acetyltransferase
proteins in both brain regions in adult male mice.
Assessment of the chromatin-modifying proteins, GCN5, PCAF, and CREB binding protein (CBP), all
acetyltransferase enzymes, indicated that DAE increases GCN5 expression the (A) male dentate gyrus,
p<.05 and decreases expression of GCN5 in the (B) male frontal cortex, p<.05. DAE has no impact on
PCAF expression in the (C) male dentate gyrus, and decreases expression of PCAF in the (D) male frontal
cortex, p<.01. DAE has no effect the expression of CBP in the (E) male dentate gyrus or the (F) male
frontal cortex, p>.05. *p<.05, **p<.01
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Perinatal arsenic exposure decreased expression of CREB and phosphorylated CREB
(Figure 9A: Male FC, t(22) = 2.012, p = .05), and p-CREB (Figure 9B: Male FC, t(21) =
2.036, p = .05).

Figure 6.9. Perinatal arsenic exposure alters CREB proteins in the frontal cortex of adult male mice.
Assessment of the chromatin associated transcription factors indicated that perinatal arsenic exposure
reduces the expression of both (A) CREB and (B) pCREB in the male frontal cortex, p<.05. *p<.05

Expression of GCN5 was not altered in the female DG or FC (Figure 10A: Female DG,
t(11) = .1402, p = .8910; Figure 10B: Female FC, t(12) = .3423, p = .7381); however
there was an modest increased in PCAF expression in the female DG similar to the
increase observed for H3K9ac (Figure 10C: Female DG, t(12) = 1.452, p = .1722),
though PCAF was not impacted by arsenic in the female frontal cortex (Figure 10D:
Female FC, t(12) = .878 , p = .3972). CREB and CBP expression were not accessed in
female brain tissue. Perinatal arsenic exposure influences the expression of GCN5 and
PCAF proteins similar to the pattern observed for H3K9ac HPTM in both brain regions
of both sexes. Additionally, perinatal arsenic exposure influences CREB and p-CREB
expression but only in the adult male frontal cortex. (n = 11-13 per assay)
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Figure 6.10. Developmental arsenic exposure does not alter histone acetyltransferase expression in
adult female mice.
Assessment of the chromatin-modifying proteins, GCN5 and PCAF, in female brain regions indicates that
perinatal arsenic exposure does not influence GCN5 expression the (A) female dentate gyrus, p>.05, or the
(B) female frontal cortex. p>.05, but does slightly increase expression of PCAF in the (C) female dentate
gyrus, p=.1, with no effect on PCAF in the (D) female frontal cortex. *p<.05

6.3.8 Repressive chromatin complex: REST/NRSF and Co-REST
Recent studies have suggested that there is extensive interaction among various
epigenetic factors, including the machinery and the modifications themselves, in order to
control gene expression (Jobe et al., 2012). Reduced histone acetylation has been
associated with repressive complexes, including the REST/NRSF complex, known for its
role in silencing neuronal programs (Ooi & Wood, 2007). In neural stem cells,
REST/NRSF inhibits programs responsible for neural fate specification and
differentiation (Gao et al., 2011). As such, we assessed the expression of REST/NRSF
and its co-repressor Co-REST in the dentate gyrus and frontal cortex of adult male mice.
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Surprisingly, perinatal arsenic exposure did not impact the expression of REST/NRSF or
Co-REST in the dentate gyrus of adult males (Figure 11A: Male DG REST, t(22) = .4959,
p = .6249; Fig 11B: Male DG Co-REST, t(24) = .04476, p = .9647). However, we did
observe an increase in the expression of both REST and Co-REST in the male frontal
cortex (Figure 11C: Male FC REST, t(20) = 2.612, p = .0167; Fig 11D: Male FC CoREST, t(20) = 2.861, p = .0097). This increased REST/NRSF and Co-REST expression
parallels decreased histone acetylation observed in the frontal cortex. (n = 11-14 per
assay)

Figure 6.11. Perinatal arsenic exposure alters proteins in the REST chromatin silencing complex
based on sex and brain region.
Assessment of chromatin associated factors, responsible for silencing of genes associated with neural
lineages, indicated that perinatal arsenic exposure does not impact the expression of (A) REST in the male
dentate gyrus or (C) Co-REST in the male dentate gyrus. However, REST expression is increased in the (B)
male frontal cortex, p<.05 and Co-REST expression is increased in the (D) male frontal cortex, p<.01.
*p<.05, **p<.01

186

6.4 Discussion
Many researchers are interested in how toxins impact epigenetic processes in order to
elucidate potential mechanisms of action in the body. While the impact of arsenic
exposure on the epigenome has been extensively studied in the context of cancer research,
the influence of this toxicant in the brain, particularly as it relates to epigenetics, is not
well understood. Additionally, as the developing brain can be vulnerable to several
insults, including arsenic, the genetic programs that are initiated, executed, and
subsequently terminated via epigenetic processes may be sensitive as well (Calkins &
Devaskar, 2011). Thus, determining the long-term impact of fetal exposures on the status
of factors associated with epigenetic control of genetic programs could provide a window
into how fetal programming leads to disease susceptibility in adulthood. This study
provides the first step in demonstrating that perinatal exposure to 50 ppb arsenic,
throughout all three trimesters of development, influences histone modifications and the
expression of chromatin-modifying proteins in the adult mouse brain long after
subjection to arsenic has diminished. Notably, the impact of this exposure paradigm is
related to the type of histone modification (e.g. methylation or acetylation), the location
of the modification (e.g. the dentate gyrus or frontal cortex), and the sex in which the
modification is present (e.g. male or female arsenic-exposed offspring). Such
specification of arsenic toxicity may shed light on its potential mechanisms of action in
altering the adult brain.

Data provided here demonstrate a differential effect of perinatal arsenic exposure
dependent on brain region. We have previously shown that our exposure model alters
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expression of several genes associated with neurogenesis in the adult dentate gyrus (Tyler
& Allan, 2013). The genetic programs involved in the processes of adult neurogenesis are
highly orchestrated by epigenetic factors (Covic et al., 2010). As such, to evaluate the
regulation of neurogenesis, we sought to first demonstrate that arsenic impacts epigenetic
processes in this brain region, possibly leading to aberrant gene expression. We chose to
assess H3K4me3 and H3K9me3, as both of these modifications are influenced by arsenic
(Zhou et al., 2008) and each is present on either actively transcribed or repressed genes,
respectively (Kouzarides, 2007). Surprisingly, we found no differences in H3K9me3
levels, as anticipated based on arsenic cell culture studies; potential reasons for this
include the dose and timing of arsenic exposure or the cell type, as in vitro studies use
direct application of high concentrations of arsenite on cancer cells (Chervona et al.,
2012a; Hong & Bain, 2012b). We did observe an increase in H3K4me3 levels in the
dentate gyrus of adult males, and a decrease in levels in adult females in the same region,
opposite of the expression patterns for this HPTM measured in human PBMCs (Chervona
et al., 2012b). To determine a possible mechanism for this altered level of modification,
we analyzed the expression of MLL1, a histone methyltransferase responsible for
trimethylation of H3K4 (Bannister & Kouzarides, 2011). We found increased expression
of MLL1 in arsenic-exposed adult males and decreased expression in females (both in the
dentate gyrus); this demonstrates that the level of histone modification is possibly due to
the level of expression of its modifier. MLL1 has been implicated in subventricular zone
neurogenesis and mediates the conversion of silent bivalent domains to active domains
containing H3K4me3 (Lim et al., 2009); as we have previously demonstrated deficits in
subgranular zone neurogenesis in the dentate gyrus in adult males, the increased
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expression of MLL1 and H3K4me3 could be a compensatory mechanism to counteract
the deleterious effects of arsenic, which are perpetuated into adulthood.

Histone trimethylation of lysine 4 has been associated with histone acetylation, as it is
thought that histone modifications create crosstalk and a particular “code” for regulation
of expression (Kouzarides, 2007; Jobe et al., 2012). We found no differences in overall
histone acetylation in the dentate gyrus of either sex, but we did observe an increase in
H3K9 acetylation levels in the male dentate gyrus with a slight increased trend in the
female dentate gyrus. This was unexpected, as human studies have demonstrated that
arsenic exposure is inversely correlated with H3K9ac levels (Chervona et al., 2012b);
however, a different study demonstrated that arsenic exposure via inhalation was directly
correlated to H3K9ac levels in leukocytes (Cantone et al., 2011). Additionally, increased
acetylation occurs in response to oxidative stress induced by arsenic exposure in vitro; as
such, the expression profile of H3K9ac in the dentate gyrus may be a residual response to
arsenic toxicity during the embryonic period, though this has yet to be assessed (Li et al.,
2001; Sun et al., 2009b). GNC5 and PCAF are histone acetyltransferase enzymes found
in multi-subunit mammalian complexes, SAGA (STAGA, TFTC) and ATAC, and either
complex can use either protein as the acetyltransferase for particular acetyl modifications
in vitro (Wang et al., 2008b). Conditional deletion of GCN5/PCAF together significantly
reduces H3K9ac (Jin et al., 2011); as such we assessed the expression of both GCN5 and
PCAF to determine their correlation to H3K9ac levels. Interestingly, increased H3K9ac
in the male and dentate gyrus was concurrent with increased expression of GCN5 (but not
PCAF) and the trend of increased H3K9ac in the female dentate gyrus was concurrent
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with increased PCAF (but not GCN5), though arsenic has been shown to alter GCN5
expression (Nelson et al., 2009). While the histone acetyltransferase proteins are
segregated into distinct families, extensive crosstalk between PCAF and CREB binding
protein (CBP) has demonstrated to play a role in acetylation (Liu et al., 1999; Nagy &
Tora, 2007); however, perinatal arsenic exposure did not impact CBP expression in the
male dentate gyrus, though there was an effect in the male frontal cortex.

Arsenic can accumulate in particular brain regions, including the hippocampus (in which
the dentate gyrus is located) and the frontal cortex (Sanchez-Pena et al., 2010). To
demonstrate region specificity of arsenic toxicity for the dentate gyrus, we assessed
histone modifications in the frontal cortex of both males and females. Surprisingly, we
observed increased expression of both H3K4me3 and associated MLL1 in the male
frontal cortex, similar to the pattern observed in the dentate gyrus in the males. MLL1 has
been found in GABAergic and cortical neurons, and remodeling mechanisms in the
frontal cortex that involve both H3K4me3 and MLL1 have been implicated in the
etiology of schizophrenia (Huang et al., 2007). However, the role of MLL1 and
H3K4me3 in the frontal cortex, especially as it pertains to depression and metal toxicity
like arsenic, is unknown. Interestingly, we found the perinatal arsenic exposure
influences acetylation in a region- and sex-specific manner similar to that of methylation.
Acetylation of H3K9 was reduced in the adult male frontal cortex, with no effect in the
female frontal cortex; GCN5 and PCAF expression followed suit (decreased expression
of both in the male frontal cortex), suggesting again that histone modifications are
dependent on the expression of their modifiers long after arsenic exposure has essentially
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ceased, though there is approximately 5 ppb arsenic in tap water. While there was no
observable change in overall histone acetylation or CBP expression, perinatal arsenic
expression reduced both CREB and p-CREB in the male frontal cortex (unlike the
dentate gyrus). Histone acetylation facilitates the binding of transcription factors (such as
CREB) to increase gene transcription, and CREB, known to be paramount for learning
and memory, has also been shown to be neuroprotective and to mediate the efficacy of
antidepressants (Sakamoto et al., 2011). Interestingly, aberrant epigenetic processes have
been implicated in the etiology of psychiatric disorders, such as depression, but have
been specific to measurements in the hippocampus and the amygdala (Sun et al., 2013).
Thus, it is possible that concurrent decreased acetylation and CREB/p-CREB in the
frontal cortex may be one molecular mechanism by which arsenic increases susceptibility
to depression. We are currently assessing the falsifiability of this new hypothesis.

Currently, a consensus on the “epigenetic orchestration” of adult neurogenesis has yet to
be determined, yet there is one chromatin remodeling factor thought to play a paramount
role: repressor element 1 (RE1) silencing transcription factor or neuron restrictive
silencing factor, REST/NRSF. This factor has been termed the “master negative regulator”
of neurogenesis (Gao et al., 2011). As perinatal arsenic exposure reduces adult
neurogenesis in the dentate gyrus of adult mice, we assessed the expression of
REST/NRSF and its cofactor, Co-REST. We observed no changes in REST/NRSF or CoREST expression in the dentate gyrus. MLL1 has been shown to antagonize the
expression of REST/NRSF; thus, it is possible that increased H3K4me3 and MLL1
expression observed in differentiated dentate granule neurons is associated with reduced
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or normalized levels of REST/NRSF (Ballas et al., 2005; Ballas & Mandel, 2005).
Conversely, we report increased levels of REST/NRSF and Co-REST in the frontal
cortex of adult males. Increased REST/NRSF expression has been found as a normal part
of aging and is reduced in mild cognitive impairment and Alzheimer’s disease (Lu et al.,
2014). However reduced expression of REST/NRSF is required for differentiation, and in
mature neurons, REST/NRSF is present but not active (Gao et al., 2011). Activation of
REST/NRSF expression can occur in response to neuronal insult (Kaneko et al., 2014).
While these studies demonstrate that the precise role of REST/NRSF in the brain is still
under investigation, our findings suggest that REST/NRSF expression in the brain may
be vulnerable to arsenic toxicity. Overall, we provide results establishing that arsenic
impacts the molecular expression of proteins important for neuronal programs in the
frontal cortex; this raises more questions as to the deficits in specific frontal cortex
functioning in our perinatal arsenic exposure model.

It should be noted that sex-dependent changes in molecular components, including
histone modifications in response to arsenic exposure, have been demonstrated in prior
studies. In humans exposed to low to moderate levels of arsenic (50-500 ppb), high
urinary arsenic levels are correlated with high levels of H3K4me3 and H3K27me3 in
peripheral blood mononuclear cells from females, but the reverse of this expression is
present in males (Chervona et al., 2012b). In utero arsenic exposure alters global DNA
methylation profiles in cord blood with a greater influence in males than females
(Broberg et al., 2014). Indeed, many of the changes that we observed using our perinatal
arsenic exposure paradigm have been demonstrated in males (Martinez-Finley et al.,
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2011; Goggin et al., 2012). Finally, several sex-dependent alterations in cognition and
intelligence measures have been observed among males and females, suggesting that
arsenic may disrupt endocrine function, possibly mediating differences observed in these
studies (Vahter, 2009; Hughes et al., 2011). As such, our future studies, particularly as
they pertain to endocrine function and epigenetic processes will include females.

In conclusion, we have provided evidence suggesting the perinatal arsenic exposure
impacts histone modifications in the brain during adulthood. We have shown that levels
of H3K4me3 and H3K9ac are altered in a region- and sex-specific manner, and that the
chromatin modifying proteins responsible for these modifications also have altered
expression profiles that parallel histone modification levels. Additionally, we observed
sex-specific influences of arsenic that are antithetical to prior observations in human
studies, likely due to cell type in which histone modifications were measured and the
extent of arsenic exposure. Indeed, we did not observe changes in many histone
modifications, including H3K9me3 or H3ac, as expected, suggesting that the timing and
dose of exposure used in cell culture studies as compared to our in vivo studies plays a
role in the damage arsenic elicits. Importantly, data demonstrating region specificity
suggest a new avenue of research for arsenic toxicity: epigenetic regulation of frontal
cortex functionality. Overall, these findings are the first step in analyzing the effect of
developmental arsenic exposure on epigenetic programming of gene expression in the
adult brain; further studies will evaluate the impact of histone modifications on gene
expression and the potential aberrant fetal programming of these epigenetic modifications
that may be perpetuated into adulthood.
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7.0 General Discussion
7.1 Summary of Findings
Over 100 million people worldwide are exposed to levels of arsenic that well exceed the
World Health Organization limit of 10 µg/L (parts per billion, ppb); as such, arsenic
contamination and subsequent exposure via drinking water is considered a major public
health epidemic. Exposure to this metalloid affects almost every organ system in the body,
including the brain. Several epidemiological studies have provided evidence suggesting a
link between arsenic exposure and increased rates of psychiatric disorders, including
depression in adult populations (reviewed in Chapter 2). Additionally, children with
arsenic exposure have deficits in intelligence measures and difficulty with certain forms
of learning and memory (Calderon et al., 2001; Calderon et al., 2013). It is currently
unknown if these exposed children will also have an increased risk of developing a
psychiatric disorder, but prospective studies are currently underway. Research using
rodent models for assessing the effect of arsenic has demonstrated that developmental
exposure has long-lasting consequences into adulthood including deficits in learning and
memory, molecular aberrations in the hypothalamic-adrenal-pituitary (HPA) axis, and
depressive-like symptoms (Martinez et al., 2008; Martinez-Finley et al., 2009; Goggin et
al., 2012). However, the mechanistic link between arsenic exposure and these behavioral
outcomes is still not well understood.

One neurobiological mechanism that underlies deficits in hippocampal learning and
memory and increased risk of psychiatric disorders, such as anxiety and depression, is
that of aberrant adult hippocampal neurogenesis (AHN). The studies described in this
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dissertation were designed to characterize the impact of perinatal arsenic exposure (50
ppb during all three trimester equivalents) on the susceptibility to depression, with a
particular focus on adult neurogenesis as a candidate mechanism of action. Two overall
aims were developed to test the hypothesis that perinatal arsenic exposure leads to a
depressive-like endophenotype via aberrant epigenetic regulation of neuronal genes
involved in AHN in adult mice. This hypothesis is supported by literature demonstrating
that in both human and rodent studies, depressive-like symptoms correlate with reduced
hippocampal volume associated with reduced AHN and that the efficacy of
antidepressants is dependent on intact AHN (Santarelli et al., 2003; Boldrini et al., 2013).
Additionally, studies have demonstrated that epigenetic processes intricately control gene
expression for all components of AHN and that aberrant epigenetic regulation may
contribute to the etiology of depression (Mateus-Pinheiro et al., 2011). Control of AHN
requires appropriate expression of several chromatin-modifying proteins to impose
distinct histone modifications on particular genes to maintain the neurogenic niche or to
implement maturation programs. Epidemiological and in vitro cell culture studies have
separately provided evidence that arsenic exposure leads to aberrant histone
modifications (Ramirez et al., 2008; Zhou et al., 2008; Zhou et al., 2009; Chervona et al.,
2012b). Additionally, one study has shown that early developmental exposure to arsenic
(in the ppm range) alters that DNA methylation patterns in the brain for genes that are
important for neuronal plasticity (Martinez et al., 2011). These observations support the
overall hypothesis that arsenic exposure during development interferes with the
epigenetic environment of the hippocampus leading to susceptibility to depression in
adulthood (See Figure 7.1).
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Figure 7.1 Overall model of processes impacted by perinatal arsenic exposure
Perinatal arsenic exposure damages epigenetic and neurogenic processes associated with depression. Aims
were developed to assess hypothesis that perinatal arsenic exposure increases susceptibility to depression in
adulthood by inducing deficits in adult neurogenesis via altered epigenetic mechanisms, like histone
modifications. Boxes under each aim present findings from the studies described in this dissertation.
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Aim 1 experiments in this dissertation were designed to assess the hypothesis that
perinatal arsenic exposure results in deficits in adult neurogenesis and hippocampaldependent behavioral tasks, both of which can be rescued by chronic antidepressant
treatment. Thus, the first set of experiments established arsenic-induced morphological
and functional damage to the hippocampus: maternal consumption of 50 ppb arsenic in
drinking water resulted in reduced differentiation and survival of neural progenitor cells
in the dentate gyrus of the hippocampus in adult male offspring concurrent with increased
susceptibility to stress-induced depression as measured by learned-helplessness and
forced-swim tasks after exposure to a predator odor (Chapters 4 and 5). Additionally,
stress responses, which are altered in depressed patients, were blunted in arsenic-exposed
animals as measured by plasma corticosterone levels (CORT) after TMT exposure.

A second set of experiments for Aim 1 were performed to determine the reversibility of
arsenic-induced damage, thereby demonstrating causality of aberrant AHN as a
mechanism of action. Deficits in AHN were ameliorated using a novel chronic,
intermittent environmental enrichment approach in which animals experience enrichment
for a few hours daily and are returned to their home environment (Chapter 4). This model
allows for novelty of the environment and restoration of the stress response, and while
this enrichment paradigm is important for animal studies, it does not translate directly for
human therapies. A chronic regime of fluoxetine, a selective serotonin reuptake inhibitor
antidepressant commonly prescribed as Prozac®, was provided for one month via
drinking water to adult male animals perinatally exposed to arsenic. Fluoxetine treatment
prevented depressive-like behaviors in all behavioral tasks in arsenic-exposed animals,
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and ameliorated arsenic-blunted stress responses and deficits in neural progenitor cell
differentiation and survival (Chapter 5). These studies demonstrated that hippocampal
morphological and behavioral damage induced by perinatal arsenic exposure is reversible
with chronic fluoxetine treatment, resulting in restored resiliency to depression via a
neurogenic mechanism.

Aim 2 experiments were designed to determine the validity of a second hypothesis:
perinatal arsenic exposure alters histone methylation and acetylation patterns on
neurogenesis-related genes. Thus, these studies were performed to investigate arsenic’s
effect on the molecular components of AHN in the dentate gyrus and the epigenetic
regulation of neuronal genes. Deficits in AHN were associated with abnormal neuronal
gene expression within the pathways involved in Alzheimer’s disease, apoptosis,
axonogenesis, growth, Notch signaling, and transcription factors in the dentate gyrus.
Additionally, some of this aberrant gene expression was ameliorated with chronic
intermittent exposure to enrichment, suggesting reversibility of arsenic damage (Chapter
4). To identify potential epigenetic mechanisms by which arsenic imparts dentate-specific
damage, global post-translational histone modifications (PTHM) were assessed along
with the expression of several chromatin-modifying proteins. Perinatal arsenic exposure
resulted in increased histone 3 lysine 4 trimethylation and histone 3 lysine 9 acetylation
in the dentate gyrus of adult males with altered expression of their respective histone
methyl- and acetyltransferase modifiers, Mll1 and GCN5/PCAF. However, arsenic did
not impact overall acetylation of H3 or trimethylation of H3K27 or H3K9, as seen in
previous studies. These effects were specific to the adult male dentate gyrus, as the effect
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of arsenic exposure on histone modifications was dependent on region of interest and sex,
as described in Chapter 6. Additionally, chromatin-modifying proteins including REST,
Co-REST, CREB binding protein (CBP), and factors involved in neurogenesis including
BDNF and CREB were not altered in the dentate gyrus of arsenic-exposed mice,
implying that further analysis of the mechanism of arsenic-induced damage in the dentate
is required. Sequencing analysis (ChIP-Seq) using the dentate gyrus of adult males after
developmental arsenic exposure (PD70) will demonstrate which genes have histone 3
lysine 4 trimethylation occupancy, and thus, may be considered, up-regulated in response
to arsenic; this analysis is currently underway.

Data presented in this dissertation demonstrates that developmental arsenic exposure
alters hippocampal morphology by inducing deficits in AHN, alters expression of genes
associated with neurogenesis, and increases activating posttranslational modifications of
histones in the dentate gyrus. Deficits in hippocampal morphology and gene expression
were associated with behaviors indicative of depression and aberrant responses to stress.
These alterations were restored using two therapeutic approaches: a novel environmental
enrichment paradigm and chronic antidepressant administration, confirming that aberrant
adult neurogenesis is one mechanism by which arsenic alters the brain. Arsenic likely
impacts AHN by altering epigenetic programming during development that is perpetuated
into adulthood, resulting in the phenotypes measured here. Thus, future studies might aim
to further characterize the epigenetic modifications present on neural progenitor cells in
the embryonic brain when arsenic is present.

199

7.2 Interpretation and Significance of Results

7.2.1 Significance of depressive-like symptoms and altered stress responses in adult male
mice perinatally exposed to arsenic
The contribution of environmental factors in the etiology of depression, while widely
acknowledged, has not been thoroughly investigated. Epidemiological studies of toxininduced depression have suggested an association between exposure and an increased
risk of development of a psychiatric disorder (Zierold et al., 2004; Sen & Sarathi Biswas,
2012; Beard et al., 2013; Freire & Koifman, 2013; Malekirad et al., 2013; Ojo et al.,
2013; Weisskopf et al., 2013). Additionally, the fetal origins of disease hypothesis
postulates that the early environment plays a role in the development of diseases in
adulthood; thus, it is likely that toxin exposure during development may also contribute
to a predisposition for depression or other psychiatric disorders (Bale et al., 2010).

As discussed in Chapter 5, exposure to a mild stress (footshock) on the first day of a
learned helplessness (LH) task was sufficient to induce depressive-like symptoms in adult
arsenic-exposed mice, but not in control animals. Chronic LH has been used to generate
depression in other rodent models; therefore, we wanted to evaluate a mild LH paradigm
in which the stress is minimal and does not induce a depressive-like phenotype in control
animals. This finding suggests that arsenic “primes” a depressive-like response to a mild
stressor. Indeed, arsenic-exposed mice exhibited depressive-like symptoms on the forced
swim task after a 10-minute exposure to a predator odor (TMT) (Chapter 5). Therefore,
adult male mice perinatally exposed to arsenic will have a depressive-like phenotype after
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the stress response is activated, suggesting a lack of resiliency to stress. Resiliency, while
difficult to measure, has been implicated in depression, as individuals with robust
homeostatic responses to stress are often considered resistant to depression (Krishnan &
Nestler, 2008).

Chronic stress paradigms are used to produce depressive-like symptoms in rodents and
create hyperactivity of the HPA axis, as described in the Introduction. The Allan lab has
previously published findings demonstrating that arsenic exposure during development
increases circulating corticosterone (CORT) levels in adolescent mice (PD35) and
reduces expression of the glucocorticoid receptor in the hippocampus, likely impeding
the inhibitory tone the hippocampus provides for the HPA axis (Goggin et al., 2012). As
such, an additional stress like that provided in each of the behavioral tasks presented here,
would facilitate a stress response leading to depressive-like behavior. Indeed, these
findings were corroborated by demonstrating that in adult male mice, CORT levels are
elevated, and the stress response to TMT is diminished compared to control animals
(Chapter 5). Blunted HPA axis feedback has been measured in depressed patients, along
with increased circulating cortisol (human equivalent of CORT), validating the
depression endophenotype observed in the arsenic-exposed animals (Wainwright &
Galea, 2013). Thus, these results provide greater evidence that arsenic may predispose an
individual for developing depression via lack of resiliency to stress. By demonstrating
that arsenic exposure leads to aberrant stress responses that may result in greater risk for
developing a psychiatric disorder like depression, these findings have provided more
evidence of the contribution of the environment in the etiology of depression.
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7.2.2 Significance of altered adult hippocampal neurogenesis after perinatal arsenic
exposure
As explained in the Introduction, adult hippocampal neurogenesis is comprised of several
processes

including

proliferation

of

neural

progenitor

cells

(NPCs),

differentiation/maturation of these cells into neurons, and the survival and incorporation
of these cells in the hippocampal circuitry. Assessment of proliferation of NPCs
demonstrated that perinatal exposure to arsenic only reduced proliferation by 13%, which
was not significant (Chapter 4). However, one caveat to this finding is that the BrdU
labeling method that was employed may have underestimated that total degree of
neurogenesis. The 12-hour pulse chase assay labels a small percentage of the
proliferation progenitors as a representation of the total quantity of the progenitor niche.
This method of labeling is considered the gold standard of the field; however, if arsenic
alters cell cycle dynamics, as seen in cell culture studies (Sidhu et al., 2006), then it is
possible that the timing of proliferation is different from that of control animals (not
exposed to arsenic). This change in cycle dynamics would not be evident from the
lineage tracer assay employed in these studies; thus, it is possible that the molecular
mechanisms of proliferation are altered without this being represented with
immunohistochemistry (IHC) measurement. The use of environmental enrichment
increased proliferation of both control and arsenic-exposed animals (Chapter 4); however,
the extent of increased proliferation in arsenic animals was not significant. Thus, if the
proliferation potential of neural progenitor cells after arsenic exposure is indeed not
different from that of controls, we would have expected the response to enrichment to be
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equivalent among the two. Since the response was blunted in arsenic-exposed animals, it
may be proposed that arsenic impacts proliferation in a manner that is not measurable
using methods employed in these studies. It would be important to determine if arsenic
impacted cell cycle dynamics; this could be accomplished using flow cytometry for
measuring G0/G1, S, and M/G2 to definitively state that arsenic does not impact
proliferation. However, it should be noted that the lack of impact on proliferation does
corroborate other findings in cell culture and animals studies demonstrating that arsenic
preferentially impacts differentiation and not proliferation of stem cells (Hong & Bain,
2012a).

Perinatal arsenic exposure reduced the number of differentiated progenitor cells
(BrdU+NeuN+) by 55% and the number of surviving cells (BrdU+) by 53% one month
after BrdU administration (Chapters 4 and 5). Other toxins found in water, including
heavy metals like mercury and lead, have been shown to impact AHN, specifically
differentiation (Jaako-Movits et al., 2005). Indeed, in vitro assessment of neurogenesis
suggests that arsenic suppresses differentiation but not proliferation of neural stem cells,
concurrent with reduced expression of pro-neural genes such as neurogenins and
NeuroD1 (Hong & Bain, 2012a). The reduction in differentiation but not proliferation
may underlie the learning and memory deficits observed in arsenic-exposed animals. It is
thought that deficits in AHN lead to altered synaptic plasticity and are associated with
deficits in learning and memory paradigms. Indeed, there is a critical window of
maturation for newborn neurons from 1-2 weeks (after proliferation has been assessed but
prior to maturation assessment) (Aasebo et al., 2011); as such, the lack of maturing
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newborn neurons during learning experiences may underlie both the learning deficits and
the depressive-like symptoms observed in this arsenic model.

The mechanism by which arsenic reduces the number of differentiated cells may be
twofold: the first is that of epigenetic regulation of genes responsible for neurogenesis as
discussed later. The second is that the arsenic may impact the stages of maturation,
particularly including increased excitability (glutamatergic inputs) and synaptic plasticity
(lower threshold for long-term potentiation) that are required for these newborn neurons
to become integrated into the hippocampal circuitry. Other prenatal toxin exposures like
maternal alcohol consumption have been shown to alter the synaptic connections among
older dentate granule cells and newborn neurons later in life. Glutamatergic and
GABAergic inputs into the newborn neurons are affected by prenatal alcohol exposure,
resulting in inappropriate firing of excitatory and inhibitory field potentials (Brady et al.,
2013; Kajimoto et al., 2013). This has yet to be measured in developmental or adult
arsenic exposure studies.

The data demonstrating that perinatal arsenic results in long-lasting deficits in
differentiation and survival of neural progenitor cells in the dentate gyrus of adult males
with depressive-like symptoms provides yet another study elucidating the link between
neurogenesis and depression. There are some conflicting results in the literature
concerning the connection between adult neurogenesis and depression. Ablation of AHN
does not always produce a depressive-like phenotype in rodent models, suggesting the
validity of the neurogenic hypothesis of depression is questionable; however, the
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variability in results reported is likely due to the method, extent, and timing of ablation of
AHN (Petrik et al., 2012). A second facet of the neurogenic hypothesis purports that
AHN is required for the efficacy of antidepressant therapy. While both stress and
antidepressant treatment regulate neurogenesis, demonstrating that AHN is causal in
mediating the effects of stress and antidepressants, thereby inducing depression, is still
under investigation (Mahar et al., 2014). Some studies have shown that intact AHN is not
necessary for mediating the response to antidepressants (Jedynak et al., 2014); however,
again the method of ablation likely contributes to these results. The findings presented in
this dissertation would further support the neurogenic hypothesis of depression,
suggesting that animals with depressive-like symptoms have concurrent reduced AHN
and yet have sufficient quantities of newborns neurons (not complete ablation) for the
action of an antidepressant, such as fluoxetine. However, these findings are correlational,
and causality has yet to be demonstrated.

7.2.3 Significance of reversibility of arsenic-induced behavioral and molecular damage
The potential to restore resiliency to stress-induced depression in arsenic-exposed
animals was assessed using pharmacological treatment regime, as described in Chapter 5.
It is known that fluoxetine, a selective serotonin reuptake inhibitor, leads to alleviation of
depression in some patient populations after chronic intake. Additionally, as described in
the Introduction, antidepressants can increase AHN with concurrent reversal of
depressive-like symptoms in rodents that are chronically stressed.

205

As presented in Chapter 5, arsenic-exposed animals were provided a chronic treatment
regime of 100 mg/L of fluoxetine in their drinking water for one month. Treatment with
fluoxetine prevented depressive-like behaviors in the behavioral tasks described above,
namely the LH and FST after exposure to a stressor; this not only demonstrates the
predictive validity of these tasks in this depression model but also the reversibility of
arsenic-induced damage. Additionally, fluoxetine ameliorated blunted HPA axis stress
responses, providing further evidence of the link between stress, neurogenesis, and
depression. Fluoxetine treatment likely repaired behavioral and morphological damage by
increasing the expression of several proteins involved in neurogenesis, including brain
derived neurotrophic factor (BDNF), the cAMP response element binding protein
(CREB), the glucocorticoid receptor (GR), and histone deacetylase 2 (HDAC2).
Interestingly, the protein expression in the dentate gyrus of these four targets was not
impacted by arsenic exposure (Chapter 5); this finding suggests that fluoxetine bypasses
damage induced by arsenic to restore AHN and prevent a depressive-like phenotype in
mice developmentally exposed to arsenic.

Exposure to an enriched environment has also been demonstrated to increase
neurogenesis; as discussed in Chapter 4, arsenic-exposed animals were provided access to
an enriched environment for one month. This access was daily but intermittent in the time
of day and in the allotment of time in the enrichment; this variation allowed for novelty
of the environment. Previous studies have shown that with developmental toxin exposure
(prenatal alcohol), the neurogenic response to experience in enrichment is blunted (Choi
et al., 2005; Kajimoto et al., 2013); therefore, this new “playground” model of
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enrichment was developed. It was hypothesized that since arsenic induces alterations in
stress responding and part of the experience in enrichment requires mild activation of the
stress response, a period of “nonstressful” home activity may be required for efficacy of
the enrichment. Animals also experienced social interaction with other animals not from
their home cage; toys were periodically moved to activate spatial learning, and a running
wheel was provided, as exercise has been shown to enhance proliferation. Interestingly,
experience in enrichment (EE) increases both proliferation and differentiation in arsenicexposed animals (though only significantly for differentiation). Additionally, aberrant
gene expression (discussed below) was reversed in some cases in the EE arsenic-exposed
mice compared to non-EE arsenic-exposed mice, again suggesting the reversibility of
arsenic-induced damage. It is unclear if reversibility of these deficits would have
appeared if animals had been in a different enrichment paradigm (See Limitations).
However, it can be discerned that both environmental and pharmacological interventions
are suitable to reverse deficits in AHN induced by perinatal arsenic exposure. This may
be useful for therapeutics, as many people have an adverse reaction to the notion of
taking antidepressant medications.

The fact that both pharmacological and environmental paradigms were able to reverse the
behavioral endophenotypes and deficits in AHN suggest that interventions for
developmental arsenic exposure are possible. The mechanism by which these treatments
reverse deficits is interesting but not entirely clear. Fluoxetine was able to reverse deficits
in AHN and did so, likely, by increasing GR, BDNF, HDAC2, and CREB. However,
there were no molecular deficits induced by arsenic for these four proteins. Additionally,

207

EE reversed gene expression of some genes that were altered after arsenic exposure,
including Creb1, but these gene sets did not completely overlap with the genes altered in
EE control animals (see below). This suggests that fluoxetine and EE may possibly
bypass the damage done by arsenic to improve AHN and behavioral outcomes; yet this
begs the question as to actual damage imparted by arsenic exposure.

7.2.4 Significance of genetic outcomes in arsenic-exposed adult male mice
To elucidate if there was transcriptional dysregulation after perinatal arsenic exposure,
we assessed mRNA expression using a microarray of genes specifically associated with
neurogenic programs (Chapter 4). Arsenic exposure resulted in up-regulation of several
genes associated Alzheimer’s disease; this finding suggests a molecular mechanism
supporting epidemiological studies showing a correlation between arsenic exposure and
Alzheimer’s disease (O'Bryant et al., 2011). Additionally, arsenic exposure resulted in
down-regulation of growth factors involved in axonogenesis, neurite outgrowth, and
maturation (including doublecortin), all of which are important and necessary for proper
differentiation. This molecular evidence corroborates morphological evidence: arsenic
likely impedes the newborn neuron’s ability to develop into a mature neuron, possibly
leading to decreased numbers of differentiated neurons and decreased survival but not
proliferation. Indeed, while cell death was not directly assessed, perinatal arsenic
exposure did up-regulate factors associated with apoptosis. In other studies,
developmental arsenic exposure increases apoptosis in other parts of the hippocampus
(not in the dentate gyrus) (Fan et al., 2013); however, adult exposure does not result in
increased apoptosis in the dentate gyrus (Liu et al., 2012). Studies investigating the effect
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of perinatal arsenic exposure on apoptosis would aid in determining the fate of newborn
neurons that do not functionally mature and integrate into the hippocampal circuitry. It is
possible that reduced differentiation could occur due to either 1) increased apoptosis or 2)
lack of activation of neuronal programs in favor of self-renewal gene expression.
Interestingly, Dll1 was up-regulated in arsenic-exposed animals in the dentate gyrus; this
ligand promotes Notch signaling, which enhances proliferation of progenitor cells.
Down-regulation of Ascl1, a target of Dll1 was also observed; this bHLH transcription
factor promotes differentiation. As such, increased Notch signaling may confer a genetic
program for maintenance of the stem cell niche as a result of arsenic exposure but at the
expense of differentiation. Thus, it can be further hypothesized that ChIP-Seq will reveal
increased H3K4me3 occupancy of Notch pathway components in the dentate gyrus.

It should be noted that some aberrant mRNA expression as a result of perinatal arsenic
exposure was reversed when animals experienced enrichment for one month (Chapter 4).
This exposure paradigm resulted in increased expression of both proliferation and
differentiation factors to levels previously measured in control animals; our findings
suggest that enrichment shifts the focus from proliferation to differentiation by inhibiting
pro-proliferative factors such as Noggin, Notch, and Sox3. Additionally, in arsenicexposed animals, axonogenesis and transcription factor gene expression was up-regulated
in response to enrichment. This is yet another piece of evidence suggesting that arsenicinduced damage is reversible and that genes associated with neurogenesis are
dynamically expressed and responsive to the external environment. This finding furthered
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the concept that epigenetic regulation of neurogenesis likely plays a role in the response
of the dentate gyrus to arsenic.

7.2.5 Significance of epigenetic outcomes in arsenic-exposed adult mice
The findings from Chapters 4 and 5, that enrichment and fluoxetine were able to reverse
arsenic-induced morphological and behavior damage, lead to us to further question the
mechanism by which arsenic alters neurogenesis. Toxin exposure outcomes may be
mediated through modifications of genetic programs, but the mechanism is not well
understood. In one study, arsenic exposure increased DNA methylation on genes
associated with plasticity, but the response of histone modifications in the adult brain to
developmental arsenic toxicity had yet to be determined. We found that perinatal arsenic
exposure altered some global histone posttranslational modifications (HPTM) in the
dentate gyrus. The levels of two activating marks, H3K4 trimethylation and H3K9
acetylation, were increased in the dentate gyrus of arsenic-exposed adult males. Yet,
these two particular marks were decreased in the frontal cortex of the same adult males.
Additionally, female mice seemed to be robustly unaffected by arsenic exposure, with
only H3K4 trimethylation decreased in the dentate gyrus. These findings suggest that the
response to arsenic is likely both region and sex-dependent (see Future Directions). To
determine the mechanism by which arsenic alters histone modifications, the expression of
chromatin modifying proteins that are responsible for imparting these particular HPTMs
were assessed. Expression of MLL1, the histone methyltransferase for H3K4me3,
matched that of the histone modification: increased in the dentate gyrus of males, and
decreased in the frontal cortex of males and the dentate gyrus of females. A similar
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pattern was observed for GCN5 and PCAF, both histone acetyltransferase proteins
responsible for H3K9 acetylation (among other marks). This result is specific to the
lysine residue on which histone acetylation occurs as overall acetylation and expression
of the histone acetyltransferase, CREB binding protein (CBP) was not affected by arsenic
exposure in either brain region. Additionally, the master negative regulator of neuronal
gene expression, REST and its cofactor, Co-REST, which we would have expected to be
altered, as both are involved in neurogenesis, were unaffected by perinatal arsenic
exposure in the adult dentate gyrus. Both proteins negatively regulate the neurogenic
program in neural stem cells; yet, as described later, the heterogeneous population of the
dentate gyrus is predominantly comprised of mature granule neurons with low expression
of REST/CoREST. As such, further analysis of adult NPCs specifically, may provide a
different outcome. Interestingly, we found REST and Co-REST expression were
increased in the frontal cortex of arsenic-exposed males. At this point, the consensus in
the literature suggests that the particularly distinct roles that REST/Co-REST play may be
tissue and context dependent (Gao et al., 2011). The results described here offer the first
insight into how arsenic impacts the epigenetic landscape of histone modifications in the
brain, suggesting that dysregulation of chromatin modifying factors may be the
mechanism by which arsenic impairs gene expression. Relating these epigenetic
modifications to behavior will require the use of epigenetic therapeutics and silencers to
demonstrate causality.
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7.3 Limitations and Critique of Studies
The studies presented in this dissertation are not without limitations. For each of the
experiments and results outlined above, there are caveats to the interpretation of findings
and possibly other techniques that can be used to answer these questions.

For example, there are several other measures for assessment of a depressive-like
endophenotype in rodent models. We did not employ the sucrose preference test due to
lack of face validity or the tail suspension task due to the inherent confound in using that
particular assessment for C57BL/6 mice (as described in the Introduction). However, it
may have been useful to assess animals’ behavior in all possible behavioral
measurements, including those related to depression and anxiety, to create a broad picture
of the behavioral endophenotype elicited by perinatal arsenic exposure. Indeed, anxiety
assessments would help further characterize the extent of arsenic-induced damage in the
susceptibility to psychiatric disorders overall. This model uses very low doses of arsenic
exposure, and while observationally, there are behavioral differences among control and
exposed animals, characterizing these differences using the appropriate behavioral tasks
has been difficult (See Future Directions).

Additionally, one design flaw is the administration of fluoxetine: several groups have
used either gavage or i.p. injection for direct administration of fluoxetine in assessment of
adult neurogenesis to directly control the amount of antidepressant (Malberg et al., 2000;
Malberg & Duman, 2003; Wang et al., 2008a). However, one seminal paper that
demonstrated the requirement of adult neurogenesis for the efficacy of antidepressant
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actions did use oral administration via drinking water (Santarelli et al., 2003). As
neurogenesis is highly sensitive to stress and arsenic-exposed animals display HPA axis
hyperactivity, we designed the fluoxetine administration to be as “stress-free” as possible.
While, we feel, the results from the fluoxetine studies on AHN are robust, we can only
assess the approximate amount of fluoxetine required to increase AHN as 20 mg/kg/day
based on the oral consumption of the fluoxetine solutions (Chapter 5). Therefore, this
administration model is not sufficient for deriving a dose-response relationship between
fluoxetine consumption and degree of increased AHN. Indeed, the same could be true for
the use of environmental enrichment: many studies determining the impact of EE require
that the animals live continuously in the enrichment. Our intermittent design was based
on previous studies demonstrating that the neurogenic response to EE is diminished with
exposure to prenatal toxins when animals live in enrichment (Choi et al., 2005). Based on
these findings, we developed a “playground” model of enrichment to provide novelty and
increased social interaction, which have been shown to be important for differentiation of
AHN (Fabel et al., 2009). However, from our model we cannot determine if “normal” EE
would have elicited the same response of increased AHN after developmental arsenic
exposure. Additionally, our findings do not aid in determining which component of EE is
most important for ameliorating arsenic-induced deficits in AHN: novelty, social
interaction, exercise, or toys.

The assessment of neurogenesis, while compelling and robust, also has its own
limitations. The use of BrdU has been called into question over the last few years of
research, as the antibody concentration and particular thymidine analog selection has
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been shown to affect the cell counts, possibly providing a window into the inherent
variability in assessment of AHN and the conflicting results reported in the neurogenesis
literature (Leuner et al., 2009). Additionally, while we implemented a pulse-chase assay
considered to be the optimal paradigm for BrdU labeling, there are transgenic models that
label neural stem cells more efficiently without the toxic side effects, such as cell death
(Lagace et al., 2007). However, replacing C57BL/6 mice with Nestin-CreERT2/YFP mice
would not only require re-characterizing the arsenic exposure paradigm, but would also
require tamoxifen injections to activate the CRE recombinase for Nestin+ neural stem
cells. Thus, the BrdU injection scheme for only 12 hours was the least stressful process of
labeling cells. It should be noted that some groups prefer to use only Ki67, an
endogenous marker of cell cycle activity, to label proliferating cells (Kee et al., 2002);
however, it is difficult to determine the number of cells that are maturing from the time of
birth without using a thymidine label. One possible alternative that is less toxic and still
provides robust labeling is the use of 5-ethyl-2'-deoxyuridine (EdU); this label is mostly
used for pulse chase assays in conjunction with BrdU but can be used alone as well
(Bradford & Clarke, 2011).

Finally, it should be noted that the dentate gyrus is a very heterogeneous tissue with
several different cell types all undergoing different processes and thus different gene
expression and regulation. As such, a limitation to these findings is that gene and protein
expression analysis was performed on this heterogonous cell population of the dentate
gyrus. For example, global histone modifications as measured by western blot analysis do
not provide specificity for the modification present in specific cell types; this can be
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overcome using immunohistochemistry methods, which would provide resolution for the
type of cell containing the histone modification. However, western blot analysis was
chosen to answer the question of the impact of arsenic exposure on the overall expression
of the histone modification. Additionally, it is likely multiple histone modifications that
were assessed are present in every cell type; using double-labeling IHC for several
histone modifications may be more useful to demonstrate colocalization of expression
levels. We were concerned with the degree of expression of histone modifications for the
purposes of knowing which modifications to assess in chromatin immunoprecipitation
next generation sequencing. However, the extent to which arsenic exposure impacts
histone modifications on particular cell types thus possibly leading to deficits in AHN
cannot be deduced from our findings (See Future Directions).

7.4 Future Directions
As with any study, there are many remaining questions that require further investigation.
I have condensed the seemingly endless possibilities for future studies into distinct sets of
inquiry: the effect of arsenic on embryonic programming, restoration of function, the
frontal cortex, female mice, and micro-RNA expression and regulation. First, alternative
methods of measurements that should be considered for future directions will be
discussed.

7.4.1 Alternative strategies for measurements
As described in the limitations section above, one caveat to the molecular findings
presented in this dissertation is that analysis was performed on the heterogeneous dentate
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gyrus tissue (though this tissue is less heterogeneous than the entire hippocampus).
Additionally, even measurements of embryonic neurogenesis (discussed below), would
only provide morphological assessment of the impact of perinatal arsenic exposure, not
gene or protein expression in specific cell types. Consequently, for this research, methods
to separate cell populations would be useful. This could be accomplished with flow
cytometry, which would use cell membrane identification for either endogenous or
exogenous markers for neurons and neural stem cells. However, the current methods for
isolation of NPCs from the dentate gyrus use cell culture coupled with flow cytometry
(Gilley et al., 2011). Laser capture microdissection of labeled neural stem cells or
neurons in the adult or postnatal brain, followed by single cell transcriptomics would
provide information as to the effect of arsenic on particular cell populations (Kohen et al.,
2014). This could be accomplished using the transgenic model, the Nestin:CreERT2:YFP
transgenic mouse model that with tamoxifen injection can birthdate neural stem cells
(Kajimoto et al., 2013); however, the arsenic exposure paradigm would need to be
characterized in this new model.

7.4.2 Embryonic programming during arsenic exposure
Assessment of the effect of arsenic during embryonic brain development would answer
many questions, but most importantly, are deficits observed in adulthood remnants of
developmental alterations? This question could pertain to embryonic neurogenesis or to
epigenetic programming.
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7.4.2.1 Developmental neurogenesis
It is estimated that almost 95% of the granule cells of the dentate gyrus are generated
during postnatal development; thus, the contribution of newborn neurons from NPCs in
the adult is quite small (Shors et al., 2012). Thus, it is likely that the granule neurons
present during development of the dentate gyrus are impacted by perinatal arsenic
exposure. Molecular aberrations measured in the adult dentate gyrus may be altered
genetic programs of these older granule cells rather than the newly differentiated
newborn neurons from adult neurogenesis. Additionally, arsenic could impact neurogenic
programs in neural stem cells that are left over from development, which reside in the
subgranular zone to form the adult neural progenitor pool. Further, aberrant early
programming of genetic programs due to environmental factors, can lead to increased
risk of psychiatric disorders (and other adverse health outcomes) in adulthood (Stolp et
al., 2012). Thus, it would be useful to characterize the impact of arsenic exposure on
components of embryonic neurogenesis, providing a possible mechanism for these
perpetuated deficits in adulthood. Embryonic neurogenesis can be difficult to measure, as
several areas of the brain have neural progenitor cells that are dividing, maturing, and
creating the circuitry of the brain; assessment between embryonic day 14.5 and 16.5, at
the peak period of cortical neurogenesis and again at postnatal day 23 after the dentate
gyrus if fully formed, would provide the most compelling results.

7.4.2.2 Epigenetic regulation during embryonic development
The results provided in Chapter 6 suggest that arsenic exposure during development leads
to aberrant epigenetic programming in the adult dentate gyrus. It is possible that arsenic
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induces an imbalance between proliferation and differentiation: up-regulation of MLL1 is
important for proliferation and was found to be increased in arsenic-exposed adult males
in the dentate gyrus, and deficits in AHN present as reduced numbers of differentiated
neural progenitor cells. The brain may respond to arsenic toxicity by upregulating selfrenewal and proliferative factors at the expense of neural factors for differentiation, as
suggested by the results presented in Chapter 4. To determine the validity of this
assertion, the molecular programs in proliferating neural progenitors versus neurons
would need to be determined in both the embryonic and adult brain. This would require
one of the two strategies mentioned before, flow cytometry or laser cell capture.
Separation of two cell populations followed by assessment of gene expression, histone
modifications, chromatin modifying proteins, and eventually the epigenetic regulation of
altered gene expression (ChIP-qPCR) would test the hypothesis that arsenic alters the
balance between proliferation and differentiation via aberrant epigenetic programming
during development. It is possible that this altered epigenetic programming due to arsenic
exposure is either 1) simply damage induced by arsenic that reverses once arsenic
exposure ceases or 2) a compensatory response to arsenic that is perpetuated into
adulthood. Results from these studies regardless of outcome (similar or opposite
expression profiles from that measured in adulthood), would provide an answer to the
response of the brain to arsenic exposure.

7.4.3 The regulation and expression of micro-RNAs after developmental arsenic exposure
The findings presented in Chapter 6 are the first to demonstrate the long-lasting effects of
perinatal arsenic exposure on histone modifications and chromatin modifying proteins in
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the brain. One particular set of observations described in Chapter 6 raises questions of
how arsenic impacts the expression, function, and regulation of micro-RNAs. A recent
study demonstrated that REST and CREB were responsible for the modulation of miR-92 expression during in vitro neuronal differentiation (Laneve et al., 2010); developmental
arsenic exposure altered expression of CREB and REST/NRSF and Co-REST in the
frontal cortex in adult males, suggesting that miR-9 may be influenced by arsenic
exposure. Indeed, inhibition of miR-9 has been shown to decrease neuronal
differentiation (Krichevsky et al., 2006), while loss of miR-9 has been reported in
Alzheimer’s disease (a disease that has been associated with arsenic exposure) (Packer et
al., 2008). miR-9 is highly expressed in the brain, along with miR-124, and cell cultures
studies have reported its involvement with embryonic neural progenitor maintenance
demonstrating that miR-9 targets some neurogenesis-related genes (Coolen et al., 2013).
Additionally, there is extensive crosstalk among epigenetic factors in controlling cell
function; for example, miR-137 inhibits expression of EZH2, thereby maintaining the
self-renewal of the neural stem cell pool, while miR-124 reduces expression of REST,
allowing for the differentiation and maturation of neurons (Shi et al., 2010). And while
the effect of arsenic on micro-RNAs has not been fully explored, especially in the context
of the brain, it has been demonstrated that arsenic may act through miR-9 to promote
abnormal angiogenesis in carcinoma cell culture studies (Bailey & Fry, 2014). It is
plausible that damage generated by arsenic exposure in the brain could be mediated by
micro-RNAs, as such, the effect of developmental arsenic exposure on micro-RNA
expression and function, particularly miR-9 and miR-124, should be investigated.
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7.4.4 Mechanisms of therapeutic interventions as a window into the toxicity of arsenic
exposure
The findings of the reversal of arsenic-induced damage after chronic fluoxetine treatment
or experience in enrichment lead to further questions on the mechanism of therapeutics
after arsenic exposure. How does enrichment impact the stress response after perinatal
arsenic exposure? Are deficits in AHN ameliorated after “normal” enrichment? How
does chronic fluoxetine impact the gene expression in arsenic-exposed animals? How
does enrichment or fluoxetine impact the expression of epigenetic modifiers or histone
modifications? Answering these questions was beyond the scope of the experiments for
this dissertation; however, understanding the mechanism of reversal of arsenic-induced
damage may be essential in characterizing how arsenic impacts the brain. For example, if
fluoxetine was found to restore proper histone acetylation in the frontal cortex after
perinatal arsenic exposure, this might lead to the use of more specific epigenetic
therapeutics, like histone deacetylase inhibitors (HDACis) for treating patients with
arsenic exposure to restore proper brain function. Indeed, the use of HDAC inhibitors for
alleviating cognitive deficits and depressive-like symptoms is gaining traction; to
demonstrate causality in arsenic-mediated alterations in histone acetylation, treatment
with an HDACi such as sodium butyrate or valproate and subsequent assessment of
cognitive function and histone acetylation would be useful.

7.4.5 The contribution of the frontal cortex in arsenic-induced depression
The studies presented in this dissertation largely focused on the damage induced by
arsenic in the dentate gyrus of the hippocampus. The frontal cortex (FC) is responsible
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for “executive functioning”, or the ability to plan, control and direct appropriate
behaviors. Deficits in FC functioning have been implicated in the etiology of depression:
the perceived lack of control over a situation and the subsequent passive behavior and
maladaptive response to stress is likely mediate through the FC in depressed patients
(Holmes & Wellman, 2009). The dentate gyrus receives inputs from the FC via the
entorhinal cortex; FC signaling may be partially responsible for sending inappropriate
messages to the dentate gyrus thereby contributing to the altered AHN after perinatal
arsenic exposure. Additionally, FC tissue was used in the histone modifications studies
for Aim 2B to demonstrate the specificity of arsenic-induced damage on the dentate
gyrus (Chapter 6). We did not expect to have findings specific to the FC; as such, these
new observations lead to the question of how arsenic impacts the behavioral,
morphological, and molecular components of the frontal cortex. It would be interesting to
assess the impact of perinatal arsenic exposure on frontal cortex function using FCspecific behavioral tasks, especially since epidemiological studies have shown an
association between arsenic-exposure and attention deficits in human populations.
Cognitive flexibility (and thus FC functioning) can be assessed using reversal learning,
attentional set shifting, or a combination of the two. In reversal learning, the animal
learns to associate a reward with certain cues and lack of a reward with a different set of
cues; after attaining the initial association, the reward and cue coupling are reversed, such
that the animal has to learn a different association for the reward. Reversal learning can
be implemented in many tasks for working memory like the 8-way radial arm or spatial
memory like the Morris Water Maze. However, the use of these behaviors requires
hippocampal functioning; therefore, it would be more appropriate to assess reversal
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learning in a different context, for example in a buried food pellet test or in a Y-maze.
The ability to shift attention from one set of cues to another for proper reversal learning is
predominately mediated by the frontal cortex; assessing this behavior in the arsenicexposed animals would provide useful information as to the effect of perinatal arsenic
exposure on frontal cortex functioning. Additionally, prefrontal cortex neurons have been
shown to be highly sensitive to stress and undergo synaptic remodeling. Assessment of
dendritic arborizations or synapses in the FC (using either IHC or western blotting for
PSD-95), if the behavioral deficits are found, would provide another piece of evidence
demonstrating FC dysfunction in this toxin exposure model.

7.4.6 Are female mice resistant to arsenic toxicity?
Experiments from Aim 2B are the first to suggest that perinatal arsenic exposure
preferentially impacts protein expression in adult males and that adult female mice may
be more resilient to arsenic toxicity. Indeed, this discrepancy among sex is common in
toxin exposures, particularly when the HPA axis is involved. As such, new questions as
to the effect of arsenic on females, including behavioral, morphological, and molecular
outcomes are raised from these findings. Thus, future studies on the impact of perinatal
arsenic exposure, particularly during embryonic development, should include females. A
previous finding from the Allan lab determined that female mice perinatally exposed to
arsenic exhibit depressive-like behavior in a stressful learned helplessness task. Thus, it
would be useful to characterize the depressive-like endophenotype in female offspring in
greater detail, as females are preferentially impacted by depression in the human
population.
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7.5 Summary
The studies outlined in this dissertation were designed to determine if adult hippocampal
neurogenesis is a candidate mechanism by which perinatal arsenic exposure induces
greater risk of developing depression in adulthood. The experiments initially sought to
determine the behavioral and morphological damage imparted by perinatal arsenic
exposure on the hippocampus. In this way, experiments performed characterized stressinduced depression as a behavioral endophenotype of perinatal arsenic exposure in adult
male mice and ascertained the potential reversibility of depressive-like behavior using
pharmacotherapy

and

environmental

enrichment.

Concurrent

measurement

of

proliferation, differentiation, and survival of neural progenitor cells in the dentate gyrus
was assessed, providing greater evidence of the connection between aberrant AHN and
depression. Additionally, reversal of these morphological deficits using two different
therapeutic methods demonstrates the potential transient nature of arsenic-induced
hippocampal damage and provides insight suggesting that an intact progenitor niche may
afford the efficacy of antidepressant treatment. Further studies were developed to
determine the epigenetic mechanism by which arsenic impairs adult hippocampal
neurogenesis; dentate-gyrus specific alteration of gene expression specifically associated
with neurogenesis provided information demonstrating the potential opposing genetic
programs of progenitor maintenance and neuronal maturation. Increased expression of
active transcriptional histone modifications were found in arsenic-exposed adult males,
along with aberrant expression of particular chromatin-modifying proteins. Subsequent
analysis of an active transcriptional mark on gene expression, specifically in the dentate
gyrus, will further provide evidence of genes up-regulated in response to developmental
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arsenic exposure. It is possible that increased expression of certain genes in the dentate
gyrus may inadvertently impact adult neurogenesis by promoting self-renewal and
maintenance over maturation of neural progenitor cells, leading to deficits in AHN and
increased depressive-like symptoms. However, further studies elucidating the causality of
this potential mechanism are required. Overall, results provided in this dissertation imply
that toxin exposure to an environmentally-relevant dose of arsenic that is present in nonmunicipal areas, rural well water, and in developed and developing countries alike, can
have a profound impact on brain structure and signaling, leading to increased
susceptibility to psychiatric disorders, such as depression. This may provide implications
for either 1) alterations in water treatment regimens or 2) regulation of arsenic exposure
from multiple sources.
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A8: Chromatin Immunoprecipitation for Dentate Gyrus
To our knowledge, chromatin immunoprecipitation on the mouse dentate gyrus has not
been performed to date. Since we observed changes in gene expression and histone
modifications specifically in the dentate gyrus, assessment of the occupancy for particular
histone modifications (H3K4me3) on genes in the dentate gyrus was determined via
ChIP-Seq. The following is the protocol developed for ChIP on dentate gyrus tissue
derived from adult male mice PD70.
Chromatin immunoprecipitation.
Dentate gyrus tissue obtained from adult male mice was homogenized in a Biomasher II
disposable microhomogenizer (Kimble Chase) using a 1% formaldehyde crosslinking
solution (1% formaldehyde, 1 mM EDTA, 0.5 mM EGTA, 50 mM HEPES, pH 8.0) for
15 minutes. Reagents from the ChIP-IT® Express Chromatin Immunoprecipitation Kits
from Active Motif (53008) were used for some steps in the protocol. A 1X Glycine
solution (Active Motif) was added to each reaction for 5 min. Homogenates were
centrifuged at 1000 × g for 6 min at 4°C and washed with 1X PBS containing 1 µg/µl
protease inhibitor cocktail (Sigma, P8340). Cell pellets were resuspended in cell lysis
buffer containing 0.5% Triton-X 100 (v/v), 85 mM KCl, 5 mM HEPES, and 2 µg/µl
protease inhibitor cocktail and allowed to sit on ice for 30 min. Cells were centrifuged as
before, resuspended in cell lysis buffer, and repelleted as before. The pellet was
resuspended in nuclear lysis buffer containing 50 mM Tris, 10 mM EDTA, 1% SDS, and
2 µg/µl protease inhibitor cocktail. Crosslinked chromatin was sheared via sonication.
Samples were sonicated 10 times for 10 s with 2 min on ice in between rounds to yield
approximately 300-500 base pair chromatin. The size of the chromatin was determined
using 10 uL of sample treated with 10 mg/ml proteinase K for 45 min at 50°C and run on
1.5% (w/v) agarose gel for 45 min. See Figure A.8.1. Samples were centrifuged at 14,000
× g for 10 min at 4°C. At this point, the supernatant was snap frozen and stored at -80°C.
The antibody of interest was incubated with magnetic beads for 4 hours at 4°C prior to
the IP. ChIP-ready 800 µg chromatin was incubated overnight with magnetic beads
(Active Motif) and the antibody of interest (RNA Polymerase II (Qiagen, GAM-111),
H3K4me3 (Millipore 04-745) or IgG (Qiagen, GAM-8208). A small fraction of the
chromatin was saved as input DNA. The following day, samples were washed at 4°C and
the DNA eluted using the ChIP DNA Purification Kit from Active Motif (58002).
Library Preparation and ChIP-Seq
Library preparation of H3K4me3 immunoprecipitated DNA from two control and two
arsenic samples was performed by Epigenome Center at the University of Southern
California. Libraries were quantitated and size distribution determined using a Qubit
fluorometer and an Agilent 2100 Bioanalyzer, respectively. Sequencing was performed
using the on an Illumina Hi-Seq platform at the University of Southern California using
50 single end reads. Data quantification and analysis is currently underway.
The following table provides some information concerning the parameters of the
chromatin immunoprecipitation protocol, including tissue type and amount used,
preparation, chromatin amount, antibody type and concentration, and IP volume.
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Table A8. Chromatin immunoprecipitation optimization
Tissue

Conc. Of
Chromat
in (ug/ul)

Chroma
tin Used
(ug)

Total
Volume
of IP
(ul)

Antibod
y Type

Amt Ab
used
(ul)

Magneti
c beads
(ul)

DNA
conc.
(ug/ul)

Total
DNA

Preparation

2DG

0.60

100

341

5

25

0.0604

3.02

Tyler

2 DG

1.00

50

127

5

25

0.05

2.5

Active Motif

3 DG

0.66

200

611

8

50

0.14

7

Tyler

6 DG

0.74

200

552

Active
Motif
Active
Motif
Active
Motif
Millipore

8

50

0.29

14.5

Tyler

3/6 DG

0.70

116

335

Millipore

5

25

0.107

5.35

Tyler

2 HIPP

1.94

700

450

Millipore

10

50

1.83

82.35

Active motif

4 HIPP

9.80

500

200

8

50

4.94

247

Active motif

4 HIPP

1.00

50

200

5

25

0.0324

1.62

Tyler

4 HIPP

9.80

500

200

8

50

7.62

381

Tyler/Active motif

6 DG

2.03

700

450

Active
Motif
Active
Motif
Active
Motif
Millipore

10

50

1.29

58.05

Tyler/Active motif

12 DG

13.88

700

150

Millipore

10

50

3.83

172.35

Tyler/Active motif

A

B

Figure A8.1. Agarose gel stained with ethidium bromide to demonstrated size of DNA in ChIP with
1kb DNA ladder. A) Hippocampal tissue with either 10 (lane 1) or 12 (lane 2) rounds of sonication,
and B) Dentate gyrus tissue from arsenic (lane 1) or control (lane 2) with 12 rounds of sonication.

Antibody validation was performed using input DNA and the antibodies IgG and
H3K4me3 (Qiagen) on hippocampal tissue for the genes Gapdh and Myod1. H3K4me3,
an activation histone modification, should be present in sufficient quantities for detection
in Gapdh (positive control) but not on Myod1 (negative control). An IgG antibody is used
as a negative control for this validation. Figure A8.2 shows lower CT values (greater
DNA expression) of Gapdh for the H3K4me3 ChIP (blue) compared to the IgG ChIP
(green). Figure A.8.3 shows higher CT values (less DNA expression) of Myod1 for the
H3K4me3 ChIP (blue) compared to the IgG ChIP (green).
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Appendix A8 Continued:

Figure A8.2. Cycle threshold plots for Input DNA (red), H3K4me3 (blue), and IgG (green) for Gapdh
produced via qRT-PCR via hippocampal tissue.

Figure A8.3. Cycle threshold plots for Input DNA (red), H3K4me3 (blue), and IgG (green) for Myod1
produced via qRT-PCR via hippocampal tissue.
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Abbreviations Used
5HTA1
ACTH
AHN
AML
APL
BDNF
BrdU
CARM1
CBP
ChIP-Seq
CNS
CORT
CREB
CRH
DAE
DAT
DCX
DEX
DG
DNMT
DSM-V
ECS
EE
EPA
FC
Fgf1
FST
GCL
GR
GSH
GWAS
H3K27me3
H3K4me3
HAT
HDAC
HDACi
HPA
HPTM
iAs

serotonin 1A receptor
adrenocorticotropic hormones
adult hippocampal neurogenesis
acute myeloid leukemia
acute promyelocytic leukemia
brain-derived neurotrophic factor
bromodeoxyuridine
cofactor associated arginine methyltransferase
CREB binding protein
chromatin-immunoprecipitation followed by next generation sequencing
central nervous system
corticosterone
cAMP response element binding protein,
adrenocorticotrophin releasing hormone
developmental arsenic expousre
dopamine transporter
doublecortin
dexamethasone
dentate gyrus
the DNA methyltransferases
Diagnostic and Statistical Manual of Mental Disorders, version 5
Electroconvulsive seizure therap
experience in enrichment; environmental enrichment
Environmental Protection Agency
frontal cortex
fibroblast growth factor 1
forced swim task
granule cell layer
glucocorticoid receptor
glutathione
genome-wide association studies
histone 3 lysine 27 trimethylation
histone 3 lysine 4 trimethylation
histone acetyltransferase
histone deacetylase
histone deacetylase inhibitor
hypothalamic-pituitary-adrenal
histone posttranslational modifications
inorganic arsenic
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LH
MAOi
MAPK
Mdb1
MDD
MeCP2
MLL
MR
MWM
NaB
NET
NIMH
NPCs
NRSF
NSC
OFT
PAE
PCAF
PcG
PD
PBMCs
PMSF
ppb
ppm
PRC1
PRC2
PRMT
PVN
REST
SAHA
SAM
SEM
SERT
SIRT
SNPs
SSRI
TAPs
TCA
TrxG
TST
WHO

learned helplessness task
monoamine oxidase inhibitors
Mitogen-activated protein kinase
methyl CpG binding protein 1
major depressive disorder
methyl CpG binding protein 2
Mixed lineage leukemia factor
mineralocorticoid receptors
Morris water maze
sodium butyrate
norepinephrine transporter
National Institutes of Mental Health
neural progenitor cells
neuron restrictive silencing factor
neural stem cells
open field test
perinatal arsenic exposure
P300/CBP-associated factor
polycomb group
postnatal day
peripheral blood mononuclear cells
phenylmethylsulfonyl fluoride
parts-per-billion
parts-per-million
polycomb repressive complex 1
polycomb repressive complex 2
protein arginine methyltransferase
paraventricular nucleusof the hypothalamus
RE1-Silencing Transcription factor
suberoylanilide hydroxamic acid
s-adenosyl methionine
standard error of the mean
serotonin transporter
sirtuin deacetylase proteins
single nucleotide polymorphisms
selective serotonin reuptake inhibitors
transiently amplifying cells
tricyclic antidepressant
trithorax group
tail suspension test
World Health Organization
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